Libraries of expressible gene sequences

Information

  • Patent Application
  • 20030134302
  • Publication Number
    20030134302
  • Date Filed
    August 01, 2002
    21 years ago
  • Date Published
    July 17, 2003
    20 years ago
Abstract
The invention described herein comprises libraries of expressible gene sequences. Such gene sequences are contained on plasmid vectors designed to endow the expressed proteins with a number of useful features such as affinity purification tags, epitope tags, and the like. The expression vectors containing such gene sequences can be used to transfect cells for the production of recombinant proteins. A further aspect of the invention comprises methods of identifying binding partners for the products of such expressible gene sequences.
Description


FIELD OF THE INVENTION

[0002] The invention disclosed herein relates to the fields of genomics and molecular biology. More specifically the invention relates to libraries of expressible gene sequences and recombinant cells transfected therewith.



BACKGROUND OF THE INVENTION

[0003] Recent breakthroughs in nucleic acid sequencing technology have made possible the sequencing of entire genomes from a variety of organisms, including humans. The potential benefits of a complete genome sequence are many, ranging from applications in medicine to a greater understanding of evolutionary processes. These benefits cannot be fully realized, however, without an understanding of how and where these newly sequenced genes function.


[0004] Traditionally, functional understanding started with recognizing an activity, isolating a protein associated with that activity, then identifying and isolating the gene, or genes, encoding that protein. Each gene of interest was identified, isolated and expressed separately, a relatively time consuming process.


[0005] Recently, breakthroughs in high through-put DNA sequencing technology have allowed massive amounts of gene sequence information to become available to the public. Yet methods of expressing these sequences to produce the proteins encoded by them for study have still required that each sequence be manipulated one at a time. Accordingly, a need exists for large numbers of expressible gene sequences. The invention described herein addresses this and related needs as will become apparent upon inspection of the specification and the appended claims.



BRIEF DESCRIPTION OF THE INVENTION

[0006] The present invention comprises libraries of expressible gene sequences. Such gene sequences are contained on plasmid vectors designed to endow the expressed proteins with a number of useful features such as affinity purification tags, epitope tags, and the like. The expression vectors containing such gene sequences can be used to transfect cells for the production of recombinant proteins.


[0007] A further aspect of the invention comprises methods of identifying binding partners for the products of such expressible gene sequences.







BRIEF DESCRIPTION OF THE FIGURES

[0008]
FIG. 1 shows a schematic representation of the vaccinia topoisomerase type I cloning method used in the practice of the invention method.







DETAILED DESCRIPTION OF THE INVENTION

[0009] The present invention comprises libraries of expressible gene sequences. Such gene sequences are contained on expression vectors which can be useful for transfecting cells and producing recombinant proteins. The expression vectors may additionally contain sequences that will endow the expressed proteins with a variety of useful features, such as peptides that aid in purification, epitope tags useful in identifying recombinant protein, and the like.


[0010] The libraries of the invention are created by employing a high through-put methodology comprised of several steps. In the first step, the gene sequences that are to be expressed are amplified. By “amplification” it is meant that the copy number of the gene sequence(s) is increased. One commonly used method of amplification is the polymerase chain reaction (PCR). In brief, starter DNA is heat-denatured into single strands. Two synthetic oligonucleotides, one complementary to sequence at the 3′ end of the sense strand of DNA segment of interest and the other complementary to the sequence at the 3′ end of the anti-sense strand of a DNA segment of interest, are added in excess to the DNA sequence to be amplified and the temperature is lowered to 50-60° C. The specific oligonucleotides hybridize with the complementary sequences in the DNA and then serve as primers of DNA chain synthesis, which requires the addition of a supply of deoxynucleotidesand a temperature-resistant DNA polymerase, such as Taq polymerase, which can extend the primers at temperatures up to 72° C. When synthesis is complete, the whole mixture is heated further (up to 95° C.) to melt the newly formed DNA duplexes. When the temperature is lowered again, another round of synthesis takes place, since an excess of primer should still be present. Repeated cycles of synthesis and melting quickly amplify the sequence of interest. A more detailed description of PCR can be found in Erlich, Ed, PCR Technology: Principles and Applications for DNA Amplification, W. H. Freeman and Co., 1992 and Erlich, et al., Eds, Polymerase Chain Reaction, Cold Spring Harbor Laboratory, 1989, both of which are incorporated by reference herein.


[0011] Starter DNA can come from a variety of sources. It can be total genomic DNA from an organism, for example, or can be cDNA that has been synthesized from cellular mRNA using reverse transcriptase. Genomic DNA and cDNA are distinguished in that genomic DNA contains introns, DNA which is spliced out during post-transcriptional RNA processing and cDNA does not. Sources of suitable RNA include normal and diseased tissues, cellular extracts, and the like.


[0012] The desired gene sequences can come from any source. The examples presented below show the amplification of all open reading frames (ORFs) from a single organism, Saccharomyces cerevisiae, for example. By “open reading frame” it is meant a segment of DNA that exists between a start codon and a stop codon and is likely to represent a gene. An open reading frame is also sometimes called a coding region to indicate that it contains only those nucleic acids that actually encode a protein. The examples presented below further show the amplification of a group of human genes thought to be important in the development of cancer.


[0013] Public databases exist that contain the entire or partial genome of a particular organism, for example yeast (Saccharomyces cerevisiae), prokaryotes (Bacillus subtilis, E. coli, Borrelia burgdorferi, Helicobacter pylori, Mycoplasma genitalium, and the like), fish (Fugu rubripes), mammals (human, mouse), plants (rice, cotton) and the like. Well known databases include GenBank, Unigene, EMBL, IMAGE and TIGR, for example. Public databases such as these can be used a source of gene sequences for use in the method of the invention. Such DNA sequence databases generally give each unique sequence an identifying number, such as a GenBank accession number. Generally, the organization creating and maintaining the database provides software tools for searching the database files for a particular record, such as by accession number, name, or sequence.


[0014] The primers employed in the amplification step are specific for each desired gene sequence and include a variety of unique features. For example, the 5′ “sense” primer starts with the sequence 5′-CACCATG . . . (the start codon is underlined). The CACC sequence is added as a Kozak consensus that aids in translational efficiency. When the gene sequence being amplified represents a full-length gene, the 3′ “antisense” codon is designed to make the amplification product end at the 3rd position of the last codon of the gene being amplified, plus a single adenine residue. This facilitates the fusion of the coding region in-frame with a heterologous peptide sequence such as an epitope tag, an affinity purification tag, and the like (see below). The sequence specific primers used in the practice of the invention are designed to prime sequence between the start and stop codon of an open reading frame. The use of such primers will produce a specific coding region that can be further processed according to the methods disclosed herein. Methods of designing sequence specific primers are well known in the art.


[0015] The gene sequence need not encode a full-length sequence, however, as the invention methods are equally suitable for any gene sequence, including Expressed Sequence Tags (ESTs). The primers can be synthesized and dried in multiwell formats, such as 96-well microtiter plates to facilitate identification and further processing.


[0016] The amplified gene products are next isolated from the other components of the amplification reaction mixture. This purification can be accomplished using a variety of methodologies such as column chromatography, gel electrophoresis, and the like. A preferred method of purification utilizes low-melt agarose gel electrophoresis. The reaction mixture is separated and visualized by suitable means, such as ethidium bromide staining. DNA bands that represent correctly sized amplification products are cut away from the rest of the gel and placed into appropriate corresponding wells of a 96-well microtiter plate. These plugs are subsequently melted and the DNA contained therein utilized as cloning inserts. The use of gel electrophoresis has the advantage that the practitioner can purify the desired amplified gene sequence while additionally verifying that the sequence is of the correct size, i.e., represents the entire desired gene sequence.


[0017] The purified, amplified gene sequences are next inserted into an expression vector. A variety of expression vectors are suitable for use in the practice of the present invention, both for prokaryotic expression and eukaryotic expression. In general, the expression vector will have one or more of the following features: a promoter-enhancer sequence, a selection marker sequence, an origin of replication, an affinity purification tag sequence, an inducible element sequence, an epitope-tag sequence, and the like.


[0018] Promoter-enhancer sequences are DNA sequences to which RNA polymerase binds and initiates transcription. The promoter determines the polarity of the transcript by specifying which strand will be transcribed. Bacterial promoters consist of consensus sequences, −35 and −10 nucleotides relative to the transcriptional start, which are bound by a specific sigma factor and RNA polymerase. Eukaryotic promoters are more complex. Most promoters utilized in expression vectors are transcribed by RNA polymerase II. General transcription factors (GTFs) first bind specific sequences near the start and then recruit the binding of RNA polymerase II In addition to these minimal promoter elements, small sequence elements are recognized specifically by modular DNA-binding/trans-activating proteins (eg. AP-1, SP-1) which regulate the activity of a given promoter. Viral promoters serve the same function as bacterial or eukaryotic promoters and either provide a specific RNA polymerase in trans (bacteriophage T7) or recruit cellular factors and RNA polymerase (SV40, RSV, CMV) Viral promoters are preferred as they are generally particularly strong promoters.


[0019] Promoters may be, furthermore, either constitutive or, more preferably, regulatable (i.e., inducible or derepressible). Inducible elements are DNA sequence elements which act in conjunction with promoters and bind either repressors (eg. lacO/LAC Iq repressor system in E. coli) or inducers (eg. gal1/GAL4 inducer system in yeast). In either case, transcription is virtually “shut off” until the promoter is derepressed or induced, at which point transcription is “turned-on”.


[0020] Examples of constitutive promoters include the int promoter of bacteriophage λ, the bla promoter of the β-lactamase gene sequence of pBR322, the CAT promoter of the chlorampheicol acetyl transferase gene sequence of pPR325, and the like. Examples of inducible prokaryotic promoters include the major right and left promoters of bacteriophage (PL and PR), the trp, reca, lacZ, LacI, AraC and gal promoters of E. coli, the α-amylase (Ulmanen Ett at., J. Bacteriol. 162:176-182, 1985) and the sigma-28-specific promoters of B. subtilis (Gilman et al., Gene sequence 32:11-20(1984)), the promoters of the bacteriophages of Bacillus (Gryczan, In: The Molecular Biology of the Bacilli, Academic Press, Inc., NY (1982)), Streptomyces promoters (Ward et at., Mol. Gen. Genet. 203:468-478, 1986), and the like. Exemplary prokaryotic promoters are reviewed by Glick (J. Ind. Microtiot. 1:277-282, 1987); Cenatiempo (Biochimie 68:505-516, 1986); and Gottesman (Ann. Rev Genet. 18:415442, 1984).


[0021] Preferred eukaryotic promoters include, for example, the promoter of the mouse metallothionein I gene sequence (Hamer et al., J. Mol. Appl. Gen. 1:273-288, 1982); the TK promoter of Herpes virus (McKnight, Cell 31:355-365, 1982); the SV40 early promoter (Benoist et al., Nature (London) 290:304-310, 1981); the yeast gal1 gene sequence promoter (Johnston et al., Proc. Natl. Acad. Sci. (USA) 79:6971-6975, 1982); Silver et al., Proc. Natl. Acad. Sci. (USA) 81:5951-5955, 1984), the CMV promoter, the EF-1 promoter, Ecdysone-responsive promoter(s), and the like.


[0022] Selection marker sequences are valuable elements in expression vectors as they provide a means to select, for growth, only those cells which contain a vector. Such markers are of two types: drug resistance and auxotrophic. A drug resistance marker enables cells to detoxify an exogenously added drug that would otherwise kill the cell. Auxotrophic markers allow cells to synthesize an essential component (usually an amino acid) while grown in media which lacks that essential component.


[0023] Common selectable marker gene sequences include those for resistance to antibiotics such as ampicillin, tetracycline, kannamycin, bleomycin, streptomycin, hygromycin, neomycin, Zeocin™, and the like. Selectable auxotrophic gene sequences include, for example, hisD, which allows growth in histidine free media in the presence of histidinol.


[0024] A preferred selectable marker sequence for use in yeast expression systems is URA3. Laboratory yeast strains carrying mutations in the gene which encodes orotidine-5′-phosphate decarboxylase, an enzyme essential for uracil biosynthesis, are unable to grow in the absence of exogenous uracil. A copy of the wild-type gene (ura4+ in S. pombe and URA3 in S. cerevisiae) will complement this defect in trans.


[0025] A further element useful in an expression vector is an origin of replication sequence. Replication origins are unique DNA segments that contain multiple short repeated sequences that are recognized by multimeric origin-binding proteins and which play a key role in assembling DNA replication enzymes at the origin site. Suitable origins of replication for use in expression vectors employed herein include E. coli oriC, 2 μ and ARS (both useful in yeast systems), sf1, SV40 (useful in mammalian systems), and the like.


[0026] Additional elements that can be included in an expression vector employed in accordance with the present invention are sequences encoding affinity purification tags or epitope tags. Affinity purification tags can are generally peptide sequences that can interact with a binding partner immobilized on a solid support. Synthetic DNA sequences encoding multiple consecutive single amino acids, such as histidine, when fused to the expressed protein, may be used for one-step purification of the recombinant protein by high affinity binding to a resin column, such as nickel sepharose. An endopeptidase recognition sequence can be engineered between the polyamino acid tag and the protein of interest to allow subsequent removal of the leader peptide by digestion with Enterokinase, and other proteases. Sequences encoding peptides such as the chitin binding domain (which binds to chitin), glutathione-S-transferase (which binds to glutathione), biotin (which binds to avidin and strepavidin), and the like can also be used for facilitating purification of the protein of interest. The affinity purification tag can be separated from the protein of interest by methods well known in the art, including the use of inteins (protein self-splicing elements, Chong, et al, Gene 192:271-281, 1997).


[0027] Epitope tags are short peptide sequences that are recognized by epitope specific antibodies. A fusion protein comprising a recombinant protein and an epitope tag can be simply and easily purified using an antibody bound to a chromatography resin. The presence of the epitope tag furthermore allows the recombinant protein to be detected in subsequent assays, such as Western blots, without having to produce an antibody specific for the recombinant protein itself. Examples of commonly used epitope tags include V5, glutathione-S-transferase (GST), hemaglutinin (HA), the peptide Phe-His-His-Thr-Thr, chitin binding domain, and the like.


[0028] A further useful element in an expression vector is a multiple cloning site or polylinker. Synthetic DNA encoding a series of restriction endonuclease recognition sites is inserted into a plasmid vector downstream of the promoter element. These sites are engineered for convenient cloning of DNA into the vector at a specific position.


[0029] The foregoing elements can be combined to produce expression vectors useful in creating the libraries of the invention. Suitable prokaryotic vectors include plasmids such as those capable of replication in E. coil (for example, pBR322, ColE1, pSC101, PACYC 184, itVX, pRSET, pBAD (Invitrogen, Carlsbad, Calif.) and the like). Such plasmids are disclosed by Sambrook (cf. “Molecular Cloning: A Laboratory Manual”, second edition, edited by Sambrook, Fritsch, & Maniatis, Cold Spring Harbor Laboratory, (1989)). Bacillus plasmids include pC194, pC221, pT127, and the like, and are disclosed by Gryczan (In: The Molecular Biology of the Bacilli, Academic Press, NY (1982), pp. 307-329). Suitable Streptomyces plasmids include plJlOl (Kendall et al., J. Bacteriol. 169:4177-4183,1987), and streptomyces bacteriophages such as φC31 (Chater et al., In: Sixth International Symposium on Actinomycetales Biology, Akaderiiai Kaido, Budapest, Hungary (1986), pp. 45-54). Pseudomonas plasmids are reviewed by John et al. (Rev. Infect. Dis. 8:693-704, 1986), and Izaki (Jpn. J. Bacteriol. 33:729-742, 1978).


[0030] Suitable eukaryotic plasmids include, for example, BPV, vaccinia, SV40, 2-micron circle, pcDNA3.1, pcDNA3.I/GS, pYES2/GS, pMT, p IND, pIND(Sp1), pVgRXR (Invitrogen), and the like, or their derivatives. Such plasmids are well known in the art (Botstein et al., Miami Wntr. Symp. 19:265-274, 1982; Broach, In: “The Molecular Biology of the Yeast Saccharomyces: Life Cycle and Inheritance”, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y., p. 445-470, 1981; Broach, Cell 28:203-204, 1982; Dilon et at., J. Clin. Hematol. Oncol. 10:39-48, 1980; Maniatis, In: Cell Biology: A Comprehensive Treatise, Vol. 3, Gene Sequence Expression, Academic Press, NY, pp. 563-608,1980.


[0031] Construction of chimaeric DNA molecules in vitro relies traditionally on two enzymatic steps catalyzed by separate protein components. PCR amplification or site-specific restriction endonucleases are used to generate linear DNAs with defined termini that can then be joined covalently at their ends via the action of DNA ligase. DNA ligase has limitations, however, in that it is relatively slow acting and temperature sensitive.


[0032] Thus, when inserting the purified, amplified gene sequence into the expression vector the use of an enzyme that can both cleave and religate DNA in a site specific manner is preferred. Any site-specific enzyme of this type is suitable, for example, a type I topoisomerase or a site-specific recombinase. Examples of suitable site-specific recombinases include lambda integrase, FLP recombinase, P1-Cre protein, Kw recombinase, and the like (Pan, et al, J. Biol. Chem. 268:3683-3689, 1993; Nunes-Duby, et al, EMBO J. 13:4421-4430, 1994; Hallet and Sherratt, FEMS Microbio. Revs 21:157-178, 1997; Ringrose, et al, Eur J. Biochem 248:903-912, 1997).


[0033] A particularly suitable enzyme for use in creating the libraries of the invention is a type I topoisomerase, particularly vaccinia DNA topoisomerase. Vaccinia DNA topoisomerase binds to duplex DNA and cleaves the phosphodiester backbone of one strand. The enzyme exhibits a high level of sequence specificity, akin to that of a restriction endonuclease. Cleavage occurs at a consensus pentapyrimidine element 5′-(C/T)CCTT in the scissile strand. In the cleavage reaction, bond energy is conserved via the formation of a covalent adduct between the 3′ phosphate of the incised strand and a tyrosyl residue of the protein. Vaccinia topoisomerase can religate the covalently held strand across the same bond originally cleaved (as occurs during DNA relaxation) or it can religate to a heterologous acceptor DNA and thereby create a recombinant molecule.


[0034] When the substrate is configured such that the scissile bond is situated near (within 10 basepairs of) the 3′ end of a DNA duplex, cleavage is accompanied by the spontaneous dissociation of the downstream portion of the cleaved strand. The resulting topoisomerase-DNA complex, containing a 5′ single-stranded tail, can religate to an acceptor DNA if the acceptor molecule has a 5′ OH tail complementary to that of the activated donor complex.


[0035] In accordance with the present invention, this reaction has been optimized for joining PCR-amplified DNA fragments into plasmid vectors (See FIG. 1). PCR fragments are naturally good surrogate substrates for the topoisomerase I religation step because they generally have 5′ hydroxyl residues from the primers used for the amplification reaction. The 5′ hydroxyl is the substrate for the religation reactions. The use of vaccinia topoisomerase type I for cloning is described in detail in copending U.S. patent application Ser. No. 08/358,344, filed Dec. 19, 1994, incorporated by reference herein in its entirety.


[0036] The gene sequence being inserted into the expression vector can insert in either the sense or antisense direction. Therefore, the creation of a useful library should include verification of both the size and orientation of the insert to insure that the gene sequence will express the desired protein. Preferably, the insert plus vector is utilized in a standard bacterial transformation reaction and the contents of the transformation plated onto a selective growth media. Bacterial transformation and growth selection procedures are well known in the art and described in detail in, for example, Ausubel, et al, Short Protocols in Molecular Biology, 3rd ed. 1995.


[0037] Individual bacterial colonies are picked and grown in individual wells of a 96 well microtiter plate containing selective growth media. An aliquot of these cells is used directly in a diagnostic PCR reaction. Primers for this reaction are designed such that only plasmids with correctly oriented inserts give amplification product. The amplified DNA is separated and visualized by SDS-PAGE gel electrophoresis using standard protocols (see Ausubel, et al, Short Protocols in Molecular Biology, 3rd ed. 1995).


[0038] Performing the PCR reaction directly from the cultured cell lysates, rather than first preparing DNA from the bacteria, is a particular advantage as it significantly reduces both the time needed to generate the required data and the cost of doing so.


[0039] Once plasmids containing the gene sequence insert in the correct orientation have been identified, plasmid DNA is prepared for use in the transformation of host cells for expression Methods of preparing plasmid DNA and transformation of cells are well known to those skilled in the art. Such methods are described, for example, in Ausubel, et al, supra.


[0040] Prokaryotic hosts are, generally, very efficient and convenient for the production of recombinant proteins and are, therefore, one type of preferred expression system. Prokaryotes most frequently are represented by various strains of E. coli. However, other organisms may also be used, including other bacterial strains.


[0041] Recognized prokaryotic hosts include bacteria such as E. coli and those from genera such as Bacillus, Streptomyces, Pseudomonas, Salmonella, Serratia, and the like. However, under such conditions, the polypeptide will not be glycosylated. The prokaryotic host selected for use herein must be compatible with the replicon and control sequences in the expression plasmid.


[0042] Suitable hosts may often include eukaryotic cells. Preferred eukaryotic hosts include, for example, yeast, fungi, insect cells, and mammalian cells either in vivo, or in tissue culture. Mammalian cells which may be useful as hosts include HeLa cells, cells of fibroblast origin such as VERO, 3T3 or CHOK1, HEK 293 cells or cells of lymphoid origin (such as 32D cells) and their derivatives. Preferred mammalian host cells include nonadherent cells such as CHO, 32D, and the like. Preferred yeast host cells include S. pombe, Pichia pastoris, S. cerevisiae (such as INVSc1), and the like.


[0043] In addition, plant cells are also available as hosts, and control sequences compatible with plant cells are available, such as the cauliflower mosaic virus 35S and 19S, nopaline synthase promoter and polyadenylation signal sequences, and the like. Another preferred host is an insect cell, for example the Drosophila larvae. Using insect cells as hosts, the Drosophila alcohol dehydrogenase promoter can be used. Rubin, Science 240:1453-1459, 1988). Alternatively, baculovirus vectors can be engineered to express large amounts of peptide encoded by a desire gene sequence in insects cells (Jasny, Science 238:1653, 1987); Miller et al., In: Genetic Engineering (1986), Setlow, J. K., et al., eds., Plenum, Vol. 8, pp. 277-297). The present invention also features the purified, isolated or enriched versions of the expressed gene products produced by the methods described above.


[0044] Kits comprising one or more containers or vials containing components for using the libraries of the present invention are also within the scope of the invention. Kits can comprise any one or more of the following elements: one or more expressible gene sequences, cells which are, or can be, transfected with such gene sequences, and antibodies recognizing the expressed gene product or an epitope tag associated therewith. Cells suitable for inclusion in such a kit include bacterial cells, yeast cells (such as INVSc1), insect cells or mammalian cells (such as CHO).


[0045] In one embodiment, such a kit comprises a detergent solution, preferably the Trax® lysing reagent (6% NP-40 and 9% Triton X-100 in 1×PBS). Also included in the kit can be one or more binding partners, e.g., an antibody or antibodies, preferably a pair of antibodies to the same expressed gene product, which preferably do not compete for the same binding site on the expressed gene product.


[0046] In another embodiment, a kit comprises more than one pair of such antibodies or other binding partners, each pair directed against a different target molecule, thus allowing the detection or measurement of a plurality of such target molecules in a sample. In a specific embodiment, one binding partner of the kit may be pre-adsorbed to a solid phase matrix, or alternatively, the binding partner and matrix are supplied separately and the attachment is performed as part of the assay procedure. The kit preferably contains the other necessary washing reagents well-known in the art. For EIA, the kit contains the chromogenic substrate as well as a reagent for stopping the enzymatic reaction when color development has occurred. The substrate included in the kit is one appropriate for the enzyme conjugated to one of the antibody preparations. These are well-known in the art The kit can optionally also comprise a target molecule standard; i.e., an amount of purified target molecule that is the target molecule being detected or measured.


[0047] In a specific embodiment, a kit of the invention comprises in one or more containers: (1) a solid phase carrier, such as a microtiter plate coated with a first binding partner; (2) a detectably labeled second binding partner which binds to the same expressed gene product as the first binding partner; (3) a standard sample of the expressed gene product recognized by the first and second binding partners; (4) concentrated detergent solution; and (5) optionally, diluent.


[0048] In another embodiment, the invention features methods of screening cells for binding partners of an expressed gene product of the invention. By “natural binding partner” it is meant a molecule that interacts specifically with the expressed gene product. Binding partners include ligands, agonists, antagonists and downstream signaling molecules such as adaptor proteins and may be identified by techniques well known in the art such as co-immunoprecipitation or by using, for example, a two-hybrid screen. (Fields and Song, U.S. Pat. No. 5,283,173, issued Feb. 1, 1994 and, incorporated be reference herein.).


[0049] Binding partners contemplated by the invention may additionally be antibodies. The term “antibody” is used herein in the broadest sense and specifically includes intact monoclonal antibodies, polyclonal antibodies, multispecific antibodies (e g bispecific antibodies) formed from at least two intact antibodies, and antibody fragments, including single chain antibodies, so long as they exhibit the desired binding properties as described herein Various procedures well-known in the art may be used for the production of polyclonal antibodies to an epitope or antigen of interest. A host animal of any of a number of species, such as rabbit, goat, sheep, horse, cow, mice, rat, etc. is immunized by injection with an antigenic preparation which may be derived from cells or microorganisms, or may be recombinantly or synthetically produced. Various adjuvants well known in the art may be used to enhance the production of antibodies by the immunized host, for example, Freund's adjuvant (complete and incomplete), mineral gels such as aluminum hydroxide, surface active substances such as lysolecithin, pluronic polyols, polyanions, peptides, oil emulsions, keyhole limpet hemocyanins, dinitrophenol, liposomes, potentially useful human adjuvants such as BCG (Bacille Calmette-Guerin) and Propionibacterium acanes, and the like.


[0050] The term “monoclonal antibody” as used herein refers to an antibody obtained from a population of substantially homogeneous antibodies, i.e., the individual antibodies comprising the population are identical except for possible naturally occurring mutations that may be present in minor amounts. Monoclonal antibodies are highly specific, being directed against a single antigenic site. Furthermore, in contrast to conventional (polyclonal) antibody preparations which typically include different antibodies directed against different determinants (epitopes), each monoclonal antibody is directed against a single determinant on the antigen. Preferred antibodies are mAbs, which may be of any immunoglobulin class including IgG, IgM, IgE, IgA, and any subclass or isotype thereof.


[0051] In addition to their specificity, monoclonal antibodies are advantageous in that they are synthesized by hybridoma culture, uncontaminated by other immunoglobulins. The modifier “monoclonal” indicates the character of the antibody as being obtained from a substantially homogeneous population of antibodies, and is not to be construed as requiring production of the antibody by any particular method. For example, the monoclonal antibodies to be used in accordance with the present invention may be made by the hybridoma method first described by Kohler et al, Nature, 256:495 (1975), or may be made by recombinant DNA methods (see, eg., U.S. Pat. No. 4,816,567, incorporated by reference herein). The “monoclonal antibodies” may also be isolated from phage antibody libraries using the techniques described in Clackson et al., Nature, 352:624-628 (1991) and Marks et al., J. Mol. Biol., 222:581-597 (1991), for example.


[0052] The monoclonal antibodies contemplated for use herein specifically include “chimeric” antibodies (immunoglobulins) in which a portion of the heavy and/or light chain is identical with or homologous to corresponding sequences in antibodies derived from a particular species or belonging to a particular antibody class or subclass, while the remainder of the chain(s) is identical with or homologous to corresponding sequences in antibodies derived from another species or belonging to another antibody class or subclass, as well as fragments of such antibodies, so long as they exhibit the desired biological activity (U.S. Pat. No. 4,816,567; Morrison et al., Proc. Natl Acad Sci USA, 81:6851-6855 (1984)).


[0053] “Humanized” forms of non-human (e.g., murine) antibodies are chimeric immunoglobulins, immunoglobulin chains or fragments thereof (such as Fv, Fab, Fab′, F(ab′)2 or other antigen-binding subsequences of antibodies) which contain minimal sequence derived from non-human immunoglobulin. For the most part, humanized antibodies are human immunoglobulins (recipient antibody) in which residues from a complementarity-determining region (CDR) of the recipient are replaced by residues from a CDR of a non-human species (donor antibody) such as mouse, rat or rabbit having the desired specificity, affinity, and capacity. In some instances, Fv framework region (FR) residues of the human immunoglobulin are replaced by corresponding non-human residues. Furthermore, humanized antibodies may comprise residues which are not found in either the recipient antibody or in the imported CDR or framework sequences. These modifications are made to further refine and maximize antibody performance. In general, the humanized antibody will comprise substantially all of at least one, and typically two, variable domains, in which all or substantially all of the CDR regions correspond to those of a non-human immunoglobulin and all or substantially all of the FR regions are those of a human immunoglobulin sequence. The humanized antibody optimally also will comprise at least a portion of an immunoglobulin constant region (Fc), typically that of a human immunoglobulin. For further details, see Jones et al., Nature, 321:522-525 (1986); Reichmann et al., Nature, 332:323-329 (1988); and Presta, Curr Op. Struct. Biol., 2:593-596 (1992). The humanized antibody includes a PRIMATIZED™ antibody wherein the antigen-binding region of the antibody is derived from an antibody produced by immunizing macaque monkeys with the antigen of interest.


[0054] “Antibody fragments” comprise a portion of an intact antibody, preferably the antigen binding or variable region of the intact antibody. Examples of antibody fragments include Fab, Fab′, F(ab′)2, and Fv fragments; diabodies; linear antibodies (Zapata et al. Protein Eng. 8(10):1057-1062 (1995)); single-chain antibody molecules, multispecific antibodies formed from antibody fragments, and the like.


[0055] Particularly preferred in the practice of the invention are single-chain antibodies. “Single-chain” or “sFv” antibodies are antibody fragments comprising the VH and VL domains of an antibody, wherein these domains are present in a single polypeptide chain. Preferably, the Fv polypeptide further comprises a polypeptide linker between the VH and VL domains which enables the sFv to form the desired structure for antigen binding. For a review of sfvs see Pluckthun in The Pharmacology of Monoclonal Antibodies, vol. 113, Rosenburg and Moore Eds., Springer-Verlag, New York, pp. 269-315 (1994).


[0056] Large quantities of single chain antibodies with uncharacterized randomized binding specificity can be produced using a number of methodologies known in the art. Random peptide libraries can be created in filamentous phage particles (Daniels and Lane, Methods 9(3):494-507, 1996; Reichmann and Weill, Biochemistry 32(34):8848-8855; Rader and Barbas, Curr Opin Biotechnol 9(4):503-508, 1997; Iba and Kurosawa, Immunol Cell Biol 75(2):217-221, 1997), for example, or similarly in yeast, bacteria, and the like. Other methods for creating random libraries of sFvs include various solid state synthesis methods.


[0057] The term “diabodies” refers to small antibody fragments with two antigen-binding sites, which fragments comprise a heavy-chain variable domain (VH) connected to a light-chain variable domain (VL) in the same polypeptide chain (VH-VL). By using a linker that is too short to allow pairing between the two domains on the same chain, the domains are forced to pair with the complementary domains of another chain and create two antigen-binding sites. Diabodies are described more fully in, for example, EP 404,097; WO 93/11161; and Hollinger et al., Proc. Nail. Acad. Sci. USA, 90:6444-6448 (1993).


[0058] Methods of identifying specific antibodies are well known in the art and include methods such as ELISAs, Western blots, immunoprecipitation, and the like (see, for example, Ausubel, et al, Short Protocols in Molecular Biology, 3rd ed. 1995, incorporated herein in its entirety). One method of large scale, high through-put screening for specific antibodies is described in co-pending US application entitled Microarrays and Uses Therefor, filed Feb. 4, 1999, U.S. Ser. No. 09/245,615.


[0059] The invention will now be described in greater detail by reference to the following non-limiting examples.



EXAMPLES


Example 1


High-Throughput Expression of Yeast ORFs

[0060] The following example illustrates the creation of a library of expressible yeast gene sequences.


[0061] Amplification


[0062] 6,032 yeast ORFs and a corresponding gene-specific primer of the 3′ end of each were obtained from Research Genetics (Huntsville, Ala.) in a 96-well microtiter plate format at a concentration of 0.3 ng/μl. Each gene specific primer was designed to exclude the gene's stop codon. Since the templates each contain a common sequence immediately 5′ of the start ATG (5′-GCAGTCCTGGAATTCCAGCTGACCACC) (SEQ. ID. NO.: 1), each template could be amplified with a common 5′ primer.


[0063] 5 μl of ORF template was added to a fresh 96-well microtiter plate (polycarbonate Thermowell Thinwall, Model M. Cat #6511) using a 12 channel pipetter. 6 μl of specific 3′ primer solution (2 μM) was added and the total volume per well brought to 30 μl with PCR cocktail, immediately after which the plate was placed on ice. (PCR cocktail for 120 reactions—720 μl 5×Buffer J, 48 μl dNTPs (50 mM stock), 12 μl common 5′ primer (1 μg/μl stock), 48 μl Taq DNA polymerase (Boeringer-Mannheim or Promega, 5 units/μl), 1.92 μl Pfu DNA polymerase (Stratagene, cat. #600153-81, 2.5 units/μl) and 1464 μl distilled water. 5×Buffer J: 300 mM Tris (pH 9.5), 75 mM ammonium sulfate, 10 mM MgCl2). The rubber Hybaid Micromat lid was washed by soaking in 0.1 M HCl, the rinsed for 2 minutes with distilled water and dried completely before applying to the 96-well plate.


[0064] The PCR reaction was performed using a Hybaid, Ltd. (Middlesex, UK) thermo-cycler according to the manufacturer's instructions. The conditions used were as follows: pre-melt step: 94° C.×4 min; melt step: 94° C.×30 sec, anneal step: 58° C.×45 sec, extend step: 72° C.×3 min—repeated for 25 cycles; final extension: 72° C.×4 min; final block temperature set to room temp (approx. 22° C.). The plates were stored at 4° C.


[0065] Purification


[0066] The plates were spun briefly at 1000 rpm, then 10 μl of 6×gel loading dye was added to each well (6×gel loading dye: 6 mM Tris (pH 8), 6 mM EDTA, 0.03% Bromphenol Blue, 30% glycerol). The entire contents of each well were loaded onto a 1% low melt agarose (Invitrogen #46-0150) gel (plus ethidium bromide at 20 μl of a 10 mg/ml solution added to 400 mls of agarose) in IX TAE (50×TAB=242 g Tris base, 57.1 ml glacial acetic acid, 100 ml 0.5 M EDTA, pH 8.0 per liter (water)) and run at 110-120 volts for 1.25 to 1.5 hours. A UV light box was used to visualize the amplification products and ensure that only correct-sized PCR products are used in the insertion step.


[0067] Insertion into Expression Vector(s)


[0068] The portion of each lane containing the amplified gene sequence was cut from the gel and transferred to a well in a 96-well microtiter plate, melted on a heat block (75° C.), and a portion of the melt multi-channel pipetted into a 96-well microtiter plate (7 μl/well) containing one of two expression vectors: TOPO-adapted pcDNA3.1/GS or pYES2/GS (see Example 3, below). The plate was covered with parafilm and incubated at 37° C. for 7 minutes. Top 10 Chemically Competent Cells (Invitrogen) were added to each well (45 μl/well, O.D.=4.7), whereupon the plate was re-covered and incubated on ice for 5 minutes. The cells were then heat shocked on a 42° C. block for 1 minute and returned to ice for 1 minute. An aliquot of SOC medium was added to each well (150 μl, 20 g tryptone, 5 g yeast extract, 0.5 g NaCl, 250 mM KCl, 20 ml 1M glucose/liter), and the plate was incubated at 37° C. for 90 to 120 minutes.


[0069] The contents of each well were plated onto a LB(10 g tryptone, 5 g yeast extract, 10 g NaCl per liter)/1.5% agar petrie plate containing the appropriate selection marker (ampicillin (50 μg/ml) for pYES2/GS and Zeocin™ (25 μg/ml) for pcDNA3.1/GS). The petrie plates were grown overnight at 37° C.


[0070] Verification of Size and Orientation


[0071] Contamination is a potentially serious problem in this step. Care should be taken to guard against contaminating the process through airborne contamination, unsterile reagents or equipment, or well-to-well contamination.


[0072] Eight colonies were picked from each petrie plate and placed in eight individual wells of a 96-well microtiter plate. Each well contained 100 μl of 2×LB plus 100 μg/ml ampicillin or 50 μg/ml Zeocin™ as appropriate for the expression vector used. The plates were incubated overnight at 37° C.


[0073] The plates were spun briefly at 1000 rpm. The cells were stirred by pipetting up and down in a pipetter, then 2 μl from each well was transferred to a corresponding well in a PCR reaction plate containing 28 pi/well PCR cocktail (PCR cocktail for 840 reactions—5040 μl 5×Buffer J, 336 ill dNTPs (50 mM stock), 84 μl common 5′ primer (1 μg/μl stock, Dalton Chemical Lab. Inc, Ont. CAN), 84 μl 3′ H6stopprevu primer (1 μg/μl, Dalton Chemical Lab. Inc, Ont. CAN), 336 μl Taq DNA polymerase (Boeringer Mannheim or Promega 5 units/μl), and 17.64 mls distilled water. H6stopprevu primer has the sequence 5′ AAA CTC AAT GGT GAT GGT GAT GAT GACC-3′) (SEQ. ID. NO.: 2).


[0074] The PCR reaction was run essentially as described above with the following cycle: pre-melt step: 94° C.×10 min; melt step: 94° C.×1 min, anneal step: 67° C.×1 min, extend step: 72° C.×3 min−35 cycles; final extension: 72° C.×4 min; final block temp set to room temp (approximately 22° C.). The plates were spun briefly at 100 rpm and 6 μl of 6×gel loading dye added to each well. Samples were run on a 1% agarose gel which was subsequently stained with ethidium bromide Only plasmids with correctly oriented inserts give an amplification product in this step.


[0075] The location of the positive clones was entered into a database and a spreadsheet of positive clones generated. The spreadsheet was downloaded onto a Qiagen BioRobot 9600™ to direct the re-racking of the positive cultures into deep-well culture blocks. Essentially, a single positive culture for each clone was grown and used to prepare plasmid DNA according to the Quia-Prep Turbo protocol.


[0076] CHO cells or were transfected with the prepared plasmid DNA using the Pfx-6 PerFect Lipid system (Invitrogen, Cat #T930-16). Yeast cells (INVSc1) were transfected using the S.C. EasyComp Transformation kit (Invitrogen, Cat #K5050-01). Expression was verified by Western blot using anti-V5 antibody to detect the epitope tag. All of the yeast ORFS were expressed in either pYES or pDNA3.1. Table 1 below lists the yeast proteins successfully produced using the yeast ORFs.
1TABLE 1Yeast ORFsPlate NameORF IdentiferProtein descriptionM12 E2YAL003W447-987 Translationelongation factor EF-1beta GDP\/GTPexchange factor forTeflp\/Tef2p(22.77/40)M12 D4YAL005CHeat shock protein ofHSP70 familycytoplasmic(70.65/45)M12 E5YAL007C(23.68/32)M11 H1YAL009WProtein required formeiosis (28.60/30)M135 F2YAL012Wcystathionine gammalyase(43.45/43)M11 D2YAL013W(39.93/40)M11 E2YAL014C(22.58/31)M12 F5YAL015CDNA glycosylase(43.92/48)M12 D6YAL016Wprotein phosphatase2A regulatory subunitA (69.96/56)M136 H1YAL020C(36.66/47)M12 F4YAL022C(56.90/56)M11 E4YAL030W216-467 vesicle-associated membraneprotein(synaptobrevin)homolog (12.98/20)M136 D1YAL034W-A(31.9/28)M12 H5YAL037W(29.48/33)M136 H4YAL038WPyruvate kinase(55.11/60)M136 G5YAL039Ccytochrome c hemelyase (CCHL)(29.62/45)M136 C4YAL044CH-protein subunit ofthe glycine cleavagesystem (19.50/36)M12 G6YAL045C(11.25/11)M11 C7YAL049C(27.09/37)M135 H4YAL053W(86.24/64)M136 B5YAL055W(19.91/28)M12 G7YAL056W(93.28/98)M12 B3YAL059W(23.43/34)M11 D8YAL060W(42.13/45)M12 A5YAL061W(45.98/40)M11 F8YAL062W(50.48/50)M11 H9YAR002W(59.4/60)M12 F1YAR003W(46.97/53)M12 C3YAR008W34 kDa subunit of thetetrameric tRNAsplicing endonuclease(30.46/38)M12 B5YAR010C(48.43/45)M11 C11YAR023C(19.72/30)M12 B4YAR027W(25.96/40)M12 C5YAR028w(25.85/30)M12 B7YAR030C(12.46/12)M135 E2YAR035WOuter carnitineacetyltransferasemitochondrial(75.68/76)M12 E3YAR037W(21.34/25)M12 C4YAR040C(13.12/20)M138 E1YAR052C(13.89/36)M14 F1YAR062W(21.89/36)M138 H5YBL001CExtraCellular Mutant(11.47/10)M137 B1YBL002WHistone H2B (HTB1and HTB2 code fornearly identicalproteins) (14.52/25)M14 B3YBL003CHistone H2A (HTA1and HTA2 code fornearly identicalproteins) (14.55/15)M13 F3YBL005W-A(48.51/48)M13 C2YBL010C(30.83/35)M333 D1YBL011W(83.6/93)M138 A6YBL015Wacetyl CoA hydrolase(57.97/60)M137 C1YBL016Wcdc2+\/CDC28related kinase withpositive role inconjugation(38.94/45)M310 B1YBL019W(57.31/64)M13 G3YBL020W67 kDa integralmembrane protein(63.25/70)M13 D4YBL021Ctranscriptionalactivator protein ofCYC1 (15.87/20)M13 G2YBL027W387-954 Ribosomalprotein YL14 (ratL19) (rp33) (RPL19Aand RPL19B code foridentical genes)(20.9/32)M137 C4YBL028C(11.69/20)M137 G6YBL031W(37.29/38)M14 B7YBL033CGTP cyclohydrolaseII (37.98/38)M137 D3YBL035CB subunit of DNApolymerase alpha-primase complex(77.58/80)M13 H3YBL036C(28.30/32)M138 C5YBL038WMitochondrialribosomal proteinMRPL16 (25.63/30)M137 B2YBL041Wproteasome subunit(26.62/36)M13 H2YBL043WExtraCellular Mutant(28.48/45)M13 A4YBL044W(13.53/17)M13 C5YBL046W(48.62/55)M138 F2YBL050W147-995 peripheralmembrane proteinrequired for vesiculartransport between ERand Golgi (32.23/35)M137 C2YBL057C(23.57/36)M14 C10YBL058Wisolated as asuppressor of thelethality caused byoverexpression of thephosphoproteinphosphatase 1catalytic subunitsencoded by GLC7(46.64/50)M13 B4YBL060W(75.68/75)M137 D1YBL064C(28.74/36)M15 A1YBL080C62-kDa protein(59.54/60)M141 C1YBL081W(40.59/60)M16 F1YBL082CResistance toHansenula Killer 1hypothetical F-458protein (50.41/50)M15 H5YBL086C(51.29/?)M15 H4YBL093Cnuclear protein(24.23/36)M15 D7YBL095W(29.81/50)M140 E3YBL099Wmitochondrial F1F0-ATPase alpha subunit(60.06/60)M15 B6YBL101W-A(48.29/48)M310 C1YBL105Cputative proteinkinase (126.64/150)M16 A3YBL107C(21.59/31)M15 C4YBR002C(31.49/32)M15 B5YBR003Whexaprenylpyrophosphatesynthetase (52.14/55)M16 H3YBR004C(47.66/48)M15 F7YBR005W(23.54/40)M140 D4YBR010WHistone H3 (HHT1and HHT2 code foridentical proteins)(15.07/20)M15 C5YBR011CInorganicpyrophosphatase(31.60/50)M15 E6YBR012C(15.32/18)M15 G7YBR012W-A(48.51/64)M15 A3YBR014C(22.46/22)M15 E4YBR016W(14.19/14)M15 F6YBR018Cgalactose-1-phosphateuridyl transferase(40.29/45)M15 H7YBR019CUDP-glucose 4-epimerase (76.92/76)M141 A3YBR024W(33.22/37)M16 D3YBR025C(43.47/43)M15 G6YBR026CNuclear protein thatbinds to T-rich strandof core consensussequence ofautonomouslyreplicating sequence(41.83/41)M140 G3YBR031Wlarge ribosomalsubunit protein 2A(39.93/42)M140 F6YBR034Cprotein argininemethyltransferase(mono- andasymmetricallydimethylatingenzyme) (38.31/50)M15 A8YBR035Cpyridoxine(pyridoxiamine)phosphate oxidase(25.11/32)M255 C1YBR036Ccontains 9 or 10putative membranespanning regions\putative Ca2+binding protein(homology to EF-hand Ca2+bindingsite) (45.13/55)M16 H1YBR046C(36.77/35)M15 A7YBR050C(37.21/50)M140 E1YBR052C(23.13/34)M15 G5YBR057CMuddled Meiosis(40.29/70)M19 B1YBR061C(34.13/40)M143 A4YBR063C(44.47/48)M143 C7YBR066C(24.23/25)M19 A2YBR068Cprobable amino acidpermease for leucinevaline and isoleucine(67.02/67)M19 C2YBR070C(26.10/40)M143 B4YBR071W(23.32/33)M142 E6YBR072Wheat shock protein 26(23.65/32)M143 B2YBR077C(17.85/32)M142 B5YBR079C(106.07/106)M19 E3YBR080Ccytoplasmic proteininvolved in proteintransport between ERand Golgi\ATPase (83.41/080)M19 F3YBR081Ctranscription factor(146.55/050)M19 G3YBR082C143-542 ubiquitin-conjugating enzyme(16.49/16)M202 D1YBR083Wtranscriptionalregulator of Ty1expression (53.57/64)M19 A4YBR084C-A509-1076 Ribosomalprotein YL14 (ratL19) (rp33) (RPL19Aand RPL19B code foridentical genes)(20.9/?)M19 C4YBR085WmitochondrialADP\/ATPtranslocator(33.88/50)M143 D6YBR088Cprofilerating cellnuclear antigen(28.41/0)M19 A5YBR090C-A11-kDa nonhistonechromosomal protein(10.92/10)M143 C2YBR091C(12.02/16)M143 D3YBR092CAcid phosphataseconstitutive(51.40/50)M19 E5YBR094W(82.94/80)M19 F5YBR095C(49.86/50)M20 E1YBR098W(51.92/48)M143 D4YBR101C(31.93/32)M142 E10YBR105C(39.85/45)M143 F1YBR106WMay be a membraneprotein involved ininorganic phosphatetransport andregulation of Pho81pfunction (20.79/0)M143 E4YBR109CCalmodulin (16.20/12)M20 G7YBR111C(25.44/30)M143 A8YBR112CGeneral repressor oftranscription (withTup1p)\mediatesglucose repression(106.29/100)M19 H7YBR113W(17.71/70)M20 F6YBR118Wtranslationalelongation factor EF-1 alpha (50.49/55)M19 F8YBR119W98-986 U1 snRNP Aprotein (32.89/36)M143 B8YBR120C(17.85/36)M19 H8YBR121CGlycyl-tRNAsynthase (73.40/90)M19 A9YBR122CMitochondrialribosomal proteinMRPL36 (YmL36)(21.59/30)M142 A3YBR123Ctranscription factortau (TFIIIC) subunit95 (71.42/75)M19 E9YBR126C56 kD synthasesubunit of trehalose-6-phosphatesynthase\/phosphatasecomplex (54.48/55)M19 F9YBR127C(56.90/36)M20 D9YBR128C(37.87/37)M143 B9YBR129C(36.11/40)M19 A10YBR130C(46.78/50)M143 E2YBR131W(77.55/72)M19 F10YBR135Wsubunit of the Cdc28protein kinase(16.61/16)M143 C9YBR137W(19.8/30)M143 F2YBR139W(55.99/0)M20 E9YBR144C(11.47/32)M19 A12YBR146WProbablemitochondrialribosomal protein S9(30.69/31)M265 B1YBR149W(37.95/40)M20 F9YBR152W(32.12/50)M19 H12YBR153WProtein involved inthe biosynthesis ofriboflavin second stepin the riboflavinbiosynthesis pathway(26.95/40)M145 C4YBR158W(60.5/98)M144 B9YBR161W(41.47/52)M144 B1YBR162C(50.08/60)M145 B2YBR162W-AProtein thatparticipates insecretory pathway(7.36/10)M145 D4YBR165W(30.58/36)M144 H6YBR166CPrephenatedehydrogenase(NADP+) (49.75/50)M145 C1YBR169CMember of the 70-kDa heat-shockprotein family(76.36/98)M144 C3YBR171Wintegral membraneglycoprotein(22.77/32)M145 E4YBR173C(16.31/35)M144 D9YBR176WExtraCellular Mutant(34.43/45)M145 D1YBR177C(49.64/60)M144 D3YBR179CYeast fzo homolog(drosophilamelanogaster fuzzyonionsgene) Reference:HalesK.G. and Fuller M.T.-1997Developmentallyregulatedmitochondrial fusionmitochondrial fusionmediated by aconserved novelpredicted GTPase.Cell. 90 121-129.(94.08/98)M144 H5YBR181C359-1063 40Sribosomal geneproduct S10(26.07/32)M145 F5YBR182C(49.75/0)M144 E3YBR187W(30.91/36)M144 E4YBR188C(15.43/20)M144 A6YBR189W421-1001 RibosomalproteinSUP46\/RPS13(YS11A) (YP28) (E.coli S4) (ratS9) (21.56/33)M144 F1YBR193C(24.56/34)M144 F1YBR193C(24.56/34)M145 F2YBR194W(13.64/20)M144 F4YBR196Cphoshogluco-isomerase(60.97/60)M144 B6YBR197C(23.90/32)M145 E6YBR199WPutative alpha-1 2-mannosyltransferase(51.15/64)M144 G9YBR200Wcontains two SH3domains (60.72/64)M144 G4YBR204C(41.38/38)M144 C6YBR205WPutative alpha-1 2-mannosyltransferase(44.55/48)M145 F1YBR209W(11.66/16)M144 F2YBR210W(15.73/16)M144 H4YBR212Wnegative growthregulatory protein(74.03/74)M144 D6YBR213W(30.35/38)M145 H5YBR214W(58.08/90)M144 E6YBR221Cbeta subunit ofpyruvatedehydrogenase (E1beta) (40.39/42)M202 E1YBR222C(59.76/70)M145 A6YBR230C109-502 (14.85/18)M144 H8YBR231C(33.46/42)M145 H1YBR233W(45.54/60)M144 C5YBR236CRNA (guanine-7-)methyltransferase(capmethyltransferase)(47.99/52)M144 F6YBR237WRNA helicasehomolog (93.5/95)M144 H2YBR242W(26.39/32)M255 D1YBR243CUDP-N-acetyl-glucosamine-1-Ptransferase (GPT)(49.31/38)M145 B4YBR244W(17.93/0)M144 A9YBR247CPutative 57 kDaprotein with anapparent MW of 70kDa by SDS-PAGE(53.26/55)M144YBR248CglutamineD10amidotransferase:cyclase (60.75/61)M147 A1YBR249C3-deoxy-D-arabino-heptulosonate 7-phosphate (DAHP)synthase isoenzyme(40.73/50)M24 C1YBR251WProbablemitochondrialribosomal protein S5(33.88/40)M146 B4YBR253Wtranscription factor(13.42/18)M146 D7YBR256CRiboflavin synthasealpha-chain(26.21/26)M25 D1YBR258C(15.65/20)M146 C4YBR261C(25.55/38)M146 D5YBR262C(11.69/50)M147 F6YBR263WSerinehydroxymethyltransferase mitochondrial(62.36/62)M24 A3YBR265W(35.31/35)M25 F1YBR267W(32.56/45)M146 E5YBR270C(59.98/64)M146 B1YBR273C(47.99/70 m)M146 F1YBR274W(58.08/50)M303 C1YBR283C(53.93/48)M146 F4YBR285W(15.95/30)M24 B6YBR290W(35.42/55)M25 G1YBR291Ccitrate tranporter inmitochondrial innermembrane (32.92/35)M274 D1YBR295WPutative P-typeCu(2+)-transportingATPase (133.87/125)M25 H1YCL005W(28.05/40)M147 B7YCL009CAcetolactate synthaseregulatory subunit(34.02/34)M146 B5YCL016C(34.02/34)M25 G3YCL018Wbeta-IPM(isopropylmalate)dehydrogenase(40.25/55)M147 E8YCL027WMAP kinase involvedin pheromone signaltransduction G(sub)1arrest (56.43/50)M146 C2YCL029CMicrotubule-associated proteinrequired formicrotubule functionduring mating andmitosis (48.43/70)M147 E5YCL032WProtein that interactswith Gpalp Ste4 andSte18 to regulateadaptation topheromone(38.27/48)M146 D8YCL035C(12.13/16)M147 F2YCL037CSuppressor of rho3(51.39/55)M146 C7YCL042W(13.09/30)M25 F4YCL043Cprotein disulfideisomerase (57.45/62)M22 A1YCL044C(45.90/46)M265 F1YCL045C(83.63/85)M148 D5YCL049C(34.45/64)M148 D6YCL050Cdiadenosine 5′ 5′″-P1P4-tetraphosphatephosphorylase I(35.34/50)M148 E3YCL055WMay assist Ste12p inpheromone-dependent expressionof KAR3 and CIK1(36.96/45)M149 H7YCL059CProtein essential forcell division andspore germination(34.79/36)M149 C1YCL060C(34.90/34)M148 A3YCL062W(21.56/36)M148 F3YCL063W(14.29/20)M22 E3YCL064Ccatabolic serine(threonine)dehydratase(39.63/40)M148 G7YCL067C(23.13/36)M148 B1YCL068C(20.93/33)M22 C4YCL073C(67.68/56)M149 H4YCL074W(33.99/40)M21 H2YCL075W(16.27/20)M148 G6YCLX01W(14.63/30)M22 A5YCLX03C(14.00/18)M148 H6YCLX09W(14.41/36)M148 A4YCR002Cconserved potentialGTP-ginding protein(35.45/48)M22 E6YCR003WMitochondrialribosomal proteinMRPL32 (YmL32)(20.24/55)M148 G5YCR004C(27.20/27)M148 A7YCR005Cnon-mitochondrialcitrate synthase(50.63/50)M148 E1YCR007C(26.32/40)M22 E7YCR011CATP-dependentpermease (115.42/?)M148 H5YCR012W3-phosphoglyceratekinase (45.87/45)M148 A6YCR020C(23.68/35)M22 C9YCR024C(54.25/36)M148 B5YCR025C(14.99/25)M148 H1YCR036Wribokinase (36.74/50)M148 D4YCR039C(23.13/33)M148 C5YCR040Wtranscripton factorinvolved in theregulation of thealpha-specific genes(19.46/33)M21 F1YCR045C(54.04/57)M149 E5YCR047C(30.38/40)M151 C3YCR054C(61.96/61)M151 B1YCR060W(12.32/16)M151 D3YCR062W(13.31/30)M151 G4YCR063W(17.48/17)M26 H4YCR065WDosage-dependentsuppressor of cmd1-1mutation\showshomology to forkhead family of DNA-binding proteins(58.63/60)M151 G8YCR066WZn finger proteinputative ATPase(53.68/53)M150 C1YCR068W(47.3/51)M151 D6YCR072C(56.68/64)M151 H8YCR074C(11.69/16)M151 E2YCR077CNecessary foraccurate chromosometransmission duringcell division(87.70/98)M26 A5YCR082W(14.29/16)M151 A9YCR083W(14.08/17)M150 F2YCR086W(21.01/36)M150 C5YCR088WActin binding protein(65.23/65)M151 G7YCR090C(20.05/36)M23 G5YCR091WPutativeserine\/threonineprotein kinase mostsimilar to cyclicnucleotide-dependentprotein kinasesubfamily and theprotein kinase Csubfamily (79.97/80?)M151 C5YCR096C(13.12/20)M151 B9YCR098C(57.01/20)M151 G2YCR101C(20.05/36)M151 H3YCR102C(40.51/50)M151 C9YCR106W(91.63/33)M151 A4YCRX03C(11.25/16)M150 C9YCRX07W(20.45/30)M150 H6YCRX13Wmulticopy suppressorof los1-1 (34.76/50)M26 C5YCRX14W(11.66/14)M150 E10YCRX16C(16.86/28)M26 F1YCRX17W(13.64/20)M151 G5YCRX20C(11.46/64)M150 E9YDL002CHMG1-boxcontaining protein(22.46/36)M151 D4YDL006Wserine-threonineprotein phosphatase(31.02/36)M324 D1YDL008W(18.36/34)M150 F9YDL010W(25.52/34)M151 B2YDL012C132-410 (11.88/18)M150 F4YDL014Wnucleolar proteinhomologous tomammalian fibrillarin(36.08/40)M151 E8YDL017Wprotein kinaserequired for initiationof mitotic DNAsynthesis (55.88/64)M152 A1YDL020CSuppressor of sec63(58.44/68)M153 B2YDL021W(34.32/40)M152 D3YDL022Wglycerol-3-phosphatedehydrogenase(43.12/45)M152 F2YDL029W146-1299 actin-related protein(43.12/45)M152 E3YDL030WRNA splicing factor(58.41/64)M153 E4YDL031W(109.56/109)M153 H6YDL033C(45.90/55)M153 H5YDL040CN-terminalacetyltransferase(93.97/36)M152 E8YDL042Cregulator of silentmating loci(61.85/68)M152 D1YDL044CNecessary for thestability and\/orprocessing of somelarge mitochondrialtranscripts (48.43/55)M153 D2YDL045CFAD synthetase(33.69/50)M152 C6YDL048C(55.58/60)M153 B7YDL049CKRE9 homolog(29.51/50)M152YDL051WProtein homologousA10to human La (SS-B)autoantigen(30.46/40)M152 E1YDL052Cputative 1-acyl-sn-gylcerol-3-phosphateacyl transferase(33.46/40)M152 B5YDL055CNDP-hexosepyrophosphorylase(39.74/45)M27 E5YDL056Wtranscription factor(91.74/90)M274 B2YDL059C(26.21/36)M153 H4YDL063C(68.23/60)M153 B6YDL064W149-584 (17.48/20)M153 D7YDL065C(38.53/38)M152 G8YDL066WMitochondrial formof NADP-specificisocitratedehydrogenase(47.29/50)M153 F2YDL069Ctranslational activatorof cytochrome b(25.66/36)M153 G3YDL070W(70.39/70)M28 E2YDL072C(22.46/30)M153YDL075W479-763 (12.54/20)C10M152 D5YDL079C705-1798 MDS1related protein kinase(55.22/55)M152 F7YDL081Cribosomal proteinlarge subunit L12\also known asL12eIIA (11.69/18)M152 A2YDL084W(49.27/50)M28 E1YDL085W(60.06/60)M153 A4YDL086W(30.14/33)M152 E5YDL087CEXit from Mitosis(28.74/38)M27 F9YDL089W(53.45/45)M333 C2YDL090Ccomponent of proteinprenyltransferase(47.44/55)M153 E10YDL091C(50.08/50)M27 A10YDL092WSignal recognitionparticle subunit(16.27/16)M152 B3YDL093Wdolichyl phosphate-D-mannose:proteinO-D-mannosyltransferase(81.84/82)M153 B4YDL094C(18.62/40)M255 H1YDL097C(47.77/54)M152 C9YDL098C(21.47/32)M333 D2YDL099W(37.62/42)M152 C2YDL100C(38.97/45)M152 C3YDL101Cprotein kinase(56.46/60)M153 E5YDL103C(52.50/60)M153 F6YDL104C(44.80/50)M153 A8YDL105W(44.43/44)M202 A2YDL106CHomeobox-domaincontaining proteinwhich is a positiveregulator of PHO5and other genes(61.52/100)M153YDL107Wcox1 pre-mRNAG10splicing factor(38.72/40)M152 D2YDL108W110-1002 serine-threonine kinase(33.77/40)M152 E4YDL110C(16.53/32)M29 E1YDL120WMitochondrial proteinthat regulatesmitochondrial ironaccumulation ironaccumulation(19.35/19)M155 C6YDL121C(16.42/33)M155 F8YDL123W(15.51/19)M155 B1YDL124W(34.43/40)M30 D2YDL125C209-588 (17.49/28)M29 C2YDL126CMicrosomal proteinofCDC48\/PAS1\/SEC18 family of ATPases\full length homologyto mammalian proteinVCP\involved insecretion peroxisomeformation and geneexpression (91.88/92)M155 D6YDL129W(32.12/32)M29 H2YDL131W(48.51/48)M29 A3YDL132WCell division cycleblocked at 36 degreeC.YDR009 (89.76/90)M29 C3YDL134Cserine-threonineprotein phosphatase2A (40.62/40)M29 G3YDL137WADP-ribosylationfactor 2 (20.02/20)M29 H3YDL138W(84.04/84)M155 D1YDL139C(27.20/37)M29 C4YDL141WBiotin:apoproteinligase (76.01/76)M274 C2YDL142CPhosphatidylglycerophosphate Synthase(31.26/48)M29 F4YDL144C(39.52/40)M155 F7YDL145C(132.14/98)M29 H4YDL146W(54.12/54)M29 D5YDL150WRNA polymerase III(C) subunit(46.53/46)M155 G7YDL153CSomething AboutSilencing 10(67.13/70)M29 H5YDL154W(99.22/99)M30 D1YDL155WG(sub)2-specific B-type cyclin (47.08/40)M29 C6YDL157C(13.01/13)M29 E6YDL159WMEK homolog(56.76/56)M29 F6YDL160C(55.69/55)M30 C4YDL165W(21.12/32)M155 F4YDL166C(21.70/36)M155 G6YDL168WLong-chain alcoholdehydrogenase(glytathione-dependentformaldehydedehydrogenase)(42.57/32)M29 H7YDL170Wzinc-fingertranscription factor ofthe Zn(2)-Cys(6)binuclear clusterdomain type(58.29/58)M155 G4YDL174Cmitochondrialenzyme D-lactateferricytochrome coxidoreductase(64.60/98)M29 E8YDL175C(37.87/38)M155 A8YDL177C(18.73/29)M155 C9YDL178WD-LactateDehydrogenase(Cytochrome)(58.41/64)M29 D9YDL182W(47.29/47)M29 E9YDL183C(35.23/35)M29 F9YDL184CRibosomal proteinRPL47 (YL41)(RPL47A andRPL47B code foridenticalproteins)(2.786/5)M154 G1YDL187C(12.02/27)M29 E10YDL191W495-854 Ribosomalprotein (rat L35)(13.41/31)M255 D2YDL194Wglucose transporter(97.45/150)M30 G4YDL197CAnti-silencing proteinthat causes depressionof silent loci whenoverexpressed(57.78/60)M29 D11YDL198C(33.03/33)M29 E11YDL199C(75.60/75)M310 G1YDL200C6-O-methylguanine-DNA methylase(22.69/34)M155 D8YDL201W(31.57/42)M30 B11YDL202W(27.5/27)M155 B3YDL204W(43.34/54)M29 C12YDL205Cphorphobilinogendeaminase(uroporphyrinogensynthase) the thirdstep in hemebiosynthesis(36.00/36)M154 C5YDL206W(83.93/115)M155 C7YDL208WHMG-like nuclearprotein (19.14/30)M31 A1YDL211C(40.95/41)M31 C1YDL213C(24.78/25)M156 B3YDL214C(76.92/98)M156 G4YDL216C(50.08/64)M156 G6YDL218W(34.98/34)M32 E2YDL221W(20.24/28)M31 D2YDL222C(34.02/34)M31 F2YDL224C(71.42/70)M156 H5YDL225W(60.72/90)M31 H2YDL226CADP-ribosylationfactor GTPase-activating protein(ARF GAP)(38.75/38)M31 F3YDL232W3.6-kDa proteinprobably membrane-located (4.07/4)M157 B8YDL234C(82.09/98)M157 D1YDL235CTwo-componentphosphorelayintermediate(18.40/28)M156 F1YDL236Wp-nitrophenylphosphatase(34.43/40)M157 E3YDL237W(43.01/50)M31 G4YDL241W(13.64/13)M156 B7YDL242W(12.98/18)M156 G1YDL244W(37.51/52)M156 D3YDL246C(39.30/53)M156 B5YDL248WProtein with strongsimilarity to othersubtelomerically-encoded proteins suchas Cos5p Ybr302pCos3p Cos1p Cos4pCos8p Cos6p Cos9p(42.24/48)M156 B6YDR001C(82.64/60)M31 H5YDR002W(22.22/22)M32 C1YDR003W(23.21/38)M31 C6YDR005C87-1268 (43.56/46)M31 D6YDR006C(99.14/99)M31 F6YDR008C(12.79/13)M31 G6YDR009Wgalactokinase(57.31/57)M32 A2YDR012Wlarge ribosomalsubunit protein L2B\highly similar toribosomal proteinL2A (Rpl2bp)(39.93/45)M31 F7YDR016C(10.47/10)M31 A8YDR019Cglycine cleavage Tprotein (T subunit ofglycine decarboxylasecomplex (44.03/44)M31 B8YDR020C(25.55/25)M156 G2YDR021W(44/48)M31 D8YDR022Ccik1 suppressor(21./5922)M156 C4YDR023Wseryl-tRNAsynthetase (50.9/350)M31 F8YDR024W(17.82/18)M31 G8YDR025W385-810 ribosomalprotein S18(17.27/20)M156 G3YDR030CProtein involved inthe same pathway asRad26p has beta-transducin (WD-40)repeats (55.69/55)M156 D4YDR031W(12.98/18)M31 F9YDR032C(21.81/30)M157 H1YDR035WDAHP synthase\a.k.a. phospho-2-dehydro-3-deoxyheptonatealdolasephenylalanine-inhibited\phospho-2-keto-3-deoxyheptonatealdolase\2-dehydro-3-deoxyphosphoheptonate aldolase\3-deoxy-D-arabine-heptulosonate-7-phosphate synthase(40.81/48)M156 B2YDR036C(55.03/55)M32 B3YDR037Wlysyl-tRNAsynthetase (65.12/55)M156 E7YDR042C(22.03/28)M31 A11YDR043C(25.44/25)M156 C2YDR044WCoproporphyrinogenIII oxidase (36.29/44)M32 C5YDR047W(39.93/45)M31 F11YDR048C(11.47/12)M31 G11YDR049W(69.63/?69)M156 F7YDR050Ctriosephosphateisomerase (27.31/33)M32 G1YDR051C(36.77/40)M32 D3YDR053W(14.52/16)M32 F4YDR054Cubiquitin-conjugatingenzyme E2 (32.48/50)M31 F12YDR056C(22.58/21)M34 D2YDR060W(112.86/112)M33 C1YDR061W(59.4/60)M159 A5YDR063W(16.5/30)M158 G6YDR066C(21.59/33)M158 B1YDR067C(24.67/35)M34 C4YDR070C(10.36/12)M159 B5YDR071C(21.04/30)M34 B1YDR075Wprotein phosphatasetype 2A (33.99/40)M34 C1YDR083W(44.33/41)M255 G2YDR087C(30.61/48)M158 A5YDR088Cinvolved in 3′ splicesite choices(42.05/52)M158 C2YDR092W299-730 ubiquitin-conjugating enzyme(16.94/30)M301 F1YDR097C(136.65/140)M158 C6YDR113C42-kDa nuclearprotein (41.06/55)M34 E7YDR114C(11.03/16)M159 F3YDR117C(62.28/64)M33 G8YDR121W(21.67/40)M33 H10YDR138W(82.83/80)M34 C2YDR147W(58.85/45)M159 B6YDR151C(35.78/48)M158 F6YDR153C(45.24/60)M35 A1YDR155Ccyclophilin peptidyl-prolyl cis-transisomerase (17.85/18)M160 B2YDR156WRNA polymerase Isubunit A14(15.28/25)M36 A4YDR158Waspartic beta semi-aldehydedehydrogenase(40.36/45)M161 C6YDR161WPTC1-InteractingProtein (42.68/50)M36 A8YDR162C(25.99/36)M160 B1YDR163W(19.46/32)M160 D4YDR167WTFIID subunit(22.77/34)M160 D5YDR168W(55.77/60)M160 E6YDR169Csin3 binding protein(56.46/66)M160 C1YDR171WSimilar to HSP26\expression isregulated by stressconditions (41.46/50)M35 C3YDR173C(39.08/?)M160 F3YDR174W(27.27/28)M161 C4YDR175C(35.12/45)M36 E7YDR177Wubiquitin-conjugatingenzyme (23.76/34)M161 D1YDR179C(17.85/31)M36 E6YDR183W(25.41/36)M160 G6YDR184C(32.47/45)M35 A5YDR186C(96.50/?)M160 H2YDR188WCytoplasmicchaperonin of the Cctring complex(previously calledTCP1 or TRiC)distantly related toTcp1p and to Hsp60(60.27/64)M35 D5YDR189W(73.47/75)M161 D4YDR190C(50.96/55)M161 E5YDR191W(40.81/50)M36 F7YDR192Cnucleoporin (47.33/53)M35 A6YDR194CMitochondrial RNAhelicase of the DEADbox family (73.07/?)M35 B6YDR195W(58.74/60)M161 B3YDR196C(26.54/33)M35 D6YDR197Wcytochrome btranslational activator(42.9/?)M161 E4YDR198C(52.72/34)M160 G7YDR201W(18.36/34)M160 F1YDR202C(38.64/45)M161 C3YDR204Wresponsible forrestoring ubiquinonebiosynthesis in coq4mutant (36.96/45)M161 F1YDR210W(8.46/16)M35 D8YDR213W(100.5/4?)M160 A5YDR214W(38.61/50)M36 G3YDR220C(10.70/14)M160 B6YDR223W(51.48/66)M160 B7YDR224CHistone H2B (HTB1and HTB2 code fornearly identicalproteins) (14.44/18)M160 A8YDR225WHistone H2A (HTA1and HTA2 code fornearly identicalproteins) (14.63/18)M35 A10YDR226Wcytosolic adenylatekinase (24.53/25)M35 B10YDR227Wregulator of silentmating loci (149.49/?)M160 C4YDR229W(49.94/55)M35 H12YDR249C(41.06/?)M38 H1YDR251W(91.41/98)M162 E2YDR252WNegative effect onexpression of severalgenes transcribed byRNA polymerase II\BTF3 homolog(16.5/20)M37 D1YDR253Czinc finger DNAbinding factortranscriptionalregulator of sulfuramino acidmetabolism (21.04/?)M163 G6YDR255C(46.34/60)M37 G1YDR256Ccatalase A (56.68/60)M163 C9YDR257C(54.47/64)M163 D2YDR259C(42.26/60)M162 D4YDR262W(30.03/36)M37 F2YDR263CDNA-damageinducible gene(47.33/?)M162 A6YDR264C(84.07/55)M163 B1YDR266C(70.32/80)M163 E3YDR268Wmitochondrialtryptophanyl-tRNAsynthetase (41.8/49)M37 F3YDR271C(13.56/14)M163 C8YDR272WCytoplasmicglyoxylase-II(30.35/40)M38 E8YDR273W(40.36/50)M162 B2YDR275W(25.96/38)M163 F3YDR276C(6.086/6)M37 F4YDR279W(38.61/38)M163 D1YDR282C(45.57/55)M162 H2YDR284CDiacylglycerolPyrophosphatePhosphatase(31.82/38)M38 E6YDR287W(32.12/38)M163 G9YDR289C(45.02/64)M38 D1YDR290W(12.1/15)M38 C4YDR293Cputative proteinphosphatase(137.5/3130)M37 E6YDR294C(64.82/?)M163 F1YDR298CATP synthase subunit5\oligomycinsensitivity-conferringprotein (23.45/30)M163 A4YDR300Cgamma-glutamylkinase (47.11/48)M37 F7YDR303C(97.48/?)M37 G7YDR304CCyclophilin DPeptidyl-prolyl cis-trans isomerase D(24.86/40)M163YDR305C177-743 YeastA10member of theHistidine Triadprotein family (HIT)(27.27/35)M163 G2YDR307W(72.93/75)M163 B4YDR308CRNA polymerase IIholoenzymecomponent (15.43/31)M38 E4YDR309C(42.26/48)M163 H1YDR314C(76.25/85)M163 H2YDR315C(30.94/40)M163 G8YDR320C(73.51/110)M163YDR321WAsparaginase IC10intracellular isozyme(42.02/50)M163 D4YDR324C(85.49/95)M163 A2YDR330W(55.11/70)M163 A3YDR331WProtein involved inthe attachment ofglycosylphosphatidylinositol (GPI) anchorsto proteins (45.32/62)M163 A9YDR336W(34.65/45)M163 E10YDR337WMitochondrialribosomal proteinMRPS28 (E. coliS15) (31.57/40)M163 B2YDR338C(76.48/76)M163 B3YDR339C(20.82/33)M163 E5YDR341C(66.80/70)M170 A1YDR346C(52.94/60)M170 C9YDR353WThioredoxinreductase (35.2/48)M170 B1YDR354Wanthranilatephosphoribosyltransferase (41.91/50)M274 C3YDR354Wanthranilatephosphoribosyltransferase (41.91/45)M171 F2YDR356Wputativenucleoskeletoncomponent(103.95/120)M171 F3YDR357C(13.45/20)M170 D2YDR363W(50.37/55)M171 B2YDR363W(50.37/54)M171 G3YDR365C(69.11/72)M171 H5YDR367W132-767 (24.42/38)M274 E3YDR369CDNA repair protein(93.97/98)M39 A4YDR370C(48.65/45)M171 H3YDR373W(21.01/32)M171 C7YDR376Wadrenodoxinoxidoreductasehomolog (54.34/64)M171 E8YDR377WATP synthase subunitf (11.22/20)M171 D1YDR378C(13.56/20)M171 A4YDR381WNuclear RNA-bindingRNA annealingprotein (11.77/18)M40 B6YDR383C(27.75/34)M40 H7YDR385Wtranslation elongationfactor 2 (EF-2)(92.73/85)M39 A6YDR386W(69.63/70)M39 D6YDR389WGTPase activatingprotein (GAP) forRHO1 (72.05/72)M171 E1YDR394W(47.29/50)M171 C4YDR397C130-533 (16.27/30)M171 C5YDR398W(70.84/70)M171 C6YDR399W(24.42/34)M171 F7YDR400W(41.69/50)M171 G7YDR408Cglycinamide ribotidetransformylase(23.57/33)M171 C3YDR412W(25.96/50)M171 D6YDR415C(41.27/50)M171 E6YDR423C(45.02/51)M171 D3YDR428C(28.74/38)M171 E4YDR429C(30.27/40)M171 E5YDR430C(108.82/120)M170 A9YDR432WRNA binding proteininvolved inmitochondrial proteintargeting (45.65/48)M171 H1YDR434W(58.85/98)M171 E2YDR435C(36.11/46)M171 E3YDR436Wserine-threoninephosphatase Z(78.21/88)M171 G6YDR439W(38.38/52)M41 C1YDR444W(75.68/100)M173 B6YDR446WExtraCellular Mutant(33.33/42)M41 F1YDR447C318-725 Ribosomalprotein RP51B (ratS17) (15.07/26)M42 B8YDR448W(47.85/55)M41 A2YDR450W483-876 (16.27/20)M173 E3YDR452W(74.35/98)M41 D2YDR453C(21.59/21)M173 C6YDR454Cguanylate kinase(20.60/31)M173 G3YDR468C(24.67/38)M42 C7YDR471W416-795 60Sribosomal proteinL27 identical toYhr010p (15.07/28)M42 H9YDR473C(51.62/55)M42 E1YDR474C(61.08/60)M173 H3YDR476C(24.67/33)M172 D6YDR478Winterstrand crosslinkrepair protein(21.89/36)M173 H7YDR479C(60.97/64)M172 A9YDR480WMAP kinase-associated protein(35.64/52)M173 F10YDR481Crepressible alkalinephosphatase(62.39/70)M172 B1YDR482C(14.88/28)M173 C5YDR485C(89.13/89)M173 G6YDR486C(28.85/38)M172 G7YDR487C3 4-dihydroxy-2-butanone 4-phosphatesynthase (22.91/34)M42 G8YDR488C(58.66/48)M173YDR489W(32.45/36)G10M173 D5YDR493W(13.64/23)M173 E1YDR498Cmembraneglycoprotein sortedby HDEL retrievalsystem (42.26/60)M173 H2YDR499W(82.38/92)M173 A7YDR502CS-adenosylmethioninesynthetase (42.37/33)M41 E9YDR510WSuppressor of MifTwo (11.22/20)M173 G9YDR512C(20.60/28)M172 F10YDR513WGlutaredoxin(thioltransferase)(glutathionereductase) (15.84/28)M173 A3YDR515Wregulates the copper-dependentmineralization ofcopper sulfidecomplexes on the cellsurface in cellscultured in mediumcontaining coppersalts (49.38/50)M173 C4YDR516C(55.03/64)M172 E5YDR517W(41.03/55)M173 C7YDR518WProtein disulfideisomerase homolog(56.98/56)M173 E8YDR519WFKBP (FK506binding protein) 13\peptidylprolyl cis-trans isomeraseactivity (14.96/16)M173 D4YDR524C(53.05/60)M173 F8YDR527W(48.4/48)M172 H1YDR530C5′ 5″′-P-1 P-4-tetraphosphatephosphorylase II(35.78/50)M173 C3YDR531W(40.48/50)M173 A6YDR533C(26.10/26)M42 G6YDR534C(58.11/58)M174 E3YDR540C(19.72/34)M175 G3YEL003WPolypeptide 2 of aYeast Non-nativeActin BindingComplex homolog ofa component of thebovine NABCcomplex (13.64/30)M175 B5YEL004W(37.73/42)M175 A9YEL007W(73.47/97)M174 C1YEL009Ctranscriptionalactivator of aminoacid biosyntheticgenes (30.94/55)M175 C5YEL012Wubiquitin-conjugatingenzyme\ubiquitin-protein ligase(22.77/36)M3 G7YEL015W(60.72/64)M175YEL016C(54.36/90)C10M175 F2YEL017W(37.28/47)M175 A4YEL018W(30.8/38)M175 D5YEL019CProtein involved inDNA repair(29.40/36)M3 G6YEL021Worotidine-5′-phosphatedecarboxylase(29.48/35)M3 D1YEL024WRieske iron-sulfurprotein of themitochondrialcytochrome bclcomplex (23.76/30)M175 B4YEL026W(13.97/16)M175 A8YEL029C(34.45/47)M174 H8YEL030WExtra Cellular Mutant(70.95/98)M310 C2YEL034WTranslation initiationfactor eIF-5A(17.48/30)M174 E5YEL035C(18.39/28)M174 G6YEL036CMannan 8\Protein ofthe endoplasmicreticulum with a rolein retention ofglycosyltransferasesin the Golgi alsoinvolved in osmoticsensitivity andresistance toaminonitrophenylpropanediol(55.03/55)M174 H7YEL037Cubiquitin-like protein(43.81/60)M175 F10YEL039Ciso-2-cytochrome c(12.46/22)M3 A3YEL041W(54.56/60)M3 C6YEL044W(18.47/20)M3 C8YEL046CThreonine Aldolase(42.60/50)M175 G1YEL048C(16.75/26)M3 B3YEL049Wmember of theseripauperinprotein\/gene family(see Gene-classPAU) (13.31/15)M174 G5YEL051WVacuolar H-ATPaseD subunit of the V1catalytic sector(28.37/40)M3 D6YEL052WATPase family gene(56.1/60)M175 H1YEL056Wsubunit of acytoplasmic histoneacetyltransferase(44.22/54)M3 C4YEL058WPhosphoacetylglucosamine Mutase(61.38/64)M3 E8YEL061C(114.21/114)M3 D9YEL062WNon-membrane-embedded PESTsequence-containingprotein (68.75/68)M174 A2YEL063Carginine permease(64.93/55)M3 C3YEL064C(52.83/36)M174 H5YEL066W(19.8/32)M3 E9YEL070W(55.33/60)M3 B2YEL071W(54.67/55)M3 D3YEL072W(25.52/32)M175 H4YEL073C(11.80/26)M3 E3YER001WAlpha-1 3-mannosyltransferase(83.93/83)M174 H4YER002W(25.52/38)M175 F7YER004W(25.52/34)M310 D2YER005W(69.41/79)M174 D9YER006W(57.31/64)M177 F2YER010C(25.77/40)M177 C6YER014Wprotoporphyrinogenoxidase (59.4/64)M265 B3YER015WAcyl-CoA synthetase(fatty acid activator 2)(81.95/91)M176 E1YER016W(37.95/50)M5 E8YER020Wnucleotide bindingregulatory protein(49.5/42)M176 F1YER023Wdelta 1-pyrroline-5-carboxylate reductase(31.57/38)M176 F6YER029C(21.59/34)M177 A1YER030W(17.71/42)M176 H3YER034W(20.46/36)M176 G6YER037W(35.42/48)M177 F3YER042W(20.45/32)M176 C3YER048CDnaJ homolog with aleucine zipper(43.04/52)M176 D2YER055CATPphosphoribosyltransferase (32.70/36)M176 A6YER058WRequired forassembly of activecytochrome c oxidase(11.88/16)M176 D3YER062CDL-glycerol-3-phosphatase (27.53/36)M177 H3YER063W(24.09/50)M5 A6YER069WN-acetyl-gamma-glutamyl-phosphatereductase andacetylglutamatekinase (95.04/100)M176 F2YER076C(33.35/50)M5 B6YER077C(75.71/80)M177 B5YER079W(23.21/36)M5 C2YER089CProtein phosphatasetype 2C (51.07/55)M178 C4YER101C(47.33/60)M179 B6YER102W(22.11/36)M179 B7YER103Wmember of 70 kDaheat shock proteinfamily (70.73/98)M179 A1YER104W(22.99/38)M178 D4YER109Cputativetranscriptionalactivator of FLO1(15.54/28)M7 A3YER112WU6 snRNA-associatedprotein (20.68/55)M179 C6YER118CTransmembraneosmosensor(40.40/50)M178 B6YER119C(49.31/49)M178 D5YER125WSuppressor ofmutations in SPT3(89.1/89)M178 D1YER127W(39.48/50)M255 C3YER128W(22.44/37)M8 D3YER130C(48.76/55)M8 D4YER131W(13.2/20)M178 H1YER136WGDP dissociationinhibitor (49.72/98)M178 C2YER137C(16.31/29)M202 A3YER150W(16.49/60)M179 C2YER152C(48.76/60)M178 D2YER153Ctranslational activatorof cytochrome coxidase subunit III(27.97/35)M178 E3YER154W(44.33/50)M178 G4YER156C(37.21/45)M178 E1YER159Ctranscription factor(15.65/30)M178 E2YER161Cnon-specific DNAbinding protein (sin1)(36.66/50)M178 G5YER165WPoly(A) bindingprotein cytoplasmicand nuclear(63.58/98)M178 F3YER170WAdenylate kinase(mitochondrialGTP:AMPphosphotransferase)(24.86/33)M9 F3YFL-TYA(/75)M267 A1YFL001WSimilar to rRNAmethyltransferase(Caenorhabditiselegans) andhypothetical 28Kprotein (alkalineendoglucanase gene5′ region) fromBacillus sp.(4/8.7353)M267 E2YFL002CATP-dependent RNAhelicase (66./6966)M275 B5YFL005WRas-like small GTP-binding protein(23.7/633)M275 E6YFL006W(28.05/35)M267 F2YFL010C(23.24/34)M267 C6YFL012W(16.49/23)M275 F6YFL013C(76.25/89)M267 G2YFL016CDnaJ homologinvolved inmitochondrialbiogenesis andprotein folding(56.24/56)M10 C3YFL017C(17.52/?)M275 C4YFL018Cdihydrolipoamidedehydrogenaseprecursor (matureprotein is the E3component of alpha-ketoaciddehydrogenasecomplexes)(54.92/54)M9 A10YFL021Wtranscriptionalactivator with GATA-1-type Zn fingerDNA-binding motif(56.21/40)M267 D1YFL022CPhenylalanyl-tRNAsynthetase betasubunit cytoplasmic(55.46/59)M267 H2YFL023W(87.67/105)M267 A4YFL024C(91.55/101)M267 F7YFL027C(54.70/60)M267 G8YFL028CABC ATPase(31.82/34)M267 H9YFL029CCyclin-dependentkinase-activatingkinase (40.51/50)M267 G7YFL035CMob1p-like protein(28.52/37)M10 B6YFL037Wbeta-tubulin (50.48/?)M9 E4YFL038CRas-like GTP-bindingprotein\most similarto mammalian Rab1Aprotein (22.69/30)M274 G3YFL039C319-1436 Actin(41.46/49)M275 F5YFL040W(59.51/50)M275 A7YFL041W(68.53/98)M275 A9YFL043C(15.98/27)M9 G1YFL044C(33.14/40)M9 C3YFL045Cphospho-mannomutase(27.97/35)M9 F4YFL046W(22.88/32)M10 D7YFL047W(78.65/98)M267 F6YFL048C47 kDa type Itransmembraneprotein localized tothe Golgi (48.98/55)M267 A9YFL050CALuminiumResistance 2(94.41/104)M275 B9YFL051C(17.63/34)M275 G1YFL052W(51.36/49)M255 D3YFL053W(65.12/98)M275 H3YFL054C(71.09/65)M275 H5YFL056C(23.45/32)M275 B7YFL057C(16.75/25)M267 B9YFL058Wa thiamine regulatedpyrimidine precursorbiosynthesis enzyme(37.51/42)M275 C9YFL059W(32.89/47)M275 H1YFL060CSNZ3 proximal ORFstationary phaseinduced gene family(24.45/33)M275 B3YFL061W(24.86/32)M275 A4YFL062WProtein with strongsimilarity tosubtelomerically-encoded proteins suchas Cos5p Ybr302pCos3p Cos1p Cos4pCos8p Cos6p Cos9p(41.8/48)M9 B2YFL068W(17.71/25)M267 G5YFR001W(22.55/32)M255 E3YFR003C(17.08/41)M275 C8YFR004WSimilar to S. pombePAD1 gene product(33.77/46)M275 D9YFR005C(49.31/56)d A11YFR006W(58.96/?)M9 G3YFR007W(38.94/45)M267 G4YFR008W(24.42/36)M275 H4YFR009WMember of ATP-binding cassette(ABC) family ofproteins (82.83/80)M10 E11YFR010W(55/55)M267 E8YFR011C(18./7320)M275 D8YFR012W(22.33/27)M275 E9YFR013W(86.68/170)M9 D2YFR014Ccalmodulin dependentprotein kinase(49.09/40)M202 C3YFR015CGlycogen synthase(UDP-gluocse-starchglucosyltransferase)(77.91/110)M275 A5YFR017C(21.48/35)M267 C7YFR018C(39.96/52)M275 F9YFR021W(55.11/96)M272 A1YFR022W(80.74/101)M272 E2YFR023Wpoly(A) bindingprotein\related toPES4 proteinhomolog YHR015w(67.32/70)M273 A4YFR024C(41.06/50)M43 A6YFR025CHistidinolphosphatase(36.88/45)M273 B8YFR026C(18.62/34)M272YFR028Csoluble tyrosine-D10specific proteinphosphatase(60.64/62)M43 B6YFR032C(31.82/34)M272 H7YFR033Cubiquinol-cytochromec oxidoreductasesubunit 6 (17 kDa)(16.20/26)M43 C8YFR034Cmyc-type helix-loop-helix transcriptionfactor (34.45/48)M272 G2YFR037C(61.30/70)M272 B5YFR039C(56.13/64)M43 C6YFR040W155 kDa SIT4 proteinphosphatase-associated protein(99.66/100)M273 H6YFR040W155 kDa SIT4 proteinphosphatase-associated protein(99.66/99)M272 A8YFR041C(32.48/40)M272 F10YFR043C(26.10/33)M272 D1YFR044C(52.94/54)M255 G3YFR045W(19.69/50)M272 C4YFR046C(39.74/52)M43 B5YFR047C(32.48/40)M255 B4YFR048W(72.93/81)M333 C3YFR049Wmitochondrialribosomal protein(precursor) (13.64/14)M255 C4YFR050Cproteasome subunitnecessary for peptidylglutamyl peptidehydrolyzing activity(29.39/40)M273 E1YFR052Wcytoplasmic 32-34kDa protein(30.35/55)M272 A3YFR053CHexokinase I (PI)(also calledHexokinase A)(53.48/55)M273 G5YFR055W(37.51/45)M274 A4YGL001C(38.42/49)M272YGL002W(23.87/29)H10M273 F1YGL003C(62.39/63)M273 B3YGL004C(45.90/52)M272 E4YGL005C(30.72/40)M272 D8YGL008Cplasma membraneH+-ATPase(101.01/105)M272 F9YGL009Cisopropylmalateisomerase (85.72/95)M273 G1YGL011CProteasome subunitYC7alpha\/Y8(protease yscEsubunit 7) (27.75/31)M273 C3YGL012WSterol C-24 reductase(52.14/50)M324 E2YGL014W(97.79/105)M273YGL017Warginyl-tRNA-proteinA10transferase (55.44/70)M272YGL018C(20.37/30)A11M272 H1YGL019Wcasein kinase II betachain (30.69/40)M273 D3YGL020C(25.88/34)M272 B7YGL023C(69.88/79)M272 H9YGL025CProbable transcriptionfactor polyglutaminedomain protein(47.44/50)M272YGL026Ctryptophan synthetaseB11(77.80/82)M273 A2YGL027C(91.66/104)M273 E3YGL028C(59.65/64)M272 F4YGL029W(13.31/22)M273 B6YGL030W234-548 largeribosomal subunitprotein 32 (11.66/32)M272 C7YGL031CRibosomal proteinRPL30A (rp29)(YL21) (17.08/25)M272 E8YGL032Cadhesion subunit of a-agglutinin (9.606/20)M43 B2YGL035CZinc-finger protein(55.47/60)M272 H5YGL038Cmembrane-boundmannosyltransferase(52.83/64)M272 D7YGL039W(38.49/45)M272 C2YGL043WRNA polymerase IIelongation factor(34.1/43)M44 F3YGL044C(32.59/40)M272 A6YGL046W(28.93/35)M273 H7YGL047W(22.33/31)M273YGL049CmRNA cap-bindingD10protein (eIF-4F)130K subunit(100.57/101)M43 C10YGL050W(30.14/35)M301 A2YGL052W(11.22/18)M272 A5YGL053W(26.28/36)M272 B6YGL054C(15.21/20)M273 A8YGL055Wdelta-9-fatty aciddesaturase (56.21/60)M43 A8YGL056C(58.00/60)M272YGL057C(31.60/34)C10M202 E3YGL058WUbiquitin conjugatingenzyme involved inan error-prone DNA-damage recoverypathway (19.03/33)M310 A3YGL059W(49.06/60)M45 E1YGL061C(27.20/?)M180 B1YGL067W(42.45/50)M180 A2YGL068W(21.45/32)M180 C1YGL075C(42.60/50)M181 E5YGL080W(14.41/33)M181 G7YGL082W(42.02/62)M181 B5YGL087C97-499 homolog ofhuman CROC-1 geneprotects yeast cellsfrom DNA damage(15.28/25)M180 H8YGL090W(46.42/64)M181 G5YGL096W(30.47/20)M180 D3YGL101W(23.76/34)M180 C4YGL102C(15.65/16)M180 H7YGL105Wassociated with tRNAand amino acyl-tRNAsynthetases.(41.47/52)M180 B9YGL106Wmyosin light chain(16.5/20)M180 E1YGL107C(71.09/68)M180 E2YGL108C(15.43/20)M180 D5YGL111W(51.04/51)M180 A8YGL113W(73.59/54)M181 D1YGL115WProtein involved inderepression ofglucose-repressedgenes (35.53/48)M310 B3YGL116Wbeta-transducinhomolog (67.21/70)M180 C9YGL122Cnuclearpolyadenylated RNAbinding protein(57.78/64)M180 G1YGL123Wribosomal protein S4(28.05/34)M180 G3YGL125Wmethlyenetetrahydrofolatereductase (mthfr)(66/66)M181 D4YGL126W(41./9141)M45 A2YGL134WPHO85 cyclin(47.7/450)M44 G7YGL138C(37.98/52)M44 H7YGL146C(34.24/36)M181 F1YGL147CRibosomal proteinYL11 (rp25) (rp24)(E. coli L6) (rat L9)(21.04/40)M181 G2YGL148WChorismate synthase(41.47/50)M181 E7YGL153WPeroxisomalperipheral membraneprotein (peroxin)(37.62/57)M182 A1YGL155Wpolypeptide subunitof a yeast type 1proteingeranylgeranyltransferase (41.47/41)M183 C3YGL157W(38.38/38)M182 A2YGL164C(48.43/64)M182 D4YGL166Wregulator ofmetallothionein(CUP1) expression(24.86/36)M183 A8YGL169WProtein involved intranslation initiation(46.97/46)M182 B1YGL171WContains domainsfound in the DEADprotein family ofATP-dependent RNAhelicases\high-copysuppressor of kem1null mutant(62.25/64)M183 B2YGL172Wnuclear pore complexprotein with GLFGrepetitive sequencemotif (52.03/60)M182 E4YGL174W(29.47/36)M182 G5YGL175C(37.98/55)M183 B1YGL179C(61.63/77)M183 E3YGL181WGlycine-threonine-serine repeat protein(43.67/54)M182 A7YGL184C(51.28/51)M183 C8YGL185C(41.72/48)M183 H5YGL191Wsubunit VIa ofcytochrome c oxidase(14.3/16)M183 D8YGL193C(11.46/16)M182 E9YGL194CProtein withsimilarity to Hda1pRpd3p Hos1p andHos3p (49.75/64)M182 C7YGL200Ctype Itransmembraneprotein component ofCOPII-coated ER-derived transportvesicles (22.46/32)M183 H3YGL205Wfatty-acyl coenzymeA oxidase (82.49/82)M183 B6YGL207Wtranscription factor(113.96/113)M182 G9YGL210Wras-like GTPase(24.53/32)M274 B4YGL213Cantiviral protein(43.70/52)M183 G7YGL216W(88.66/90)M182 G2YGL220W(13.31/16)M183 B4YGL221C(31.71/36)M183 A5YGL222C(19.38/19)M183 D6YGL223C(45.90/54)M182 F7YGL224C(30.83/38)M183 G9YGL226W(13.64/13)M182 H2YGL228W(63.58/63)M183 B5YGL230C(16.20/27)M182 G7YGL232W116-928(31.9/38)M182YGL234Wglycinamide ribotideB10synthetase andaminoimidazoleribotide synthetase(88.33/88)M182 B4YGL237Ctranscriptionalactivator protein ofCYC1 (29.28/36)M182 H7YGL240W(31.24/38)M182YGL242C(19.94/32)C10M182 H1YGL243W(44.11/50)M183 B3YGL244Wnuclear proteinunknown function(61.49/68)M183 D4YGL245W(79.75/79)M183 G6YGL247W(21.78/30)M182YGL250W(27.06/38)D10M256 D3YGL253WHexokinase II (PII)(also calledHexokinase B)(53.57/55)M256 E4YGL254WSulfur permease II(33/36)M184 G6YGL256Walcoholdehydrogenaseisoenzyme IV(51./2651)M46 A6YGL258W(22.7/723)M184 A1YGL259W(18.36/28)M256 G6YGR001C443-675(21.34/31)M256 A8YGR002C(52.49/58)M256 B9YGR003W(81.95/90)M256 B1YGR004W(50.93/55)M256 D2YGR005Ctranscription initiationfactor TFIIF middlesubunit (44.03/60)M184 F4YGR007Wcholine phosphatecytidylyltransferase(also calledphosphoethanolaminecytidylyltransferaseor phosphocholinecytidylyltransferase)(35.64/36)M184 H5YGR008C(9.376/9)M256 B8YGR010W(43.56/51)M256 E2YGR013W(68.31/75)M46 H2YGR015C(36.11/40)M184 A6YGR016W(21.01/30)M184 B7YGR017W(32.78/38)M256 C8YGR018C(12.02/17)M256 D9YGR019Wgamma-aminobutyrate(GABA) transaminase(4-aminobutyrateaminotransferase)(51.92/54)M184 E2YGR021W(32.01/38)M184 B6YGR024C(26.10/34)M256 E9YGR027C(11.91/16)M256 E1YGR028W40 kDa putativemembrane-spanningATPase (39.93/50)M256 G2YGR029W(12.98/16)M184 A5YGR031W(37.73/38)M256 C7YGR033C(26.32/31)M256 F9YGR035C(12.79/17)M256 H2YGR037CAcyl-CoA-bindingprotein(ACBP)\/Diazepambinding inhibitor(DBI)\/endozepine(EP) (9.606/14)M184 A4YGR038W(24.53/34)M184 B5YGR039W(11.44/11)M184 C6YGR040WMAP protein kinasehomolog involved inpheromone signaltransduction(40.59/50)M256 D7YGR041W(60.38/63)M184 F8YGR042W(29.92/32)M256 G9YGR043C(36.66/44)M184 F1YGR044Cnegative regulator ofmeiosis (33.03/36)M256 C5YGR047Ctranscription factortau (TFIIIC) subunit131 (112.78/115)M184 D6YGR048W(39.82/50)M256 E7YGR049WProtein thatsuppresses ts allele ofCDC4 whenoverexpressed(20.68/30)M184YGR051C(11.80/12)A10M184 G1YGR068C(64.49/48)M46 A4YGR072Wup-frameshiftsuppressor (42.68/45)M256 G8YGR074WHomolog of humancore snRNP proteinD1 involved insnRNAmaturation (16.27/24)M256YGR075CRNA splicing factorA10(26.65/37)M46 B1YGR076CMitochondrialribosomal proteinMRPL25 (YmL25)(17.30/30)M184 D4YGR078CPolypeptide 3 of aYeast Non-nativeActin BindingComplex homolog ofa component of thebovine NABCcomplex (21.92/30)M256 E6YGR080W(36.63/44)M184 H7YGR081C(23.13/33)M184 A9YGR082W20 kDa mitochondrialouter membraneprotein importreceptor (20.24/20)M46 B7YGR083Ctranslational repressorof GCN4 protein(71.64/90)M185 E3YGR103W(66.66/66)M185 B7YGR106C(29.28/42)M185 A2YGR109CB-type cyclin(41.83/47)M185 G2YGR110W(49.06/50)M186 B5YGR112WMitochondrial proteinnecessary forrespiration (42.9/50)M185 G3YGR119CContains GLFGrepeats in N-terminalhalf and heptadrepeats in C-terminalhalf (59.54/62)M185 H4YGR120C(30.38/40)M185 D7YGR122W(44.33/54)M186 C1YGR124Wasparagine synthetase(63.03/63)M186 C4YGR127W(34.43/40)M185 C6YGR129W(23.76/34)M185 E7YGR130C(89.79/110)M185 C1YGR132CProhibitin(31.60/40)M186 D4YGR135Wproteasomecomponent Y13(28.49/36)M185 B5YGR136W(26.62/58)M55 A4YGR137W(13.75/15)M185 C5YGR144Wcomponent of thebiosynthetic pathwayproducing thethiazole precursor ofthiamine(35.97/60)M185 E6YGR145W(77.88/70)M185 H8YGR147CN alpha-acetyltransferase thatacts on methioninetermini (31.71/35)M54 D1YGR148CRibosomal proteinRPL30B (rp29)(YL21) (17.08/20)M54 A5YGR152CGTP-binding proteinof the ras superfamilyinvolved in bud siteselection(29.95/38)M185 F6YGR153W(23.98/34)M186 G7YGR154C(39.29/50)M55 D5YGR155WCystathionine beta-synthase (55.88/55)M55 E1YGR156W(46.86/45)M185 C3YGR158C(27.53/34)M186 F4YGR159Cnuclear localizationsequence bindingprotein (45.57/64)M186 F5YGR160W(22.44/48)M185 G6YGR161C(28.96/38)M186 H8YGR163W(37.62/45)M185 D4YGR167WClathrin light chain(25.74/28)M185 H6YGR169C(44.47/60)M54 G6YGR171Cmitochondrialmethionyl-tRNAsynthetase (63.38/63)M55 G1YGR172C(27.31/30)M185 D3YGR174CUbiquinol-cytochrome creductase assemblyfactor (18.73/27)M185 A7YGR177CAlcoholacetyltransferase(58.88/66)M185 C8YGR178C(79.45/79)M277 A1YGR180CRibonucleotideReductase (37.98/48)M276 C2YGR181W(11.66/14)M276 B3YGR182C(12.90/17)M277 F6YGR185Ctyrosyl-tRNAsynthetasecytoplasmic(43.47/50)M276 C8YGR187C(43.47/51)M276 D2YGR189C(55.80/55)M255 C5YGR192CGlyceraldehyde-3-phosphatedehydrogenase 3(36.55/47)M277 E5YGR192CGlyceraldehyde-3-phosphatedehydrogenase 3(36.55/48)M276 E6YGR193CProtein X componentof mitochondrialpyruvatedehydrogenasecomplex (45.13/63)M276 D7YGR194C(66.03/64)M277 B1YGR196C(89.90/115)M276 E2YGR197Cinvolved innitrosoguanidineresistance (60.20/63)M277 F3YGR198W(89.98/98)M276 E7YGR202Cphosphorylcholinetransferase\orcholinephosphatecytidylyltransferase(46.67/58)M276 E8YGR203W(16.49/20)M277 C1YGR204WC1-5 6 7 8-tetrahydrofolatesynthase (104.27/105)M276 F2YGR205W(32.01/37)M56 H5YGR210C(45.24/50)M276 F8YGR211W(53.57/70)M276 D1YGR212W(51.59/52)M276 D4YGR215W(12.54/16)M277 G4YGR219W(12.21/16)M276 E1YGR220CMitochondrialribosomal proteinMRPL9 (YmL9)(E. coli L3)(humanMRL3) (29.62/35)M276 E4YGR223C(49.31/53)M276 F1YGR228W(12.65/13)M277 A3YGR229C57 kDa nuclearprotein (55.58/55)M276 F3YGR230W(15.28/20)M276 F5YGR232W(25.29/26)M276 H7YGR234WFlavohemoglobin(44/48)M276 H8YGR235C(25./6636)M276 G4YGR239C(31.71/38)M277 B6YGR240Cphosphofructokinasealpha subunit(108.60/108)M276 A8YGR242W(11.33/13)M276 A9YGR243W(16.27/18)M276 H1YGR244C(47.00/50)M276 H3YGR246CRNA polymerase IIItranscription factorwith homology toTFIIB (65.59/90)M276 H4YGR247W(26.4/35)M276 H5YGR248WSimilar to SOL3(28.26/36)M277 C7YGR249W(50.27/60)M276 B8YGR250C(85.94/100)M276 B9YGR251W(21.67/35)M265 D4YGR252Wpositive regulator ofGCN4 expression andactivity of the HAP2--HAP3--HAP4transcriptionalactivation complex(48.4/56)M276 H2YGR253CProteasome subunit(28.63/36)M202 B4YGR254Wenolase I(48.28/55)M276 A5YGR255CCOQ6monooxygenase(52.72/53)M276 A6YGR256W6-phosphogluconatedehydrogenase(54.23/55)M276 A7YGR257C(40.39/47)M276 C9YGR259C(16.09/19)M276 A4YGR262C(28.74/35)M277 E6YGR264Cmethionyl tRNAsynthetase (82.64/84)M276 D9YGR267CGTP-cyclohydrolase I(26.76/35)M56 G1YGR268C(21.81/25)M276 A3YGR269W(11.99/17)M301 F2YGR274CComponent of theTAFII complexrequired for activatedtranscription(117.39/120)M277 F9YGR275W(20.57/31)M260 D2YGR277C(33.58/42)M260 G3YGR278W(63.58/64)M190 A5YGR279C(42.49/51)M49 H3YGR280C(29.84/45)M260 B1YGR284C(34.13/35)M260 E2YGR285CZuotin putative Z-DNA binding protein(47.66/55)M190 G3YGR286CBiotin synthase(41.38/49)M190 B5YGR287C(64.82/64)M260 F6YGR288W(52.14/60)M190 H3YGR294W(13.31/18)M190 H8YHL002W(49.83/60)M260 E10YHL003C(45.24/45)M260 D1YHL004Wmitochondrialribosomal protein(43.45/48)M260 E5YHL007Cputativeserine\/threonineprotein kinase(103.32/125)M190 F7YHL009C(36.33/48)M260 E1YHL012W(54.34/57)M190 H2YHL013C(33.80/48)M260 H2YHL013C(33.80/45)M190 E5YHL015W(13.42/19)M260 E9YHL018W(13.31/18)M190 E10YHL019Chomologous to themedium chain ofmammalian clathrin-associated proteincomplex (66.58/64)M190 F1YHL020Cnegative regulator ofphospholipidbiosynthesis(44.47/50)M260 A3YHL021C(51.28/51)M260 D4YHL022Cmeioticrecombination protein(43.81/52)M260 B7YHL024W(78.54/85)M190 H7YHL025Wtranscriptionalregulator (36.63/50)M260YHL027WRim 101 protein isH10similar to theAspergillus pH-response regulatorPacC (68.86/80)M260 B3YHL029C(74.72/75)M190 G5YHL031C(24.56/30)M190 A8YHL033CRibosomal proteinRPL4A (rp6) (YL5)(human L7a) (mouseL7a) (rat L7a)(RPL4A and RPL4Bcode for nearlyidentical proteins)(28.29/32)M260 G9YHL034C(32.47/44)M260 H5YHL039W(64.46/75)M260 H9YHL042W(16.61/20)M49 E1YHL044W(25.96/30)M260 F4YHL046C(13.33/22)M260 E7YHL048WProtein withsimilarity tosubtelomerically-encoded proteins suchas Cos5p Ybr302pCos3p Cos1p Cos4pCos8p Cos6p Cos9p(42.02/45)M190 C8YHL049C(29.84/38)M190 F9YHL050C1414-2866(76.78/98)M260YHR001W(48.28/52)B11M260 E3YHR002W(39.48/59)M260YHR007Ccytochrome P450B10lanosterol 14a-demethylase(58.33/60)M190YHR008CManganese-A11containing superoxidedismutase (25.66/33)M190 B2YHR009C(57.56/58)M260 H4YHR011W(49.27/50)M260 C6YHR012W168-968(31.13/47)M49 F4YHR013Csubunit of the majorN alpha-acetyltransferase(26.21/30)M260 H8YHR014W(32.12/42)M260YHR016C216-1575(51.59/55)D11M260 C2YHR017W(42.46/55)M190 F3YHR018Cargininosuccinatelyase (50.96/53)M190 H4YHR019CAsparaginyl-tRNAsynthetase (60.97/60)M260 D6YHR020W(75.79/85)M190 F8YHR022C(28.29/35)M188 A1YHR025Whomoserine synthase(39.48/39)M261 G3YHR027C(109.2/125)M188 B5YHR029C(32.47/36)M261 A8YHR030Cputative proteinkinase (53.37/58)M188 B1YHR033W(46.64/50)M261 D5YHR036W(51.92/60)M261 G6YHR037Wdelta-1-pyrroline-5-carboxylatedehydrogenase(63.46/58)M188 C7YHR039BC(12.65/18)M61 C1YHR040W(40.47/50)M188 C1YHR040W(40.47/40)M261 E5YHR043C(27.09/34)M61 B7YHR045W(61.71/45)M61 D1YHR048W(56.65/60)M188 A3YHR049W(26.84/35)M188 E6YHR052W(41.47/41)M261 F9YHR053Ccopper-bindingmetallothionein(6.746/15)M261YHR054C(38.97/36)B11M261 E1YHR055Ccopper-bindingmetallothionein(6.746/18)M261 C4YHR057CPeptidylprolylisomerase(cyclophilin) ER orsecreted (22.58/32)M188 B4YHR058C(32.48/38)M188 F6YHR060Wrequired for V-ATPase activity(20.02/30)M188 F7YHR061C(34.57/38)M261YHR062CProtein subunit ofC11nuclear ribonucleaseP (RNase P)(32.36/42)M61 E2YHR064CHsp70 Protein(62.95/64)M261 D4YHR065C(59.76/60)M261 C7YHR067W(30.91/30)M188 A9YHR070W(55/55)M261 G1YHR071WPHO85 cyclin(25./333)M188 D4YHR074W(78.6/598)M261 D7YHR075C(44.03/45)M261 G8YHR076W(41.25/43)M61 F8YHR077CProtein involved indecay of mRNAcontaining nonsensecodons (120.04/120)M61 F2YHR079Cputative proteinkinase (122.68/40)M261 A6YHR081W(20.45/31)M261 A2YHR086Wputative RNA bindingprotein (57.64/63)M188 F4YHR089Csmall nucleolar RNPproteins (22.58/30)M188 A6YHR090C(31.05/38)M261 C6YHR097C250-1225(40.47/48)M261YHR100C(20.48/25)D10M261YHR101C198-1095(36.96/48)H11M61 H2YHR103W(93.83/90)M261 A5YHR104W(36.08/40)M261 D6YHR105W(23.65/34)M188 B6YHR106WThioredoxinreductase (37.73/38)M61 H7YHR107CComponent of 10 nmfilaments of mother-bud neck (septin)(44.80/50)M261 E10YHR108W(64.46/64)M188 F9YHR109W(64.46/64)M261 F3YHR111W(48.51/59)M261 B5YHR112C(41.61/47)M188 A5YHR113W(54.01/54)M261 H7YHR114W(69.74/75)M261 B9YHR115C(45.79/56)M189 C4YHR121W(20.68/32)M189 B2YHR127W(26.84/36)M189 D3YHR128WUPRTase(27.72/36)M189 A7YHR132CExtraCellular Mutant(47.33/50)M63 F1YHR135Cmembrane-boundcasein kinase Ihomolog (59.21/60)M189 E3YHR136C17 kDa protein(16.31/28)M189 D4YHR137Waromatic amino acidaminotransferase II(56.54/64)M189 D5YHR138C(12.57/13)M189 E5YHR144CdCMP deaminase(34.45/38)M191YHR147CMitochondrialD10ribosomal proteinMRPL6 (YmL6)(23.57/32)M189 E4YHR151C(57.89/66)M191 F1YHR156C(37.43/57)M191 A8YHR161C(70.10/80)M64 G4YHR163Wweak multicopysuppressor of los1-1(30.91/32)M191 D5YHR167W(28.82/35)M189 E6YHR169W(47.52/50)M310 F3YHR170Wputative Upflp-interacting protein(57.09/64)M64 H4YHR171W(69.41/64)M255 F5YHR172WSpindle Pole Bodycomponent with anmolecular weight of97 kDa(90.64/100)M189 G3YHR174Wenolase(48.28/48)M189 F6YHR177W(49.94/52)M189 C8YHR179WNAPDHdehydrogenase (oldyellow enzyme)isoform 2 (44.11/50)M191 D4YHR182W(86.46/86)M63 G3YHR183WPhosphogluconateDehydrogenase(Decarboxylating)(53.9/50)M189 G1YHR188C(67.13/67)M189 H5YHR192W(30.69/36)M191 E8YHR193CGAL4 enhancerprotein homolog ofhuman alpha NACsubunit of thenascent-polypeptide-associated complex(19.17/34)M191YHR195W(35.42/40)B11M191 H1YHR196W(63.46/66)M189 B5YHR199C(34.13/38)M191 F8YHR201CCytosolicexopolyphosphatase(43.70/43)M191 G9YHR202W(66.33/40)M189 B3YHR205WcAMP-dependentprotein kinasehomolog suppressorof cdc25ts (90.75/98)M189 B4YHR206W(68.53/68)M191 A6YHR207C(57.89/67)M189 A6YHR208WBranched-ChainAmino AcidTransaminase(43.34/48)M191 G8YHR209W(32.12/32)M191 H9YHR210C(37.54/48)M194 G1YHR213W(21.89/32)M194 G3YHR214W(22.44/34)M65 C4YHR216W(57.64/60)M65 C3YIL003W(32.34/32)M194 H3YIL010W(23.76/36)M192 F7YIL020C(28.74/36)M194 C1YIL022W48.8 kDa proteininvolved inmitochondrial proteinimport (47.52/50)M65 F3YIL026CIrregular(126.53/50)M192 D6YIL027C(15.54/20)M192 E4YIL033Cregulatory subunit ofcAMP-dependentprotein kinase(45.79/55)M65 E1YIL038CGeneral negativeregulator oftranscription\mayinhibit RNApolymerase IItranscriptionmachinery (91.99/60)M192 F3YIL040W(15.39/22)M65 G2YIL041W(35.97/20)M192 E5YIL042C(43.47/50)M310 G3YIL043Ccytochrome breductase (35.45/42)M192 D9YIL053WDL-glycerol-3-phosphatase(29.92/38)M194 E4YIL057C(18.07/20)M194 D2YIL063CYeast Ran-Bindingprotein 2 (36.00/40)M192 G3YIL064W(28.48/36)M192 F9YIL069C413-817 40Sribosomal proteinS24E (RP50)(14.96/18)M65 G1YIL070C(29.39/36)M65 A2YIL071W(/35)M192 D8YIL076W(3/9.649)M192 G9YIL077C(35/.2339)M192 B5YIL082W(32./0140)M192 B7YIL083C(40.2/848)M67 A1YIL086C(11.35/16)M67 D2YIL087C(17.30/20)M195 A4YIL089W(22.66/33)M67 A9YIL093C(29.07/30)M67 B1YIL094C(40.84/50)M67 E2YIL095Wprobableserine\/threonine-protein kinase(89.21/90)M195 A3YIL096C(36.99/50)M195 B4YIL097W(56.87/60)M67 E5YIL098C(17.08/17)M67 F6YIL099Wintracellularglucoamylase(60.5/60)M195 A2YIL103W(46.86/56)M195 B3YIL104C(55.80/55)M195 C4YIL105C(75.49/75)M195 A5YIL106WMps One Binder(26.07/28)M195 A6YIL107C6-Phosphofructose-2-kinase (91.00/100)M195 B2YIL111W90-544 Cytochrome-coxidase chain Vb(16.72/20)M255 A6YIL113W(23.1/33)M195 B5YIL114Cvoltage dependentanion channel(YVDAC2)(30.94/40)M195 B7YIL116Whistidinol-phosphateaminotransferase(42.46/54)M67 D9YIL117C(35.01/35)M67 E1YIL118Wras homolog-GTPbinding protein(25.52/30)M195 C2YIL119Cinhibitor of ras(44.80/54)M66 D4YIL122W(38.72/38)M195 C7YIL124W(32.78/45)M67 E9YIL125Walpha-ketoglutaratedehydrogenase(111.65/116)M195 D2YIL127C(22.69/38)M195 B6YIL131C(53.37/38)M195 D7YIL132C(23.46/33)M66 F1YIL134Wmitochondrial innermembrane carrierprotein for FAD(34.32/36)M195 D3YIL136W45-kDa mitochondrialouter membraneprotein (43.34/43)M66 E4YIL138CTropomyosin isoform2 (17.74/17)M67 G9YIL141W(14.3/14)M195 E1YIL142WCytoplasmicchaperonin of the Cctring complex relatedto Tcp1p\subunitbeta (58.08/65)M67 H3YIL144W(76.12/80)M67 C7YIL147Chistidine kinaseosmosensor thatregulates anosmosensing MAPkinase cascade and issimilar to bacterialtwo-componentregulators(134.23/135)M67 H9YIL149C(184.72/185)M195 E3YIL152W(25.96/34)M66 B4YIL153W(43.34/43)M196 G5YIL154CProtein involved innucleo-mitochondrialcontrol of maltosegalactose andraffinoseutilization (38.09/38)M195 D6YIL155Cglycerol-3-phosphatedehydrogenasemitochondrial(71.42/40)M67 F8YIL156WUbiquitin-specificprotease (117.92/117)M195 F3YIL160Cperoxisomal 3-oxoacyl CoA thiolase(45.90/55)M196 H5YIL162Winvertase (sucrosehydrolyzing enzyme)(58.63/64)M196 B8YIL164C(21.92/32)M67 E7YIL171W(12.1/12)M67 C2YIL174W(8.46/8)M67 D4YIL176C(13.23/20)M195 G5YIR001C(27.53/38)M67 H8YIR003W(74.8/75)M195 A9YIR004W(47.63/89)M197 B2YIR006CPAB-dependentpoly (A) ribonuclease(162.83/180)M310 H3YIR007W(84.15/94)M198 B4YIR008Cp48 polypeptide ofDNA primase(45.02/55)M197 B7YIR010W(63.47/70)M68 C7YIR011Crestores proteintransport whenoverexpressed andrRNA stability to asec23 mutation(35.12/40)M69 C5YIR012W(47.52/50)M69 B1YIR014W(30.47/36)M198 G5YIR017CTranscriptionalactivator of sulfuramino acidmetabolism(20.60/32)M197 C7YIR018W(27.06/40)M69 A4YIR026nitrogen starvationinduced proteinphosphatase(40.07/48)M198 H7YIR027Callantoinase (50.63/52)M197 D1YIR029Wallantoicase (37.84/48)M197 E2YIR030C(26.87/33)M198 E4YIR032Cureidoglycolatehydrolase (21.48/34)M197 E7YIR034Csaccharopinedehydrogenase(41.06/48)M68 E7YIR035C(27.97/36)M197 F9YIR036C(28.96/34)M197 E1YIR037Wputative glutathione-peroxidase (18.04/33)M197 F2YIR038C(25.77/35)M197 F7YIR042C(25.99/35)M197 A4YJL003W(13.09/18)M68 E4YJL004CMulticopy suppressorof ypt6 null mutation(22.46/30)M197 H9YJL008CComponent ofChaperoninContaining T-complex subunit eight(62.51/62)M197 B4YJL011C(17.74/27)M310 A4YJL013CCheckpoint proteinrequired for cell cyclearrest in response toloss of microtubulefunction (56.68/65)M197 H7YJL014WCytoplasmicchaperonin subunitgamma (58.85/60)M69 F5YJL016W(18.92/28)M197 C4YJL019W(68.31/70)M68 G5YJL021C(40.28/50)M197 A2YJL025W(56.65/60)M68 H5YJL029C(90.45/90)M69 D4YJL030Wputative calciumbinding protein(21.67/32)M197 A9YJL031CGeranylgeranyltransferase Type II alphasubunit (PGGTase-IIalpha subunit)(31.93/40)M197 E4YJL035C(27.53/37)M197 H5YJL036W(46.64/50)M68 G2YJL043W(28.48/40)M197YJL049W(49.61/60)D10M197 F2YJL052WGlyceraldehyde-3-phosphatedehydrogenase 1(36.63/45)M197 A7YJL054W(52.69/34)M197 B8YJL055W(27.06/36)M268 B2YJL059WHomolog of humanCLN3 (44.99/45)M199 F4YJL061W82-kDa protein withputative coiled-coildomain has carboxy-terminal domaincontaining heptadrepeats that bindsNsp1p\nucleoporin(78.54/80)M268 C5YJL062W(91.41/98)M199 E9YJL065C(18.40/35)M199 B1YJL066C(27.75/40)M199 F9YJL073WDnaJ-like protein ofthe endoplasmicreticulum membrane(76.23/70)M199 B7YJL079CSimilar to plant PR-1class of pathogenrelated proteins(32.92/60)M199 D1YJL082W(80.52/80)M268 E2YJL083W(66.55/74)M71 B3YJL084C(115.09/80)M199 E8YJL088WOrnithinecarbamoyltransferase(48.51/40)M268 D1YJL090C(84.07/98)M199 F8YJL096W(24.75/30)M268 D9YJL097W(23.98/29)M199 G3YJL100W(66.88/70)M265 E5YJL103C(68.01/70)M199 G8YJL104W(16.5/20)M268 E9YJL105W(61.71/64)M268 F1YJL106WHomolog of thehuman core snRNPprotein E\Serine\/Threonineproteinkinase (71.06/88)M268 G5YJL110CGATA zinc fingerprotein 3 (60.64/70)M71 A5YJL111W(60.61/60)M71 F5YJL112W(78.65/80)M268 G1YJL114W(45.65/52)M71 D2YJL115WAnti-silencing proteinthat causes depressionof silent loci whenoverexpressed(30.8/50)M268 A3YJL115WAnti-silencing proteinthat causes depressionof silent loci whenoverexpressed(30.8/46)M71 H3YJL117WPutative inorganicphosphate transporter(34.32/40)M199 H1YJL122W(19.46/28)M71 E2YJL123C(52.61/50)M199 B4YJL124C(18.95/32)M70 G3YJL126W(33.88/40)M268 G8YJL128Cprotein kinasehomolg (73.51/80)M199 D3YJL131C(39.19/48)M199 E5YJL133Wmitochondrial carrierprotein (34.65/40)M71 F1YJL138Ctranslation initiationfactor (43.48/44)M268 D3YJL139C(47.11/53)M199 D4YJL140Wfourth-largest subunitof RNA polymeraseII (24.42/34)M199 A8YJL143W16.5 kDa innermembrane proteinrequired for import ofmitochondrialprecursor proteins(17.49/20)M70 E6YJL145W(32.45/36)M199 B2YJL146WIME2-DependentSignalling (51.7/30)M199 F3YJL147C(42.05/47)M199 E4YJL148WRNA polymerase Isubunit not shared(A34.5) (25.74/40)M199 B8YJL151C(14.66/28)M201 D2YJL155CFrutose-2 6-bisphosphatase(49.75/55)M73 H3YJL156C(75.60/80)M201 B5YJL157CFactor arrest protein(91.33/98)M73 G5YJL158CProtein withhomology toHsp150p and Pir1pPir2p and Pir3p(25.00/60)M73 B1YJL162C(53.05/64)M200 D6YJL166WUbiquinolcytochrome-creductase subunit 8(11 kDa protein)(10.45/12)M201 B7YJL167WFarnesyl diphosphatesynthetase (FPPsynthetase)(38.83/48)M201 B1YJL170CAn a-specific genethat is induced to ahigher expressionlevel by alpha factor(20.26/28)M201 B4YJL172WcarboxypeptidaseyscS (63.47/75)M72 D5YJL174W(30.47/34)M201 C7YJL175W(18.81/28)M73 F8YJL176Ctranscription factor(90.78/90)M72 C1YJL178C(21.59/28)M73 B4YJL180C(35.78/36)M201 D5YJL181W(67.32/67)M73 G8YJL184W(13.64/20)M200 E1YJL186W(64.57/77)M73 C6YJL190CRibosomal proteinRPS24 (14.33/16)M73 H8YJL192C(25.77/50)M201 A3YJL195C(25.66/25)M73 A9YJL200C(86.82/45)M200 C3YJL203WRNA splicing factor(30.91/43)M72 F8YJL208Cmitochondrialnuclease (36.22/42)M201 G1YJL210WRequired forperoxisomebiogenesis (29.92/32)M201 C3YJL211C(16.20/22)M200 A2YJL218W(21.67/31)M201 G7YJL223C(13.23/20)M73 B2YJR002W(65.34/70)M201 A2YJR002W(65.34/80)M72 C6YJR006W(53.68/55)M72 E7YJR007WTranslation initiationfactor eIF-2 alphasubunit (33.55/40)M72 H8YJR008W(37.39/42)M255 E6YJR009Cglyceraldehyde 3-phosphatedehydrogenase(36.55/50)M201 F3YJR010WATP sulfurylase(56.32/68)M73 A5YJR011C(28.74/35)M201 G5YJR012C(22.80/34)M200 D8YJR014W(21.89/34)M72 C10YJR016Cdihydroxyaciddehydratase(64.48/64)M201 C2YJR017CPeptidyl-prolylcis\/trans isomerase(PPIase) (20.93/33)M201 A5YJR019Cperoxisomal acyl-CoA thioesterase(38.42/45)M200 E8YJR022W(14.29/22)M206 A1YJR025C3-hydroxyanthranilicacid dioxygenase(19.50/34)M205 B2YJR026W(48.51/50)M205 E4YJR028W(48.51/55)M205 C2YJR034WRequired forassembly of activecytochrome c oxidase(11.99/16)M205 D3YJR043C(38.53/47)M205 G5YJR045CMitochondrial matrixprotein involved inprotein import\subunit of SceIendonuclease(71.97/72)M205 B7YJR046W(66.55/75)M205 G9YJR048Ciso-1-cytochrome c(12.1/16)M205 C1YJR049C(58.33/64)M205 E3YJR051Wosmotic growthprotein (55.22/60)M205 F4YJR052W(62.36/64)M205 C7YJR054W(54.78/55)M205 E8YJR055WProtein required forgrowth at hightemperature(18.25/32)M205 H9YJR056C(25.99/36)M205 D1YJR057Wthymidylate kinase(23.87/33)M202 B5YJR060Wbasic helix-loop-helixprotein (38.72/38)M205 A6YJR061W(102.96/100)M205 D7YJR062C52-kDa amidasespecific for N-terminal asparagineand glutamine(50.30/50)M205 F3YJR067C(15.54/25)M205 B6YJR069C(21.70/33)M205 E7YJR070C(35.78/45)M52 D2YJR074W(24.09/32.0)M205 G3YJR075Wputativemannosyltransferase(43.67/44)M52 E4YJR076CComponent of 10 nmfilaments of mother-bud neck (45.68/50)M52 E5YJR077Cmitochondrial proteinimporter receptor(34.24/38)M205 F7YJR078W(49.94/50)M205YJR080C(43.47/40)C10M205 F1YJR080C(12.46/20)M205 G2YJR083C(34.02/63)M205 D6YJR086wgamma subunit of Gprotein coupled tomating factorreceptors (12.21/16)M205 H8YJR088C(32.25/48)M205YJR089W(105.05/100)D10M205 B5YJR093C(36.00/36)M303 F3YJR094Cmeiotic geneexpression\meiosisinducing protein(39.63/50)M205 A9YJR095Wprotein related tomitochondrial carriers(35.53/40)M205 E10YJR096W(31.13/35)M205 B4YJR099Wubiquitin hydrolase(26.07/35)M205 C5YJR100C(36.00/37)M205 F6YJR101W(29.47/37)M205 H7YJR102C(22.35/28)M206 F7YJR103WCTP synthase(62.25/48)M205 H1YJR105W(37.51/47)M205 C4YJR107W(36.29/50)M205 C9YJR111C(31.26/36)M205YJR112W(22.22/30)G10M205 A2YJR113C(27.20/35)M206 E4YJR116W(30.8/34)M205 A8YJR118C(22.46/36)M205 D9YJR119C(80.11/90)M209 F2YJR123Wribosomal proteinRPS5 (mammalianS5) (previously calledrp14 S2 orYS8)(24.86/30)M62 D2YJR125C(44.91/64)M209 B1YJR129C(37.32/40)M209 G2YJR131Wspecific alpha-mannosidase(60.5/60)M53 A4YJR132W(115.4/9115)M208 F4YJR133W(23.1/33)M310 E4YJR134C(77.80/98)M208 E6YJR135CRequired formaintenance ofchromosomes andminichromosomes(26.32/36)M208 E7YJR144W(29.7/36)M208 C1YJR145C271-1042 Ribosomalprotein RPS7B (YS6)(rp5) (Rat S4) (humanS4) (RPS7A andRPS7B code foridentical proteins)(28.82/36)M209 A3YJR147W(39.49/49)M53 B4YJR148WBranched-ChainAmino AcidTransaminase(41.47/45)M209 D1YJR153W(39.82/40)M208 B2YJR154W(38.27/50)M208 B3YJR155W(31.79/40)M208 A4YJR156CThiaminebiosynthetic enzyme(37.43/50)M209 E1YJR161CProtein withsimilarity to membersof theYbr302p\/Ycr007p\/Cos8p\/Cos9p familycoded fromsubtelomeric region(42.26/42)M208 C3YKL001Cadenylylsulfate kinase(22.35/33)M208 B4YKL002W(16.72/36)M208 E1YKL006W528-815 probable 60Sribosomal proteinL14EA (15.39/18)M209 D2YKL007Walpha subunit ofcapping protein(29.59/38)M324 C3YKL009W(26.07/40)M208 H5YKL011Ccruciform cuttingendonuclease(38.86/36)M208 H7YKL013CArp Complex Subunit(18.84/30)M208 B5YKL018W(36.3/48)M208 A6YKL019WCAAXfarnesyltransferasealpha subunit(34.87/45)M208 E2YKL023W(30.58/33)M209 D3YKL024Curidine-monophosphatekinase (uridylatekinase) (22.47/34)M208 C5YKL026C(18.40/31)M208 B6YKL027w(49.38/60)M202 C5YKL035W(55/60)M208 G3YKL040C(28./2936)M208 C4YKL041W(24.7/540)M208 D5YKL042WComponent of thespindle pole body(40.04/40)M202 D5YKL043Wputative transcriptionfactor (40.47/55)M208 D6YKL051W(38.94/47)M209 H6YKL052C(32.25/48)M58 A1YKL055C(30.61/33)M58 B2YKL056C(18.40/20)M58 B3YKL059C(48.54/58)M59 E6YKL060Caldolase(39.52/39)M210 E6YKL061W(12.54/16)M210 F1YKL063C(18.40/30)M210 D3YKL065CYeast endoplasmicreticulum 25 kDatransmembraneprotein (22.69/30)M210 H4YKL067WNucleosidediphosphate kinase(16.94/28)M210 B1YKL070W(18.7/29)M58 C1YKL071W(28.37/45)M59 A5YKL074Cinvolved in early pre-mRNA splicing(58.00/60)M59 F5YKL075C(49.53/64)M59 G7YKL077W(43.23/55)M211 C4YKL081W532-1565 Translationelongation factor EF-1gamma (45.43/48)M210 H1YKL087Ccytochrome c1 hemelyase (24.67/37)M58 C2YKL088W(62.92/70)M210 F4YKL090W(48.84/64)M210 F6YKL093W(37.4/55)M59 B1YKL094W(34.54/45)M210 F2YKL096Wcell wallmannoprotein(26.4/50)M211 E3YKL103Cvacuolaraminopeptidase ysc1(56.57/64)M59 A6YKL106Waspartateaminotransferasemitochondrial(49.72/50)M210 G5YKL107W(34.1/40)M202 F5YKL109Wtranscriptionalactivator protein ofCYC1 (component ofHAP2\/HAP3heteromer) (61.05/70)M210 G6YKL116C(57.01/70)M210 A3YKL119C25.2 kDa proteininvolved in assemblyof vacuolar H(+)ATPase (23.68/34)M59 C6YKL122C(18.40/20)M210 H6YKL124Wsuppressor of SHR3(63.8/100)M210 A7YKL132C(47.33/55)M210 B2YKL134C(84.73/98)M210 B7YKL140Wsuccinatedehydrogenasecytochrome b subunit(60.49/64)M210 C2YKL142Wmitochondrialribosomal protein(24.2/36)M269 A1YKL149Cdebranching enzyme(44.58/50)M213 G1YKL150WNADH-cytochromeb5 reductase(33.33/38)M269 A3YKL151C(37.10/49)M269 D4YKL152CPhosphoglyceratemutase (27.20/35)M213 G4YKL153W(18.7/30)M77 E6YKL154W(26.95/30)M269 F7YKL156W354-599 40Sribosomal proteinS27-1 (9.13/10)M213 G2YKL159C(23.24/32)M213 H3YKL160W(16.06/36)M269 F5YKL161C(47.66/52)M78 A8YKL163WProtein containingtandem internalrepeats (35.86/40)M77 H3YKL167C16 kDa mitochondrialribosomal largesubunit protein(15.10/18)M213 A4YKL168C(80.77/50)M77 G6YKL170Wmitochondrialribosomal proteinL14 (15.39/16)M77 B8YKL171W(102.29/?)M213 B6YKL172W(47.08/64)M77 A4YKL175W(55.44/20)M269 A8YKL180W616-861(20.45/32)M77 D1YKL181Wribose-phosphatepyrophosphokinase(47.08/50)M213 A3YKL183W(33.77/34)M77 A5YKL184WOrnithinedecarboxylase(51.47/51)M78 A7YKL186CmRNA transportregulator (20.37/32)M269 D1YKL189W(44/55)M77 G2YKL190W129-604 Type 2Bprotein phosphatase\regulatory B subunitof calcineurin(19./4620)M78 B4YKL191W(58.8/560)M269 H4YKL192C(13.78/14)M78 H5YKL193CInteracts with andmay be a positiveregulator of GLC7which encodes type 1protein phosphatase(37.21/40)M77 B7YKL194Cmitochondrialthreonine-tRNAsynthetase (50.85/51)M269 D7YKL195W(47.08/58)M213 C2YKL206C(29.40/36)M213 C4YKL208W(29.92/38)M77 H1YKL213C(78.68/70)M78 B3YKL214C(22.46/32)M213 D4YKL216Wdihydroorotatedehydrogenase(34.65/40)M77 B6YKL217Wcarboxylic acidtransporter proteinhomolog (67.87/70)M77 E7YKL218C(35.89/36)M77 F8YKL219WProtein withsimilarity tosubtelomerically-encoded proteins suchas Cos5p Ybr302pCos3p Cos1p Cos4pCos8p Cos6p Cos9p(44.88/50)M213 E4YKL224C(13.56/16)M77 F7YKR001Cputative GTP-bindingprotein\similar tomammalian Mxproteins (77.47/80)M77 F4YKR006Cmitochondrialribosomal proteinYmL13 (30.38/35)M213 F4YKR007W(20.45/36)M77 E3YKR013WSimilar to plant PR-1class of pathogenrelated proteins(36.3/60)M78 G4YKR014C(25.77/32)M77 A9YKR018C(79.78/80)M214 A1YKR020W(18.25/34)M218 G1YKR021W(100.76/110)M76 H3YKR022C(35.45/40)M214 B5YKR023W(58.41/68)M214 C7YKR025W(31.13/40)M75 A4YKR030W(30.14/32)M75 A10YKR035C(23.46/23)M218 B1YKR036CCCR4 associatedfactor (72.52/85)M76 F2YKR037C(32.48/40)M214 E7YKR041W(27.61/36)M75 B10YKR043C(29.84/36)M76 G2YKR045C(21.04/30)M75 C4YKR046C(31.26/36)M76 A6YKR048Cnucleosome assemblyprotein I (45.90/50)M75 C10YKR051W(46.09/48)M214 D1YKR052Cmitochondrial carrierprotein (33.47/48)M214 E5YKR055Wras homolog-GTPbinding protein(32.12/48)M218 F5YKR056W(67.98/67)M218 E7YKR058W(52.91/80)M75 D10YKR059Wtranslation initiationfactor (43.56/50)M218 D1YKR060W(30.35/45)M218 C2YKR061Wputativemannosyltransferase\type 2 membraneprotein (46.86/58)M76 D4YKR062WSmall subunit ofTFIIE transcriptionfactor (36.29/45)M218 F7YKR066CCytochrome-cperoxidase (39.74/39)M76 D10YKR067W(81.84/43)M218 D2YKR069Wsiroheme synthase(65.34/65)M214 D4YKR070W(38.83/40)M214 H6YKR072Csit4 suppressor(61.85/61)M75 C9YKR074W(17.26/20)M214YKR075C(33.80/48)B10M218 E2YKR077W(40.04/50)M76 F4YKR078W(64.46/64)M310 C5YKR079C(92.21/100)M76 E6YKR080WNAD-dependent 510-methylenetetrahydrafolate dehydrogenase(35.31/40)M218 A7YKR081C(37.87/52)M218 E8YKR083C(14.66/35)M75 D3YKR085C22.3 kDamitochondrialribsomal large subunitprotien YmL20\homologous to L17 ofE. coli (21.48/32)M218 H4YKR087C(34.57/44)M218 F8YKR091W(16.83/35)M214 C8YKR097Wphosphoenolpyruvatecarboxylkinase(60.5/65)M202 H5YKR099W(89.32/110)M76 F3YKR101Wrepressor of silentmating loci(74.69/35)M75 C2YLL002W(48.07/48)M218 C6YLL006Wmitochondrial outermembrane protein(46.97/60)M218 C7YLL007C(73.28/75)M218 G8YLL009C(7.626/10)M79 D2YLL011Wnucleolar snRNPprotein (53.9/55)M80 E3YLL012W(63.14/63)M219 E1YLL019Cprotein kinasehomolog (81.10/90)M220 F5YLL022C(42.48/53)M220 B1YLL026Wheat shock protein104 (99.99/99)M219 F1YLL027W(27.61/40)M79 G3YLL028W(64.57/63)M219 H7YLL033W(25.41/40)M219 G1YLL035W(69.63/80)M79 H3YLL036CRNA splicing factor(55.46/64)M219 H5YLL039Cubiquitin(41.94/50)M219 A8YLL041CSuccinatedehydrogenase(ubiquinone) iron-sulfur protein subunit(29.39/34)M219 H1YLL043WSuppressor oftps1\/fdp1 andmember of the MIPfamily oftransmembranechannels\may beinvolved in glycerolefflux (73.7/81)M80 D5YLL045CRibosomal proteinRPL4B (rp6) (YL5)(human L7a) (mouseL7a) (rat L7a)(RPL4A and RPL4Bcode for nearlyidentical proteins)(28.29/36)M80 F1YLL050C194-611 Cofilin actinbinding and severingprotein (15.84/30)M80 D9YLL056C(32.81/32)M79 G1YLL058W(63.46/64)M79 C4YLL060C(25.66/32)M219 A7YLR005W(50.82/60)M79 E9YLR006CTwo-componentsignal transducer thatwith Sln 1p regulatesosmosensing MAPkinasecascade(suppressor ofsensor kinase)(78.45/78)M79 E4YLR009W(22/32)M219 D4YLR010C(17./6330)M219 D5YLR011W(21.1/230)M219 D1YLR015W(55.66/64)M219 D2YLR016C(22.47/40)M219 D3YLR017WProtein that regulatesADH2 geneexpression (37.18/48)M219 E5YLR019W(43.78/50)M219 E8YLR022C(27.53/38)M80 A6YLR026CSed5p is a t-SNARE(soluble NSFattachment proteinreceptor) required inER to Golgi transport.(37.43/25)M219 F5YLR027Caspartateaminotransferasecytosolic (47.55/50)M79 F8YLR029CRibosomal proteinRPL13A (YL10A)(rat L15) (22.47/30)M219 F8YLR030W(29.04/40)M80 C2YLR031W(20.57/32)M219 F3YLR033W(55.33/55)M219 F6YLR036C(22.46/33)M80 B10YLR037C(13.67/13)M223 E1YLR040C(24.67/38)M82 C6YLR043Cthioredoxin(11.46/12)M81 F7YLR044Cpyruvatedecarboxylase(61.96/62)M82 D6YLR051C(23.90/30)M222 G7YLR053C(11.91/22)M82 C10YLR054C(56.45/56)M223 B1YLR055Ctranscription factor(66.35/70)M81 D2YLR056WC-5 sterol desaturase(40.36/55)M81 H3YLR057W(93.5/98)M81 D5YLR058Cserinehydroxymethyl-transferase(51.62/55)M82 E6YLR059C(29.62/30)M81 H7YLR060WPhenylalanyl-tRNAsynthetase alphasubunit cytoplasmic(65.56/65)M82 H8YLR061W402-755(13.42/28)M222 A5YLR066Wsignal peptidasesubunit (20.45/34)M222 H3YLR073C(22.03/34)M81 E5YLR074C(18.39/28)M222 A6YLR075WUbiquinol-cytochrome Creductase complexsubunit VI requiringprotein (24.42/33)M82 A8YLR076C(15.43/16)M222 H7YLR077W(64.24/67)M81 D1YLR079WP40 inhibitor ofCdc28p-Clb5 proteinkinase complex(31.45/50)M223 G3YLR082CSmc4 protein memberof SMC family(43.25/55)M222 B6YLR083Cintegral membraneprotein\p24a protein(73.40/90)M222 B4YLR089C(65.25/65)M81 G5YLR090WHomolog of E. coliDnaJ closely relatedto Ydj1p (50.6/60)M81 H6YLR091W(32.34/40)M81 H6YLR091W(32.34/40)M222 B8YLR093C(27.64/39)M223 H2YLR097C(37.87/52)M81 H5YLR098CDNA bindingactivator (71.31/75)M222 D6YLR099C(43.47/48)M82 C8YLR100W(38.38/?)M81 A11YLR102C(29.28/45)M82 F1YLR103Comosomal DNAreplication initiationprotein (71.53/?)M222 E6YLR107W(44.55/48)M222 D8YLR109W(19.47/38)M81 G4YLR113Wmitogen-activatedprotein kinase (MAPkinase) (47.96/60)M81 A6YLR114C(84.07/100)M223 D1YLR119Wsuppressor of rna1-1mutation (23.54/33)M222 D7YLR124W(12.65/16)M222 F8YLR125W(15.07/40)M82 A2YLR127CAPC (anaphasepromoting complex)component (93.86/94)M82 D7YLR131Cactivator of CUP1expression (84.73/40)M222 E7YLR132C(31.93/40)M221 A3YLR137W(40.48/52)M84 C6YLR139C(70.76/70)M86 G9YLR141WUpstream activationfactor subunit(40.04/55)M221 E6YLR142Wproline oxidase(52.47/60)M84 C2YLR144CIdentified as anactivity necessary foractin polymerizationin permeabilized cells(85.72/90)M79 E4YLR009W(22/32)M219 D4YLR010C(17./6330)M219 D5YLR011W(21.1/230)M219 D1YLR015W(55.66/64)M219 D2YLR016C(22.47/40)M219 D3YLR017WProtein that regulatesADH2 geneexpression (37.18/48)M219 E5YLR019W(43.78/50)M219 E8YLR022C(27.53/38)M80 A6YLR026CSed5p is a t-SNARE(soluble NSFattachment proteinreceptor) required inER to Golgi transport.(37.43/25)M219 F5YLR027Caspartateaminotransferasecytosolic (47.55/50)M79 F8YLR029CRibosomal proteinRPL13A (YL10A)(rat L15) (22.47/30)M219 F8YLR030W(29.04/40)M80 C2YLR031W(20.57/32)M219 F3YLR033W(55.33/55)M219 F6YLR036C(22.46/33)M80 B10YLR037C(13.67/13)M223 E1YLR040C(24.67/38)M82 C6YLR043Cthioredoxin(11.46/12)M81 F7YLR044Cpyruvatedecarboxylase(61.96/62)M82 D6YLR051C(23.90/30)M222 G7YLR053C(11.91/22)M82 C10YLR054C(56.45/56)M223 B1YLR055Ctranscription factor(66.35/70)M81 D2YLR056WC-5 sterol desaturase(40.36/55)M81 H3YLR057W(93.5/98)M81 D5YLR058Cserinehydroxymethyltransferase (51.62/55)M82 E6YLR059C(29.62/30)M81 H7YLR060WPhenylalanyl-tRNAsynthetase alphasubunit cytoplasmic(65.56/65)M82 H8YLR061W402-755(13.42/28)M222 A5YLR066Wsignal peptidasesubunit (20.45/34)M222 H3YLR073C(22.03/34)M81 E5YLR074C(18.39/28)M81 E5YLR074C(18.39/28)M222 A6YLR075WUbiquinol-cytochrome Creductase complexsubunit VI requiringprotein (24.42/33)M222 A6YLR075WUbiquinol-cytochrome Creductase complexsubunit VI requiringprotein (24.42/33)M82 A8YLR076C(15.43/16)M222 H7YLR077W(64.24/67)M223 G5YLR077W(64.24/60)M81 D1YLR079WP40 inhibitor ofCdc28p-Clb5 proteinkinase complex(31.45/50)M223 G3YLR082CSmc4 protein memberof SMC family(43.25/55)M222 B6YLR083Cintegral membraneprotein\p24a protein(73.40/90)M222 B4YLR089C(65.25/65)M222 B4YLR089C(65.25/65)M81 G5YLR090WHomolog of E. coliDnaJ closely relatedto Ydj1p (50.6/60)M81 H6YLR091W(32.34/40)M81 H6YLR091W(32.34/40)M222 B8YLR093C(27.64/39)M223 H2YLR097C(37.87/52)M81 H5YLR098CDNA bindingactivator (71.31/75)M222 D6YLR099C(43.47/48)M82 C8YLR100W(38.38/?)M82 C8YLR100W(38.38/?)M81 A11YLR102C(29.28/45)M82 F1YLR103Comosomal DNAreplication initiationprotein (71.53/?)M222 E6YLR107W(44.55/48)M222 D8YLR109W(19.47/38)M81 G4YLR113Wmitogen-activatedprotein kinase (MAPkinase) (47.96/60)M81 A6YLR114C(84.07/100)M81 A6YLR114C(84.07/100)M223 D1YLR119Wsuppressor of rnal-1mutation (23.54/33)M222 D7YLR124W(12.65/16)M222 F8YLR125W(15.07/40)M82 A2YLR127CAPC (anaphasepromoting complex)component (93.86/94)M82 D7YLR131Cactivator of CUP1expression (84.73/40)M222 E7YLR132C(31.93/40)M221 A3YLR137W(40.48/52)M84 C6YLR139C(70.76/70)M86 G9YLR141WUpstream activationfactor subunit(40.04/55)M221 E6YLR142Wproline oxidase(52.47/60)M84 C2YLR144CIdentified as anactivity necessary foractin polymerizationin permeabilized cells(85.72/90)M221 F6YLR150W(30.14/42)M255 H6YLR151C(37.43/52)M84 G3YLR153Cacetyl-coenzyme Asynthetase (75.16/75)M221 G4YLR155Cnitrogen catabolite-regulated cell-wall L-asparaginase II(39.85/50)M221 A2YLR160Cnitrogen catabolite-regulated cell-wall L-asparaginase II(39.85/50)M84 A8YLR164W(18.59/19)M221 B1YLR167Wubiquitin(16.83/16)M221 B2YLR168C(25.33/35)M86 G8YLR172CS-adenosylmethionine(AdoMet)-dependentmethyltransferase ofdiphthamidebiosynthesis(33.03/40)M224 F1YLR175Wmajor low affinity 55kDaCentromere\/microtubule binding protein(53.24/60)M221 C2YLR176C(89.24/96)M86 H5YLR178Csuppressor of cdc25(24.12/38)M221 H4YLR179C(22.14/33)M221 F5YLR180WS-adenosylmethioninesynthetase (42.13/48)M221 E4YLR186W(27.83/36)M84 A7YLR187W(112.97/114)M84 D8YLR188WATP-binding cassette(ABC) transporterfamily member(76.56/76)M84 H9YLR189C(131.81/?)M84 D11YLR190W(54.12/70)M84 G1YLR191WPeroxisomalmembrane proteinthat contains Srchomology 3 (SH3)domain (42.57/45)M221 F3YLR193C(19.38/30)M84 B7YLR195CN-myristoyltransferase (50.08/32)M84 A10YLR197Whomology tomicrotubule bindingproteins and toX90565_5.cds(55.55/55)M221 D1YLR199C(24.23/36)M221 E2YLR200WPolypeptide 6 of aYeast Non-nativeActin BindingComplex homolog ofa component of thebovine NABCcomplex (12.65/18)M84 D4YLR201C(28.63/40)M84 C7YLR203CProtein involved inmaturation of COX1and COB mRNA(47.99/48)M224 H9YLR206W(67.54/76)M86 F3YLR208Wcytoplasmic proteininvolved in relase oftransport vesiclesfrom the ER(32.78/34)M84 E4YLR209C(34.24/35)M84 D7YLR211C(15.43/25)M224 H8YLR213C(46.45/54)M221 E1YLR215C(39.63/40)M86 G3YLR216Ca cyclophilin relatedto the mammalianCyP-40\physicallyinteracts with RPD3gene product(40.84/48)M84 A6YLR218C(16.53/17)M84 D10YLR221C(24.23/45)M84 D3YLR224W(40.7/40)M84 F7YLR227C(54.26/12)M85 D4YLR243W(30.03/40)M225 B2YLR248WSerine\/threonineprotein kinase(67.21/100)M226 D8YLR254C(20.82/34)M85 C1YLR255C(12.90/20)M83 H2YLR257W(35.42/?)M83 B4YLR258WGlycogen synthase(UDP-gluocse-starchglucosyltransferase)(77.66/78)M85 F4YLR259Cheat shock protein 60\chaperonin protein(62.95/65)M274 E6YLR260W(75.68/78)M85 C7YLR261CRas-like GTP bindingprotein (11.91/20)M85 G2YLR265C(37.65/37)M85 G4YLR267W(62.81/64)M85 B6YLR268WSynaptobrevin (v-SNARE) homologpresent on ER toGolgi vesicles(23.65/33)M226 E8YLR270W(38.61/48)M85 E1YLR271W(30.35/40)M83 B3YLR273CProtein similar toGac1p a putative type1 protein phosphatasetargeting subunit(71.31/45)M85 C6YLR276C(65.47/70)M85 F1YLR279W(14.3/20)M85 C2YLR280C(12.79/20)M225 E5YLR283W(34.65/35)M85 D6YLR284C(30.83/37)M85 A9YLR286CEndochitinase(61.85/66)M225 F1YLR287C(39.08/50)M265 F6YLR288Cinvolved incheckpoint controland DNA repair(52.27/60)M225 F5YLR290C(30.50/36)M225 F6YLR291Cnegative regulator ofGCN4 expression(41.94/56)M226 F7YLR300WExo-1 3-beta-glucanase (49.49/49)M83 D2YLR303W(48.95/?)M225 G6YLR307W(33.22/51)M225 A6YLR314CComponent of 10 nmfilaments of mother-bud neck (57.23/80)M85 B8YLR316C(17.96/28)M85 B4YLR321C(46.89/60)M226 A7YLR323C(28.52/38)M225 D8YLR324W(57.64/98)M88 F8YLR332WProtein required formating (41.47/55)M88 F3YLR336C(98.92/98)M88 E7YLR339C(20.26/25)M88 G8YLR340W60S ribosomal proteinP0 (L10E). (34.43/36)M88 A5YLR345W(56.1/64)M88 D10YLR349W(18.59/50)M228 C1YLR350W(23.87/33)M88 F2YLR351C(32.04/38)M88 B5YLR353W(66.44/80)M88 E6YLR354CTransaldolase enzymein the pentosephosphate pathway(36.88/45)M228 E2YLR359WAdenylosuccinateLyase (53.13/68)M88 C5YLR361C(63.61/75)M88 H7YLR363C(24.01/34)M230 H3YLR369W(72.48/64)M88 E5YLR377Cfructose-1 6-bisphosphatase(38.31/45)M333 E4YLR396C(76.04/78)M230 D7YLR412W(30.35/40)M89 A2YLR423C(45.90/50)M89 D5YLR426W152-1052(35.97/36)M89 B2YLR431C(49.86/55)M89 A3YLR432W(57.64/57)M231 E2YLR433CCalcineurin subunitA\type 2B proteinserine\/threoninephosphatase catalyticsubunit A1\cytoplasmic(60.86/61)M89 G6YLR435W(27.5/36)M89 E8YLR437C(14.66/14)M89 A1YLR438Wornithineaminotransferase(46.75/46)M229 H1YLR439WMitochondrial 60Sribosomal protein L4(35.2/45)M89 C4YLR441CRibosomal proteinanalogous to rat S3A(28.08/38)M231 B1YLR446W(47.74/50)M89 D4YLR449W(43.23/45)M229 B2YLR455W(33.55/45)M89 D3YLR456W(22.55/22)M229 H2YLR457C(35.12/55)M229 A6YLR460C(41.49/50)M89 H8YLR461Wmember of theseripauperinprotein\/gene family(see Gene_class PAU)(13.31/13)M231 C1YLR462W(22.33/34)M89 E3YLR464W793-930(23.87/23)M231 C2YML004Clactoylglutathionelyase (glyoxalase I)(35.89/48)M89 F3YML005W(50.93/50)M89 F4YML006C(85.27/100)M231 B4YML007Wjun-like transcriptionfactor (71.61/80)M89 C7YML008CS-adenoslymethionine:delta 24-methyltransferase(42.26/50)M89 G3YML011C(19.50/20)M231 C3YML012WComponent of theCOPII coat of certainER-derived vesicles(23.32/32)M231 H5YML014W(30.8/38)M89 E1YML016Cserine-threoninephosphatase Z(76.25/76)M89 D6YML028WThiol-specificantioxidant (21.67/32)M231 D1YML032C(55.47/63)M89 B5YML034W(72.37/72)M231 E1YML038C(48.65/49)M89 B4YML040W(48.51/55)M89 C5YML041C(30.83/40)M229 F4YML042WCarnitine O-acetyltransferaseperoxisomal andmitochondrial(73.81/90)M231 A7YML046WRNA splicing factorassociated with U1snRNP (69.3/83)M92 B2YML048WExtraCellular Mutant(44.44/50)M90 D5YML050W(34.32/40)M227 F7YML053C(23.45/36)M90 A1YML054CCytochrome b2 [L-lactate cytochrome-coxidoreductase](65.04/65)M90 C2YML055W(19.69/20)M92 C7YML060W43-kDa 8-oxo-guanine DNAglycosylase(41.47/50)M90 B1YML061C5′ to 3′ DNA helicase(94.52/95)M227 D2YML062C(43.25/64)M90 H4YML064C(26.98/27)M90 F5YML065W120-kDa (largest)subunit of originrecognition complex(ORC)\showshomology to Cdc6pCdc18p and Sir3p andto proteins from K.lactis S. pombe andhumans (100.65/100)M90 C1YML069WBinds to catalyticsubunit of DNApolymerase alpha(Pol1p) (60.83/65)M90 E2YML070W(64.45/64)M90 F2YML078Wcyclophilin-3(cyclosporin-sensitiveproline rotamase-3)(20.13/20)M227 A4YML079W(22.22/33)M227 B5YML080W(46.64/55)M92 E1YML085C142-1460 alpha-tubulin (49.38/65)M333 H4YML095C(23.13/34)M227 A7YML098WTFIID subunit(18.48/33)M90 B4YML101C(12.90/20)M92 G5YML102Wp60 subunit of theyeast omatinAssembly Factor-I(CAF-I) (51.59/55)M90 B6YML110C(33.80/40)M90 B9YML113Wdatin anoligo(dA).oligo(dT)-binding protein(27.49/30)M90 G1YML114C(56.13/60)M92 B3YML115CVanadate resistanceprotein (58.88/64)M202 B6YML128C(56.46/64)M92 A7YMR002W(17.37/28)M91 A1YMR004WProtein required forsorting proteins to thevacuole (56.32/48)M233 A7YMR009W(19.8/33)M91 C3YMR014W(57.2/57)M310 A6YMR015Ccytochrome P450involved in C-22denaturation of theergosterol side-chain(59.21/59)M234 E7YMR017WDBF2 InteractingProtein\SNAP 25homolog (43.78/46)M91 B1YMR020W(55.99/50)M93 C2YMR021Cmetal-bindingtranscriptionalactivator (45.90/55)M91 D3YMR022Wubiquitin conjugatingenzyme (18.36/32)M234 D6YMR024W(43.01/43)M91 B5YMR025W(32.56/40)M234 B4YMR030W(41.47/50)M93 C1YMR035WInner membraneprotease(mitochondrialprotein) (19.58/32)M234 H2YMR036C(60.97/64)M234 C4YMR037Czinc finger protein(77.47/100)M233 C5YMR038C(27.42/33)M234 H8YMR041C(36.88/48)M233YMR042WRegulator of arginine-B10responsive genes withARG81 and ARG82(19.58/34)M93 D1YMR043Wputativetranscriptionalactivator of alpha-specific genes(31.57/40)M234 A3YMR044W(52.46/98)M93 G4YMR046C(48.43/60)M91 E5YMR048W(34.98/35)M91 E1YMR051C(48.43/48)M93 B6YMR055C(33.69/40)M91 F1YMR058Wmulticopper oxidase(70.07/60)M234 A8YMR063W(26.4/33)M234 F10YMR065W(55.55/64)M234 H1YMR066W(98.89/100)M234 D3YMR067C(45.79/45)M234 F4YMR068W(46.97/50)M233 G5YMR069W(31.46/35)M234 A7YMR070Wunknown function\2Cys2-His2 zincfingers at c-terminusglutamine andasparagine rich.(54.01/54)M234 B8YMR071C(18.40/18)M93 C8YMR073C(22.14/30)M234 A2YMR074C(15.98/25)M234 G4YMR075W(75.45/80)M91 F4YMR077C(24.34/32)M303 E4YMR079W166-1071phosphatidylinositoltransfer protein(33.55/35)M255 D7YMR080Cputative helicase(106.84/100)M93 H1YMR081C(37.21/50)M234 F9YMR086W(105.71/115)M234 C2YMR088C(61.85/64)M93 C3YMR089Cmitochondrialmembrane ATPase oftheCDC48\/PAS1\/SEC18 (AAA) family(90.78/98)M234 A5YMR090W(25.08/33)M234 B6YMR091C(47.88/64)M234 C7YMR092CProtein localizes toactin cortical patches.Probable binding siteon actin lies on frontsurface of subdomain3 and 4 (67.68/75)M91 B6YMR093W(56.54/56)M242 A1YMR096WSnooze: stationaryphase-induced genefamily (32.78/46)M242 C2YMR097C(40.40/44)M242 A3YMR098C(67.45/70)M241 D4YMR099C(32.70/45)M112 D6YMR101C(37.76/45)M242 B7YMR102C(91.77/98)M242 B1YMR104Cprotein kinase(74.50/98)M242 D2YMR105CPhosphoglucomutase(62.62/62)M107 D3YMR106C(69.22/90)M242 D5YMR108Wacetolactate synthase(75.68/85)M107 A8YMR111C(50.85/60)M107 C1YMR112C(14.44/20)M242 E2YMR113W(47.08/48)M112 E3YMR114C(40.51/55)M112 F5YMR116C811-1233(35.2/38)M242 E8YMR119W(68.75/68)M112 F3YMR121C(22.47/38)M107 G5YMR123W(13.53/30)M112 E6YMR124W(103.84/110)M242 E7YMR125Wtranscriptionalactivator of glycolyticgenes (94.49/94)M242 E1YMR127CProtein involved insilencing HMRhomologous toacetyltransferases(37.21/45)M107 F4YMR130W(33.33/40)M242 F5YMR131C(56.24/75)M107 E6YMR132C(22.91/30)M242 F7YMR133WMeiosis-specificrecombination gene(47.96/47)M242 G8YMR134W(26.28/34)M112 F2YMR135W-A(19.58/32)M112 G3YMR136W(61.71/60)M242 G5YMR138WGTP-binding protein(21.12/31)M107 F6YMR139Wprotein kinase thatphosphorylates themeiotic activatorIME1 (40.81/50)M242 G7YMR140W(53.9/59)M112 G1YMR142C407-1002(22/38)M107 H3YMR144W(37./7350)M242 G6YMR147W(24.64/35)M107 F7YMR148W(16.49/30)M242 G3YMR152W(40.36/52)M242 H1YMR157C(28.08/32)M242 H2YMR158W(17.16/28)M242 B5YMR159CProtein homologousto human Sin3complex componentSAP18 possiblecoiled-coil protein(16.53/26)M242 H6YMR161WHomologous to E colidnaJ protein(24.75/34)M242 A8YMR170Caldehydedehydrogenase(NAD(P)+) likelycytosolic (55.69/62)M242 A4YMR173Wflocculent specificprotein\contains >35repeats of the aminoacid sequenceNNNDSYGS(47.41/55)M242 D9YMR177W(56.21/56)M107 B2YMR178W(30.25/36)M242 B4YMR180C(35.23/49)M242 A7YMR183C(32.48/46)M242 B8YMR184W(21.89/20)M237 F4YMR197CVti1p(23.90/34)M104 C1YMR201C112-1200(40.92/50)M237 H2YMR203WMitochondrial outermembrane protein\forms the outermembrane importchannel (42.68/48)M237 G4YMR205Cphosphofructokinasebeta subunit(105.52/125)M237 C1YMR209C(50.30/55)M104 C3YMR211W(52.46/55)M104 F4YMR213W(65.01/75)M96 F6YMR214WdnaJ homolog(44.55/48)M237 D1YMR217WGMP synthase(57.86/57)M104 A4YMR220W48 kDaPhosphomevalonatekinase (49.72/62)M104 E5YMR222C(24.56/40)M310 B6YMR224CProtein required fordouble-strand breakrepair and meioticrecombination(76.25/80)M104 E1YMR225C206-444Mitochondrialribosomal proteinMRPL44 (YmL44)(10.89/14)M104 D3YMR227CTFIID subunit(64.93/65)M104 B4YMR228WMitochondrial RNApolymerasespecificity factor(37.62/40)M104 F1YMR233W(24.97/25)M96 H3YMR235C(44.80/55)M237 B5YMR237W(79.75/88)M237 C7YMR239CRibonuclease III(51.84/58)M237 F1YMR241W(34.65/35)M237 A4YMR244C-A(11.47/16)M238 C5YMR244W(39.26/43)M202 D6YMR246Wlong-chain fatty acid-CoA ligase andsynthetase 4(76.45/98)M202 C6YMR250W(64.46/75)M237 D2YMR251W(40.47/48)M237 B4YMR252C(14.77/18)M104 B7YMR255W(20.79/36)M237 C4YMR260CTranslation initiationfactor eIFeIF-1A(16.86/21)M237 E6YMR262W(34.54/48)M237 F7YMR263W(22.22/30)M104 D8YMR264W(22.44/30)M104 F3YMR267Wmitochondrialinorganicpyrophosphatase(34.21/38)M237 F5YMR269W(15.73/25)M104 B6YMR270CUpstream activationfactor subunit(40.28/55)M104 D7YMR271COrotatephosphoribosyl-transferase 2(25.00/40)M237 E2YMR274C(34.68/38)M237 E4YMR276Wubiquitin-like protein(41.14/42)M237 G6YMR278W(68.53/75)M239 A1YMR281W(33.55/45)M240 C2YMR282Cbasic hydrophilic 67.5kDa protein(63.83/62)M97 B3YMR283CInitiator methioninetRNA 2′ -O-ribosylphosphate transferase(56.46/56)M97 E5YMR285C(56.68/55)M274 D7YMR288W(106.92/110)M97 A1YMR289W(41.35/40)M97 H1YMR290C(55.58/55)M239 D3YMR290(12.76/12)W-AM102 C4YMR291W(64.57/70)M97 G6YMR293C(51.07/55)M102 A8YMR294WCoiled-coil domainprotein required forproper nuclearmigration duringmitosis (but notduring conjugation)(41.14/55)M239 C1YMR295C(21.70/33)M240 D2YMR296CProbable componentof serinepalmitoyltransferasewhich catalyzes thefirst step inbiosynthesis of long-chain sphingolipids(61.41/64)M97 D3YMR297Wcarboxypeptidase Y(58.63/58)M239 D5YMR299C(34.45/45)M240 D6YMR300Cphosphoribosylpyrophosphateamidotransferase(56.13/53)M239 D1YMR303Calcoholdehydrogenase II(38.31/52)M97 E4YMR305C(42.82/60)M97 D9YMR309C˜100 kDacytoplasmic protein(89.45/90)M239 E1YMR310C(34.90/44)M239 F2YMR311CRegulates activity ofprotein phosphatase 1Glc7p which isinvolved in properchromosomesegregation(25.32/36)M97 E3YMR312W(30.14/40)M239 E5YMR314Walpha-type of subunitof 20S proteasome(25.85/31)M97 A7YMR315W(38.5/40)M240 H8YMR316C-B(11.35/19)M97 D1YMR316W(37.07/37)M239 H3YMR318C(39.63/52)M239 F5YMR320W(11.22/14)M240 F6YMR321C(11.58/30)M102 E8YMR322C(26.10/36)M97 E9YMR323W(48.18/50)M240 G2YMR325W(13.75/19)M102 G4YNL001Wan ORF of unknownfunction located in acentromeric regionduplicated betweenchromosomes III andXIV (DOM34homologue onchromosome III is apseudogene)(42.57/34)M202 E6YNL002C(35.45/52)M240 H7YNL004Whypothetical RNA-binding protein(47.3/48)M239 B9YNL005CMitochondrialribosomal proteinMRP7 (YmL2)(E. coli L27) (40.84/55)M102 E1YNL006W(33.44/40)M240 H2YNL007Csit4 suppressor dnaJhomolog (38.75/48)M97 A5YNL009Wperoxisomal NADP-dependent isocitratedehydrogenase(46.31/46)M97 C6YNL010W(26.62/30)M239 A7YNL011C(48.87/52)M97 G8YNL012WTranscriptionregulator (59.07/60)M240 A3YNL015WProteinase inhibitorI2B (PBI2) thatinhibits proteasePrb1p (yscB) (8.46/8)M97 G3YNL016Wpoly(A)+RNA-binding protein(49.94/50)M97 D6YNL018C(67.45/67)M239 B7YNL019C(31.37/39)M240 B8YNL020C(70.21/71)M240 H1YNL022C(53.93/50)M240 A4YNL024C(27.09/36)M97 B5YNL025CC-type cyclin(35.56/40)M97 E6YNL026W(53.45/55)M240 B7YNL027W(74.69/98)M240 C8YNL028W(11.66/16)M240 E9YNL029CPutativemannosyltransferaseof the KRE2 family(57.45/57)M240 A2YNL030WHistone H4 (HHF1and HHF2 code foridentical proteins)(11.44/14)M102 G2YNL031CHistone H3 (HHT1and HHT2 code foridentical proteins)(14.99/20)M97 A4YNL032W(31.02/55)M240 A5YNL033W(31.45/35)M240 B6YNL034W(67.43/71)M239 C7YNL035C(42.82/49)M239 D8YNL036Winvolved in secretionof proteins that lackclassical secretorysignal sequences(24.42/32)M97 G9YNL037Calpha-4-beta-4subunit ofmitochondrialisocitratedehydrogenase 1(39.63/40)M240 B2YNL038W(23.43/20)M97 A3YNL039W90 kd subunit ofTFIIIB also calledTFIIIB90 or B″ orB″90 component(65.45/65)M97 B4YNL040W(50.37/50)M240 C6YNL042W(43.67/50)M97 H7YNL043C(11.69/12)M102 C9YNL044W(17.49/20)M97 H9YNL045W(73.92/73)M243 A1YNL046W(19.03/28)M243 B2YNL047C(72.29/85)M243 B8YNL052WCytochrome-coxidase chain Va(16.94/18)M105 B8YNL053W(53.9/53)M243 B1YNL054W(128.3/6130)M105 H1YNL055COuter mitochondrialmembrane porin(voltage-dependentanion channel orVDAC) (31.26/31)M105 G2YNL056W(21.78/36)M243 B6YNL058C(34.79/48)M243 C8YNL061W90-kDa proteinlocated in nucleolusthat is homologous toa humanproliferation-associated nucleolarprotein p120(68.09/68)M105 C8YNL062CRNA-binding (zeta)subunit of translationinitiation factor 3(eIF-3) (52.61/52)M243 C1YNL063W(34.65/45)M108 E2YNL065W(64.57/64)M105 A4YNL066WProtein involved inthe aging process(46.31/64)M243 C6YNL067Wribosomal proteinRPL9 (YL11)(21.12/36)M105 A7YNL069C478-1046 Ribosomalprotein (21.89/20)M243 F9YNL070Wtranslocase of theouter mito. membrane(6.71/7)M105 C1YNL071WDihydrolipoamideacetyltransferasecomponent (E2) ofpyruvatedehydrogenasecomplex (53.13/50)M247 A2YNL072WRNase H(35) a 35kDa ribonuclease H(33.88/48)M243 G3YNL073Wmitochondrial lysine-tRNA synthetase(63.47/64)M105 B4YNL074C(49.75/50)M243 D6YNL075W(32.01/50)M243 B7YNL076Wnegative regulator ofRas cAMP pathway(64.45/70)M243 E8YNL077W(58.29/64)M108 D8YNL078W(44.88/52)M105 D1YNL079Ctropomyosin I(21.92/32)M247 B2YNL080C(40.39/47)M243 E6YNL083W(54.45/64)M247 C6YNL084CProtein necessary forinternalization ofalpha-factor receptorwhen bound to ligand(38.42/40)M243 H9YNL086W(11.33/18)M247 C3YNL089C(17.41/20)M108 B4YNL090WGTP-binding proteinof the rho subfamilyof ras-like proteins(21.23/34)M243 D7YNL092W(44.11/48)M243 F8YNL093Wrab5-like GTPaseinvolved in vacuolarprotein sorting andendocytosis(24.31/34)M243YNL094W(64.68/75)A10M247 C2YNL096C490-918(21.01/31)M105 D3YNL097C(36.33/36)M105 E4YNL098CRas proto-oncogenehomolog (35.45/48)M105 D5YNL099C(26.21/32)M243 E7YNL100W(25.85/34)M243 H2YNL104Calpha-isopropylmalatesynthase (2-IsopropylmalateSynthase) (68.12/68)M247 E3YNL105W(15.73/17)M243 G6YNL107W(24.97/36)M108 E6YNL108C(29.73/40)M243YNL110C(24.23/31)C10M108 F1YNL111Ccytochrome b5(13.23/20)M243 D4YNL113Wsubunit common toRNA polymerases I(A) and III (C)(15.73/16)M247 F4YNL114C(13.56/18)M243 G7YNL116W(57.53/64)M243 A9YNL117Wcarbon-catabolitesensitive malatesynthase (61.05/64)M105 H8YNL118C(106.73/100)M243 H1YNL119W(54.34/68)M243 A3YNL120C(17.74/25)M243 F5YNL122C(12.68/20)M247 H6YNL124W(54.23/90)M255 F7YNL128WSimilar to humantumor suppressorgene known as TEP1MMAC1 and PTEN1.Contains sequencemotifs characteristicof protein tyrosinephosphatases.(47.85/50)M105 F3YNL129W(26.51/30)M243 A7YNL131WMitochondrial importreceptor complexprotein (16.83/30)M243 C9YNL133C(19.06/20)M247 A9YNL134C(41.49/50)M243 A2YNL135Cpeptidylprolyl cis-trans isomerase(12.57/18)M243 C3YNL136W(46.86/50)M105 G4YNL138W70-kDa adenylylcyclase-associatedprotein (57.97/64)M247 A7YNL140C(20.82/31)M105 A8YNL141W(38.38/52)M243YNL142WAmmonia transportD10protein (55/55)M103 E4YNL148Ccofactor B (27./9748)M103 C5YNL149C(14.22/28)M244 F2YNL152W(45.1/57)M244 H3YNL153CPolypeptide 4 of aYeast Non-nativeActin BindingComplex homolog ofa component of thebovine NABCcomplex (14.22/26)M244 A5YNL154Cmembrane-boundcasein kinase Ihomolog (60.09/64)M244 B6YNL155W(30.25/32)M103 F4YNL156C(32.92/40)M245 B8YNL157W(18.59/34)M245 D9YNL158W(21.89/32)M245 C1YNL159C(31.82/32)M274 E7YNL160WGlycoproteinsynthesized inresponse to nutrientlimitation (39.05/42)M244 A4YNL161W(83.37/95)M110 E3YNL163C(122.13/?)M245 A7YNL164C(38.64/49)M103 D5YNL165W(44.77/52)M245 E9YNL166C(49.31/49)M245 G2YNL168C(28.52/38)M244 B4YNL169CPhosphatidylserineDecarboxylase 1(55.03/55)M245 G5YNL171C(13.45/48)M244 H8YNL173C(40.39/48)M245 F9YNL174W(21.01/37)M103 D1YNL175C(44.46/55)M110 D2YNL176C(69.99/?)M244 B5YNL178WRibosomal proteinRPS3 (rp13) (YS3)(Mammalian S3)(26.51/35)M245 H5YNL179C(15.98/28)M245 B7YNL180C(36.22/36)M110 A6YNL181W(44.88/?)M245 G9YNL182C(61.08/98)M244 F1YNL183Cprotein kinasehomolog (86.93/88)M244 C4YNL185C(17.41/26)M244 C5YNL186W(87.23/115)M103 G3YNL187W(39.48/40)M110 A5YNL188WProtein involved inspindle pole bodyduplication andkaryogamy(47.74/70)M110 B6YNL189Wkaryopherin alphahomolog of 60 kDa(59.73/59)M245 H9YNL190W(22.55/95)M244 G1YNL191W(39.48/44)M245 C4YNL193W(61.49/65)M103 B3YNL194C(33.14/42)M103 H3YNL195C(26.76/36)M110 B5YNL196C(32.81/40)M24 F10YNL198C(11.03/16)M245 G1YNL199CActivatestranscription ofglycolytic genes\homologous toGCR1\may functionin complex withGcr2p (58.77/50)M103 B2YNL200C(27.09/38)M103 C3YNL202Wsporulation-specificprotein (32.56/42)M103 A4YNL203C(22.46/32)M110 C5YNL204Csporulation-specificprotein (33.03/33)M244YNL206C(50.08/60)G10M110 F1YNL207W(46.86/46)M244 D3YNL208W(22.55/33)M244 F4YNL209WHeat shock protein ofHSP70 familyhomolog of SSB1(67.54/68)M244 F5YNL210Wmer2 splicing factor(29.81/32)M110 B4YNL211C(9.496/9)M110 D5YNL212W(86.13/86)M110 E6YNL213C(23.57/30)M110 G1YNL215W(35.31/64)M245 D3YNL216Wrepressor activatorprotein (91.08/87)M244 G4YNL217W(35.97/47)M244 G5YNL218W(64.68/74)M110 E5YNL220Wadenylosuccinatesynthetase (47.74/47)M244YNL222W(22.77/28)H10M245 B2YNL223W(55.77/64)M244 F3YNL224C(84.40/94)M110 D4YNL227C(64.93/80)M245 H7YNL228W(28.49/33)M244 G9YNL229Ctranscriptionalregulator putativeglutathionetransferase (38.97/48)M245 E10YNL230C(41.72/41)M110 A2YNL231C(38.64/?)M103 D2YNL232W(32.23/40)M110 D3YNL234W(46.97/?)M265 A8YNL236Wtranscriptionalsilencer generalrepressor of diverseset of genes(107.35/107)M103 F6YNL238WCa2+-dependentserine protease(89.65/100)M254 A1YNL239WAminopeptidase ofcysteine proteasefamily (53.24/59)M111 B2YNL240C(54.04/64)M111 E3YNL241CGlucose-6-phosphatedehydrogenase(55.58/55)M111 G5YNL243Wtransmembraneprotein (106.59/106)M254 E5YNL244Ctranslation factor(11.91/25)M254 H7YNL246W128-890(29.15/30)M111 C2YNL248C49-kDa alpha subunitof RNA polymeraseA (45.68/55)M249 C3YNL249C(59.65/58)M111 D8YNL253W(46.53/55)M254 A8YNL254C(44.14/53)M249 B1YNL255C(16.86/21)M109 G1YNL256W(95.25/95)M254 E4YNL259CAntioxidant proteinand metalhomeostasis factorprotects againstoxygen toxicity(8.066/16)M109 A6YNL260C(21.81/21)M254 G6YNL261WFifth largest subunitof origin recognitioncomplex\containspossible ATP-bindingsite(52.8/64)M249 C1YNL263C(34.57/38)M109 H1YNL264C(38.53/52)M254 D2YNL272CProtein with coiled-coil domain essentialfor vesicular transport83.52/97)M254 F3YNL274C(38.53/42)M254 F4YNL275W(63.47/63)M254 H6YNL277Whomoserine O-trans-acetylase (53.57/65)M111 G9YNL278W(116.71/116)M254 D1YNL279W(72.82/95)M249 F3YNL281W(16.94/30)M109 F3YNL282W(21.56/30)M109 H4YNL283C(55.46/80)M109 D6YNL284C(35.45/50)M249 G7YNL285W(13.64/27)M111 H9YNL286WCold sensitive U2snRNA Supressor(31.46/42)M111 A5YNL290WSubunit 3 ofReplication Factor C\homologous to humanRFC 36 kDa subunit(37.51/45)M109 A5YNL291Cplasma membraneprotein (60.31/98)M111YNL294C(58.66/64)A10M249 E2YNL296W(11.55/14)M109 H3YNL298Wprotein kinase(92.73/98)M111 A9YNL301C545-993 Ribosomalprotein rp28 (rat L18)(20.57/34)M111 A3YNL304W(39.26/50)M111 A4YNL305C(32.70/32)M109 A4YNL306W(23.98/35)M109 C5YNL307C43.1 kDaSerine\/threonine\/tyrosine protein kinase(41.38/50)M109 E6YNL308C(65.04/65)M254 D7YNL309Wsin3 binding protein(50.6/57)M111YNL310C(22.58/34)C10M111 B3YNL312W116-930 subunit 2 ofreplication factor RF-A\29\% identical tothe human p34subunit of RF-A(30.14/34)M249 E4YNL314Wpositive regulator ofallophanate induciblegenes (28.26/36)M109 D5YNL315C(35.01/40)M111 C9YNL317W(51.36/55)M254 H2YNL320W(31.45/42)M254 C4YNL322CCell wall beta-glucanassembly (34.46/50)M254 C5YNL323W(45.65/50)M111 E10YNL326C(36.99/40)M249 A3YNL328C(16.09/20)M109 F5YNL331C(41.49/50)M109 H6YNL332W(37.51/35)M249 D8YNL333WSnooze: stationaryphase-induced genefamily (32.89/40)M114 A1YNL335W(24.86/34)M113 F6YNR001Ccitrate synthase.Nuclear encodedmitochondrial protein.(52.72/67)M257 G8YNR002CPutativetransmembraneprotein (31.05/36)M257YNR003C34-kDa subunit ofC10RNA polymerase III(C) (34.90/45)M257 B1YNR004W(16.27/26)M257 E2YNR005C(14.77/18)M253 H3YNR006Whydrophilic protein\has cysteine richputative zinc fingeressential for function(68.53/100)M114 C4YNR007C(34.13/45)M253 B6YNR008W(72.82/90)M253 D7YNR009W(27.5/38)M257 H8YNR010WProtein required foraccurate mitoticchromosomesegregation (16.5/25)M257 C1YNR012WUridine kinase(55.22/55)M113 F3YNR014W(23.43/45)M253 C5YNR015WSuppressor ofMitochondrialMutation in thetRNAasp gene(42.45/47)M257 G7YNR017W23 kDa mitochondrialinner membraneprotein (24.53/32)M114 E7YNR018W(24.75/38)M257 G2YNR021W(44.55/47)M114 D4YNR023W73 kDa subunit of theSWI\/SNFtranscriptionactivation complex(62.47/70)M253 C6YNR024W(20.57/35)M114 F7YNR026Cintegral membraneprotein involved inprotein transport tothe Golgi (51.84/64)M253YNR027W(34.98/48)A10M114 D1YNR028W(33.99/40)M253 C4YNR030WExtraCellular Mutant(60.72/70)M114 D5YNR032W(40.59/48)M257 A8YNR033Wpara-aminobenzoatesynthase PABAsynthase (86.68/98)M114 G7YNR034W(35.42/40)M114 B9YNR035CArp Complex Subunit(37.65/45)M114 E1YNR036C(16.86/30)M113 H5YNR040W(28.37/50)M253 G7YNR041Cparahydroxybenzoate:polyprenyl transferase(40.95/41)M253 A9YNR042W(15.73/30)M257YNR043WmevalonateG10pyrophosphatedecarboxylase(43.67/49)M253 E4YNR046W(14.96/20)M253 F6YNR048W(43.44/60)M113 B7YNR049CMulticopy Suppressorof sec1 (23.13/20)M114 A8YNR050CSaccharopinedehydrogenase(NADP+L-glutamateforming)(saccharopinereductase) (EC1.5.1.10) (49.09/55)M253YNR051C(56.68/67)D10M114 F1YNR052CPutative transcriptionfactor (47.66/55)M253 F4YNR054C(34.79/50)M113 C7YNR057C(26.10/26)M114 B8YNR058W7 8-diamino-pelargonic acidaminotransferase(DAPA)aminotransferase(52.91/55)M253 E10YNR059W(63.91/64)M253 C3YNR061C(24.12/38)M113 B6YNR064C(31.93/64)M257 G9YNR066C(47.99/50)M253 A2YNR068C(29.95/32)M257 C3YNR069C(53.82/60)M114 H4YNR071C(37.65/45)M113 E7YNR073C(55.35/64)M257YNR075WProtein with strongB11similarity tosubtelomerically-encoded proteins suchas Cos5p Ybr302pCos3p Cos1p Cos4pCos8p Cos6p Cos9p(41.35/47)M113 C4YOL001Wnegativetranscriptionalregulator (32.34/50)M257 C7YOL003C(41.61/45)M253 E9YOL005CRNA polymerase IIsubunit (13.23/17)M257 E3YOL008W(22.88/32)M257 A5YOL009CComponent ofMitochondrialInheritance located inouter mitochondrialmembrane (29.84/40)M113 F7YOL012CHistone-relatedprotein that cansuppress histone H4point mutation(14.77/25)M257YOL013C(60.64/64)B10M116 B2YOL016Ccalmodulin dependentprotein kinase(49.20/55)M258 B1YOL023Wmitochondrialinitiation factor 2(74.47/84)M258 E3YOL02SWAffects longevity(72.71/80)M258 G4YOL026C(12.46/18)M258 G6YOL028C(26.98/38)M117 A7YOL029C(22.14/32)M258 D2YOL032W(27.17/34)M258 F3YOL033WMitochondrialglutamyl-tRNAsynthetase (59.07/69)M258 A8YOL037C(12.90/34)M258 E2YOL040CRibosomal proteinRPS21 (rp52) (E. coliS19) (rat S15) (RIGprotein)(15.65/22)M258 H4YOL042W(40.04/48)M258 G5YOL043CEndonuclease III-likeglycosylase 2(41.83/47)M258 H8YOL046C(24.67/34)M258 F2YOL048C(11.69/16)M116 H8YOL053W(43.56/45)M116 E1YOL054W(44.77/80)M258 G2YOL055C(60.64/60)M116 G3YOL056Wphosphoglyceratemutase (33.44/38)M258 B5YOL057W(78.32/85)M259 H5YOL058Warginosuccinatesynthetase (46.31/55)M258 B7YOL059WGlycerol-3-phosphatedehydrogenase(NAD+) (48.51/54)M116 F7YOL060C(77.69/77)M258 B9YOL061WPhosphoribosylpyrophosphate synthetase(ribose-phosphatepyrophosphokinase)(54.67/60)M116 H3YOL064CPutative phosphatasegene involved in salttolerance andmethioninebiogenesis\halotolerance(39.30/45)M258 C5YOL065C(42.37/48)M117 C5YOL066CDRAP deaminase(65.04/70)M116 A7YOL067CTranscription factor(bHLH) involved ininterorganellecommunicationbetween mitochondriaperoxisomes andnucleus (19.50/28)M303 D5YOL068C(55.46/65)M258 A3YOL080C(31.82/44)M117 C4YOL082W(45.76/60)M259 A6YOL083W(45.43/53)M116 D9YOL086CAlcoholdehydrogenase(38.31/45)M116 G2YOL088C(30.50/40)M258 E7YOL092W(33.99/35)M116 B8YOL093W(32.34/40)M116 E9YOL094CSubunit 4 ofReplication Factor C\homologous to humanRFC 40 kDa subunit(35.56/52)M116 H2YOL096C3 4-dihydroxy-5-hexaprenylbenzoatemethyltransferase(34.79/40)M117 F3YOL097C(47.55/50)M258 D6YOL099C(17.96/25)M116 C8YOL101C(34.35/40)M258 D3YOL104C(38.75/45)M258 E6YOL107W(37.73/42)M202 A7YOL108CTranscription factorinvolved in activationof phospholipidsynthetic genes(16.64/30)M258 G8YOL109W(12.54/24)M118 A1YOL111C(23.45/36)M118 A4YOL114C(22.35/33)M202 E7YOL116W43 kDa protein(42.13/64)M282 G7YOL118C(11.35/16)M278 D2YOL120C560-1008 Ribosomalprotein rp28 (rat L18)(RP28A and RP28Bcode for identicalproteins) (20.57/30)M115 F5YOL123WPutativepolyadenylated-RNA-binding proteinlocated in nucleus\similar to vertebratehnRNP A\/B proteinfamily (58.85/70)M282 G5YOL124C(47.66/50)M115 H7YOL125W(52.47/64)M278 E8YOL126Ccytosolic malatedehydrogenase(46.56/60)M278 E2YOL128C(41.38/49)M278 A5YOL131W(11.99/16)M115 A8YOL133W(13.42/20)M282 A8YOL134C(14.22/14)M282 B3YOL137W(54.78/64)M118 D5YOL139CmRNA cap bindingprotein eIF-4E(23.46/27)M282 B8YOL142W(26.51/34)M278 E1YOL143C6 7-dimethyl-8-ribityllumazinesynthase (DMRLsynthase) (18.62/30)M278 C4YOL146W(26.07/34)M118 E5YOL147CPeroxisomalbiogenesis protein(peroxin) involved inperoxisomeinheritance andperoxisomalproliferation(25.99/34)M278 D6YOL148Cputative transcriptionfactor (66.47/75)M115 F1YOL151W(37.73/45)M278 D4YOL154W(27.5/37)M278 D5YOL155C(106.4/0116)M278 E7YOL157C(64.82/75)M118 F1YOL159C(18.84/29)M282 D2YOL160W(12.54/12)M118 G3YOL161C(13.23/20)M282 A4YOL162W(23.76/30)M282 A5YOL163W(18.7/27)M282 A7YOL165C(15.76/19)M282 E8YOL166C(12.45/12)M118 G1YOR001WRibosomal RNAProcessing (80.74/80)M118 H3YOR003Wsubtilisin-likeprotease III(52.69/64)M278 F4YOR004W(28.05/39)M282 B5YOR005CATP dependent DNAligase (103.87/105)M278 F6YOR006C(34.46/34)M282 B7YOR007C(38.09/38)M115 G9YOR008C(41.61/55)M282 H1YOR009W(53.68/52)M282 F2YOR010CCold-shock inducedprotein of theSrp1p\/Tip1p familyof serine-alanine-richproteins (27.64/35)M282 C5YOR013W(17.37/27)M278 G6YOR014Whigh copy suppressorof rox3 and amulticopy suppressorof hsp60-ts alleles(83.48/90)M118 G9YOR016C(22.80/33)M118 H5YOR021C(23.46/36)M282 D7YOR023C(62.39/64)M282 G8YOR024W(11.88/14)M115 B2YOR025WHomolog of SIR2(49.38/55)M282 G2YOR026W(37.62/38)M282 E3YOR027Wheat shock protein(64.9/65)M265 E8YOR028C(32.48/31)M278 A7YOR030WExtraCellular Mutant(68.2/80)M118YOR032C(47.77/47)A10M115 C2YOR033CProtein thatcomplements a drug-hypersensitivemutation (77.35/75)M278 H4YOR036Wintegral membraneprotein\c-terminalTMD\located inendosome (31.79/40)M278 B6YOR037Wcytochrome cmitochondrial importfactor (44.55/49)M282 F7YOR039WCasein kinase II beta'subunit (28.49/32)M118YOR040WMitochondrialB10glyoxylase-II(31.46/45)M279 A1YOR041C(15.76/12)M119 H3YOR043WProtein involved ingrowth regulation(53.57/60)M279 G3YOR044W(17.48/23)M120 F7YOR046CRNA helicase(53.05/60)M279 B1YOR049C(38.97/43)M279 A2YOR050C(12.68/16)M120 A4YOR051C(45.45/45)M119 D5YOR052C(16.53/32)M120 G7YOR054C(74.27/?)M279 D7YOR056C(50.52/65)M280 C2YOR058Cencodes componentof the spindlemidzone (97.48/98)M279 A4YOR060C(28.30/35)M279 E5YOR062C(29.51/53)M279 E6YOR063Wribosomal protein L3(42.68/50)M279 E7YOR064C(24.12/24)M120 D1YOR065WCytochrome c1(34.1/?)M119 E1YOR073W(65.01/75)M279 B2YOR074C236-915 Thymidylatesynthase (28.6/39)M279 F5YOR078W(23.65/36)M119 A3YOR082C(12.46/20)M119 E4YOR083W(32.56/52)M119 H5YOR084W(42.68/52)M119 C7YOR085W34-kDa gammasubunit ofoligosaccharyltransferaseglycoprotein complex(38.61/45)M119YOR088W(53.13/40)B11M120 G1YOR089Csmall GTP-bindingprotein\geranylgeranylated\geranylgeranylationrequired formembraneassociation\alsoinvolved inendocytosis postvesicle internalization(23.13/33)M279 E1YOR089Csmall GTP-bindingprotein\geranylgeranylated\geranylgeranylationrequired formembraneassociation\alsoinvolved inendocytosis postvesicle internalization(23.13/33)M119 F4YOR091W(44.22/55)M119 A6YOR092WExtraCellular Mutant(67.54/60)M119YOR095C(28.41/38)B10M119YOR096W546-974C11(21.01/32)M280 D3YOR099Wtype 2 membraneprotein\probablesecretory protein(43.34/50)M120 A6YOR100C(36.00/47)M279 G5YOR102W16-kDa epsilonsubunit ofoligosaccharyltransferase complex\40\%identical to vertebrateDAD1 protein(12.87/39)M279 D2YOR106Wmember of thesyntaxin family ofproteins\predicted C-terminal TMD(31.24/43)M119 G4YOR107W(34.1/40)M120 B6YOR108W(66.55/66)M119YOR111W(25.63/34)D10M280 F2YOR114W(32.45/36)M280 E3YOR115C(29.51/31)M119 F7YOR117W(47.85/55)M120YOR119C(53.27/70)C10M202 G7YOR120WSimilar to mammalianaldo\/keto reductases(34.43/50)M120 C2YOR121C(11.14/11)M119 A5YOR123C(51.07/75)M120 H8YOR126Cisoamyl acetatehydrolytic enzyme(26.21/50)M280 H8YOR128Cphosphoribosylamino-imidazole-carboxylase(62.84/62)M279 F3YOR131C(24.01/30)M119 H7YOR133Wtranslation elongationfactor 2 (EF-2)(92.73/98)M119 C9YOR134WGTPase activatingprotein (GAP)(45.1/50)M120 F11YOR136WNAD+-dependentisocitratedehydrogenase(40.7/50)M122 C2YOR138C(73.84/74)M281 C7YOR142W(36.3/44)M281 E8YOR143CThiaminpyrophosphokinase(35.12/44)M122 B1YOR145C(30.17/38)M122YOR152C(28.29/36)G10M283 F2YOR154W(64.68/81)M122 A4YOR155C(49.53/55)M274 C8YOR156CInteracts with C-terminus of CDC12(79.89/95)M281 A6YOR157Cputative proteasomesubunit (28.74/36)M122 E9YOR159C(10.47/18)M121 C4YOR163W(20.79/20)M281 A5YOR164C(34.45/40)M122 C8YOR166C(50.41/34)M122YOR168Wglutaminyl-tRNAA11synthetase (89.1/98)M283 D1YOR169C(16.97/25)M122 D8YOR174W(31.45/45)M122YOR176WferrochelataseB11(protohemeferrolyase) (43.34/48)M122 C4YOR179C(20.71/30)M281 C5YOR180C(29.84/35)M122 A7YOR181Wprolin rich protein(69.74/80)M122YOR184WphosphoserineC11transaminase(43.56/50)M283 F1YOR185CGTP-binding protein(24.23/34)M283 B3YOR186W(15.95/26)M122 D4YOR187W(48.28/50)M122 B7YOR189W(12.87/20)M122 F8YOR190WExo-1 3-beta-glucanase (49.06/52)M122 B3YOR194CTranscription factorIIA large chain(31.49/42)M121 E4YOR195W(90.42/90)M281 D5YOR196CInvolved in lipoicacid metabolism(45.57/55)M281 F6YOR197W(49.94/60)M121 A2YOR201CRibosemethyltransferase formitochondrial 21SrRNA (45.35/55)M122 A6YOR204WATP-dependent RNAhelicase of DEADbox family\suppressor of a pre-mRNA splicingmutation prp8-1(66.55/70)M281 H6YOR213C(27.31/36)M281 C9YOR215C(20.48/30)M121YOR216C(53.37/64)G11M283 F3YOR218C(15.32/20)M122 C6YOR220W(29.36/34)M281 C8YOR222W(33.88/42)M121YOR224C16-kDa RNAH11polymerase subunit(common topolymerases I II andIII)(16.09/20)M281 D3YOR226C(17.29/18)M122 A5YOR227W(137.27/138)M121 G7YOR229WTranscriptionalmodulator (51.48/64)M121 C9YOR230WTranscriptionalmodulator (48.28/65)M121YOR232W(25.29/33)A12M123 A1YOR233Wprotein kinase(88.11/100)M124 D4YOR236Wdihydrofolatereductase (23.32/32)M124 E8YOR239W(30.8/36)M284 B8YOR240W(39.93/48)M285 B1YOR241W(60.49/60)M285 H2YOR243C(74.49/80)M285 E4YOR245C(46.01/48)M123 F6YOR246C(36.33/40)M123 G7YOR247W(23.21/34)M124 H9YOR248W(11.11/30)M123 D2YOR250C(48.98/55)M124 G3YOR251C(33.47/36)M284 H3YOR252W(15.62/25)M124 B6YOR253W(19.47/32)M123 H7YOR255W(30.69/40)M124 D1YOR257WCalcium-bindingprotein of spindlepole body (17.82/20)M284 B2YOR258W(23.98/32)M123 F3YOR259CATPase\componentof the 26Sproteasome capsubunit (48.10/55)M124 G4YOR260Wnegative regulator inthe general control ofamino acidbiosynthesis(63.69/70)M124 C6YOR261C(37.21/38)M124 F7YOR262W(38.38/40)M123 C9YOR264W(47.41/55)M284 E1YOR265WBinds to beta-tubulinand may participate inmicrotubulemorphogenesis(11.77/14)M284 C2YOR266W(46.64/50)M285 G3YOR268C(14.55/30)M124 D6YOR269WRequired for viabilityin the absence of thekinesin-related Cin8pmitotic motor.(54.45/54)M123 B8YOR271C(36.00/45)M123 D9YOR272Wmicrotubule-associated protein(50.71/60)M284 D2YOR274Wtransfer RNAisopentenyltransferase (47.29/52)M284 C4YOR276WmRNA cap-bindingprotein (eIF-4F) 20Ksubunit (17.82/30)M124 G7YOR278Wuroporphyrinogen IIIsynthase (30.46/36)M124 B9YOR279C(34.13/36)M124YOR280C(29.39/36)C10M124 G1YOR281C(31.49/32)M124 B5YOR284W(26.84/36)M124 F6YOR285W(15.4/20)M285 H5YOR286W(16.5/16)M123 D8YOR287C(33.03/48)M124YOR288CDisulfide isomeraseD10related protein(35.01/40)M123 F1YOR289W(27.72/34)M124 A8YOR294W(22.44/36)M123 E8YOR295W(25.29/36)M255 H8YOR298W(52.8/52)M123 C6YOR301W(47.96/50)M123 F8YOR303WCarbamoyl phosphatesynthetase argininespecific (45.32/48)M285 G7YOR311C(31.93/34)M285 G1YOR312C415-932 60Sribosomal proteinL18A (19.35/29)M285 F2YOR313C(37.21/47)M123 D7YOR317Wlong chain fattyacyl:CoA synthetase(77.11/80)M124 F10YOR319Whomolog ofmammalian splicingfactor\/U2 snRNPprotein (23.54/34)M124 G5YOR323Cgamma-glutamylphosphate reductase(50.29/55)M124 C7YOR324C(66.35/70)M285 C6YOR325W(17.48/19)M284 B9YOR327Cvesicle-associatedmembrane protein(synaptobrevin)homolog (12.68/22)M100 F1YOR329C(95.95/98)M293 H2YOR331C27-kDa subunit of thevacuolar ATPase\Esubunit of V1 sector(20.48/21)M100 F5YOR335CCytoplasmic alanyl-tRNA synthetase gene(105.41/98)M310 C7YOR339C(17.29/28)M310 D7YOR342C(35.12/42)M100 A1YOR344C33 kDa serine-richprotein (32.04/45)M100 G2YOR347C(55.69/60)M100 H5YOR351Ckinase involved inmeiotic chromosomepairing andrecombination(54.70/60)M100 B1YOR352W(37.84/45)M100 H2YOR355W(57.53/64)M100 E3YOR356W(69.52/69)M100 D4YOR357C(17.85/25)M100 H4YOR358WComponent alongwith Hap2p andHap3p of CCAAT-binding transcriptionfactor (26.73/40)M106 E6YOR359W(57.64/57)M293 H6YOR367W(22.11/36)M100 C1YOR368WDNA Damagecheckpoint control(44.22/64)M100 D2YOR370CRab geranylgeranyltransferase (66.46/70)M100 G3YOR372C(60.97/62)M100 B5YOR374W(57.2/60)M288 E7YOR375CNADP-specificglutamatedehydrogenase(49.97/55)M100 D1YOR376W(13.53/20)M100 A3YOR379C(12.45/16)M100 H3YOR380W(60.17/60)M100 H1YOR385W(32.01/40)M100 B3YOR387C(22.69/30)M100 C5YOR390W(41.46/41)M100 C6YOR391C(26.10/32)M293 E1YOR392W(16.38/20)M100 A2YOR393Wenolase homolog(48.28/55)M100 C3YPL001Whistoneacetyltransferase(41.25/48)M106 H5YPL004C(37.54/52)M106 G6YPL005W(66.77/66)M100 B2YPL007C(64.71/50)M293 B2YPL007C(64.71/62)M100 D3YPL009C(114.21/48)M100 B4YPL010WCoatomer complexzeta chain (zeta-COP)of secretory pathwayvesicles (20.9/32)M288 F5YPL011C(38.86/52)M100 E5YPL012W(135.29/135)M100 C2YPL015CHomolog of SIR2(39.30/45)M100 C4YPL026CSerine\/threonineprotein kinase thatsuppresses the growthdefect of snf3 mutantson low glucose(55.35/55)M126 A1YPL030W(62.48/64)M126 C2YPL031C120-1020 negativetranscriptionalregulator proteinkinase homolog(33.66/38)M126 F3YPL032C(90.78/90)M286 D4YPL033C(30.94/40)M286 E5YPL034W(18.36/31)M127 G9YPL037C(17.30/25)M127 B1YPL038W(19.58/32)M126 G3YPL040Cnuclear encodedmitochondrialisoleucyl-tRNAsynthetase(110.35/110)M287 F4YPL042Ca cyclin (SSN8)-dependentserine\/threonineprotein kinase(61.08/54)M127 E7YPL043WRNA recognitionmotif-containingprotein (75.46/80)M126 H3YPL048WCalciuim andphospholipid bindingprotein homologousto translationelongation factor-1gamma (EF-1gamma) (45.76/45)M126 D6YPL050CProtein required forcomplexglycosylation(43.48/45)M286 G6YPL051W(21.89/30)M126 G8YPL052W(22.22/30)M126YPL053Csimilar to KRE2A10(49.09/50)M126 C1YPL054W(33.22/38)M127 B2YPL055C(36.55/42)M287 B4YPL057CMulticopy suppressorof cls2-2\alsosuppresses rvs161mutations (42.05/42)M286 H6YPL059W(16.61/16)M287 D1YPL062W(14.85/26)M126 F2YPL063W(52.47/55)M126 B4YPL064C(33.14/40)M126 C5YPL065Wsoluble hydrophilicprotein involved intransport ofprecursors for solublevauolar hydrolasesfrom the lateendosome to thevacuole (26.73/32)M126 A9YPL068C(32.36/38)M126YPL069CgeranylgeranylB10diphosphate synthase(36.88/38)M126 E1YPL070W(67.43/67)M126 G2YPL071C(17.29/20)M286 G3YPL072W(55/60)M126 F6YPL074W(83./0583)M126YPL077C(26.4/332)C10M126 F1YPL078CF(1)F(0)-ATPasecomplex delta subunitmitochondrial(26.87/30)M286 F2YPL079W433-904(17.71/27)M287 G3YPL080C(11.91/12)M126 E5YPL081W509-1095(21.78/21)M126 G1YPL086C(61.30/62)M126 D4YPL088W(37.73/45)M287 G5YPL091WGlutathioneoxidoreductase(53.24/53)M127 E10YPL093W(71.38/80)M286 G1YPL094Cmembrane componentof ER proteintranslocationapparatus (31.26/38)M126 G5YPL097WTyrosyl-tRNAsynthetase (54.23/54)M126 B8YPL099C(20.05/20)M286 E8YPL100W(54.67/64)M126YPL101W(50.37/52)D10M287 G1YPL102C(11.03/11)M286 A3YPL103C(51.51/55)M127 A7YPL106CMember of the 70-kDa heat-shockprotein family(76.36/80)M287 A6YPL107W(27.49/36)M126 D9YPL108W(18.59/28)M126 E10YPL109C(59.76/59)M126 D3YPL111Warginase (36.74/40)M126 H5YPL113C(43.59/45)M126 E9YPL116W(76.78/76)M287 H1YPL118W(37.95/51)M126 E3YPL119Cputative ATP-dependent RNAhelicase\Dead boxprotein (67.90/67)M126 F4YPL120W(61.48/64)M126 D8YPL123C(47.77/55)M126 F9YPL124WNuclear importprotein (27.94/32)M129 A2YPL127Chistone H1 (28.41/38)M130 E3YPL128CTTAGGG repeatbinding factor(61.85/64)M130 D4YPL129W115-840(26.95/30)M129 G6YPL131WRibosomal proteinRPL1 (YL3) (rat L5)(32.78/40)M129 C8YPL132WPutative heme Abiosynthetic enzymeinvolved in formingthe formyl group atposition 8 of theporphyrin ring(33.11/40)M291 C8YPL133C(49.09/55)M289 B1YPL134C(34.13/40)M130 E2YPL135W(18.36/18)M289 F5YPL138C(38.86/48)M291 G5YPL139CTranscriptionalmodulator (50.63/60)M255 D9YPL141C(95.28/98)M129 C4YPL145CHomologous tohuman oxysterol-binding protein\implicated inergosterolbiosynthesis andregulation of Golgi-derived transportvesicle biogenesis(47.77/55)M130 F5YPL146C(50.08/55)M129 E8YPL148C(19.50/30)M129YPL149Winvolved in autophagyA10(32.45/34)M289 D1YPL150W(99.22/105)M129 D2YPL151C(49.64/52)M129 C3YPL152W(39.49/50)M289 E4YPL153C(90.34/98)M129 F8YPL156C(31.37/36)M129YPL157W(34.76/40)B10M130 E1YPL158C(83.41/98)M129 E2YPL159C(27.86/34)M129 H5YPL162C(30.06/40)M291 D7YPL164C(78.68/79)M130 E9YPL165C(41.06/45)M130 F1YPL166W(23.54/33)M289 F3YPL168W(47.41/50)M291 F3YPL169C(65.92/100)M129 D7YPL171CNAD(P)Hdehydrogenase(44.03/48)M130 F9YPL173W(32.78/36)M130 G1YPL174CNuclear importprotein (95.51/98)M291 G3YPL177CHomeobox-domaincontaining protein(33.69/57)M129 A6YPL178W(22.99/34)M291 C6YPL179Wprotein phosphatase Q(60.5/63)M130 G9YPL181W(55.77/50)M291 B5YPL186C(33.47/57)M130 D8YPL188W(45.65/52)M289 H1YPL190C(88.35/100)M130 B3YPL191C(39.63/49)M129 A5YPL193W(42.02/52)M129 C6YPL194W(67.43/70)M130 E8YPL196W(30.14/34)M130 C3YPL199C(26.43/38)M129 B5YPL201C(50.74/55)M130 D7YPL203W(41.91/50)M130 F8YPL204Wcasein kinase Iisoform (54.45/54)M291 F1YPL206C(35.34/37)M130 B4YPL208W(64.24/64)M289 D5YPL209CProtein kinase(40.40/50)M130 D6YPL210C(71.09/71)M130 E7YPL211W(20.02/32)M130YPL213W(26.39/32)A10M289 C2YPL214CTMPpyrophosphorylasehydroxyethylthiazolekinase (59.43/62)M130 D3YPL215W(36.96/38)M130 F7YPL219W(54.23/64)M291 B8YPL220Whomologue of the E-and Archebacterial L1ribisomal protein ofthe 60S ribosomalsubunit (23.98/33)M129YPL221W(87.34/70)H10M292 A1YPL222W(75.79/76)M132 G1YPL223C(18.51/28)M132 A3YPL225W(16.27/20)M132 G5YPL228W(60.5/68)M133 A1YPL230W(43.12/55)M132 E2YPL232W(32.01/45)M292 B3YPL233W(23.87/33)M292 H3YPL234C17-kDa subunit C ofvacuolar membraneH(+)-ATPase(18.07/32)M132 H5YPL236C(40.07/45)M132 A7YPL237Wbeta subunit oftranslation initiationfactor eIF-2(31.46/34)M133 B2YPL239W(22.11/32)M290 A3YPL240Cheat shock protein(78.02/98)M292 C3YPL241C106-887 involvementin microtubulefunction (29.59/33)M290 D5YPL243WSignal recognitionparticle subunit(66/70)M292 F5YPL244C(37./3237)M133 C8YPL245W(50.0/555)M292 C1YPL246C(28.85/29)M133 C2YPL247C(57.56/60)M132 B6YPL252C(18.95/30)M133 D8YPL253C(71.20/71)M132 D1YPL254W(53.79/55)M292 D3YPL257W(21.34/33)M255 E9YPL258C(60.64/60)M290 F5YPL259Cmedium subunit ofthe clathrin-associatedprotein complex(52.38/64)M133 B7YPL260W(60.72/70)M132 E1YPL262Wmitochondrial andcytoplasmic fumarase(fumarate hydralase)(53.79/53)M133 E2YPL263C(71.64/75)M132 C5YPL267W(23.1/34)M132 C7YPL269W(70.95/70)M290 C3YPL272C(56.90/64)M132 F3YPL273W(35.86/36)M290 H5YPL275W(26.07/36)M292 A6YPL276W(16.06/31)M133 F8YPL277C(53.60/60)M290 C1YPL278C(11.03/20)M290 D3YPL280W(26.28/34)M292 F3YPL281CEnolase-relatedsubtelomericsequence (ERR1 andERR2 code foridentical proteins)(48.10/41)M133 B5YPL282C(18.07/32)M290 F6YPR001WCitrate synthase(53.57/54)M132 G2YPR005Cpolar 32k Dacytoplasmic protein(32.47/38)M132 D4YPR007C(74.83/80)M133 C6YPR008W(76.45/76)M133 G1YPR011C(35.89/50)M290 E3YPR013C(34.90/34)M292 G3YPR014C(12.02/56)M132 E4YPR015C(27.20/34)M132 E5YPR016C(26.98/32)M290 H6YPR017CGDP dissociationfactor for Sec4p(15.76/25)M132 B2YPR020W(12.76/12)M133 E5YPR023C(44.14/55)M132 F5YPR024WMitochondrial proteinof theCDC48$$PAS1$$SEC18 family of ATPases(82.38/82)M133 G7YPR025Ccyclin(43.36/50)M290 E1YPR027C(30.50/30)M132 C2YPR028W185-676(19.91/20)M133 H7YPR033Ccytoplasmic andmitochondrialhistidine tRNAsynthetases(60.09/60)M294 A1YPR035Wglutamine synthetase(40.81/47)M134 E2YPR036W54-kDa vacuolar H(+)ATPase subunit of V1sector (52.69/52)M134 H3YPR037C(21.59/25)M295 A8YPR040W(39.37/50)M295 C9YPR041WTranslation initiationfactor eIF-5(44.66/52)M131 A7YPR048W(68.64/68)M134 C1YPR051WN-acetyltransferase(19.47/30)M294 A5YPR054WSporulation-specificMAP kinase requiredfor completion ofsporulation (42.79/55)M134YPR057WProtein involved inA10snRNP biogenesis(37.62/45)M134YPR058WputativeD11mitochondrial carrierprotein (33.88/40)M134 G2YPR060Cchorismate mutase(28.29/34)M294 G3YPR061C(33.14/43)M294 B5YPR062Wcytosine deaminase(17.49/27)M131 B6YPR063C128-509(15.51/30)M295 E9YPR065Wsite-specific DNAbinding proteinrepressor (40.59/49)M134 E11YPR066W(33/36)M131 C1YPR067W(20./4630)M294 D2YPR068CProtein withsimilarity to Hda1pRpd3p Hos2p andHos3p (51.73/60)M131 D3YPR069Cputrescineaminopropyltransferase (spermidinesynthase) (32.36/34)M134 G5YPR070W(62.47/64)M134 C7YPR071W(23.32/32)M131 F8YPR073C18-kDaphosphotyrosinephosphatase ofunknown function(17.74/25)M294YPR074CTransketolase 1D10(74.83/85)M134 F1YPR075C(39.63/48)M131 C6YPR079W(42.02/42)M134 H8YPR080Wtranslationalelongation factor EF-1 alpha (50.49/50)M295 G9YPR081C(68.01/68)M134YPR082C(15.76/25)G11M294 F2YPR084W(50.37/58)M131 A5YPR086Wtranscription factorTFIIB homolog(38.06/48)M295 C7YPR087W(11.77/14)M134 H1YPR091C(84.73/84)M294 G2YPR092W(11.22/16)M134 G4YPR093C(34.13/36)M131 D1YPR099C(13.01/13)M294 D4YPR101W(19.46/34)M131 C5YPR102C(19.27/20)M134 C9YPR104CProtein with a domainsimilar to the forkhead DNA-bindingdomain found in thedevelopmental forkhead protein ofDrosophilamelanogaster and inthe HNF-3 family ofhepatocytemammaliantranscription(102.99/102)M131 E1YPR107CYeast 30kDaHomologue(22.91/33)M295 E3YPR108W(47.3/54)M131 D5YPR110CRNA polymerase III(C) subunit(36.88/45)M131 A8YPR112C(97.60/98)M134 C2YPR115W(119.24/119)M294 B3YPR116W(30.58/42)M131 E5YPR118W(45.32/50)M131 B8YPR120C(47.88/47)M301 C4YPR121W(63.03/66)M295 D2YPR123C(15.87/25)M295 G3YPR124WHigh affinity coppertransporter into thecell probable integralmembrane protein(44.77/37)M131 C4YPR125W(50.05/55)M131 G6YPR127W(38.06/45)M294 F8YPR128C(36.11/40)M134YPR129Wmulticopy suppressorB11of clathrin deficiency(38.5/50)M263 A1YPR131C(27.64/36)M263 G2YPR133C(45.13/55)M263 E3YPR134WProtein involved insplicing introna15beta of COX1(29.59/34)M263 C5YPR136C(18.73/31)M263 B6YPR137W(63.14/80)M264 F6YPR138CAmmonia permeaseof high capacity andlow affinity(53.82/60)M264 B1YPR139C(33.03/36)M255 H9YPR140W(42.02/40)M264 C4YPR143W(27.61/47)M264 B6YPR145Wasparagine synthetase(63.03/67)M264 G6YPR146C(12.02/16)M264 C1YPR147C(33.47/40)M264 B2YPR148C(47.88/60)M263 H2YPR149Winvolved in secretionof proteins that lackclassical secretorysignal sequences(19.14/25)M263 E4YPR151C(22.69/32)M263 E5YPR152C(51.28/60)M263 A3YPR157W(51.48/64)M263 H3YPR158W(27.83/42)M264 D1YPR163CTranslation initiationfactor eIF-4B(47.99/50)M263 B3YPR165WGTP-binding proteinof the rho subfamilyof ras-like proteins(23.1/30)M263 A4YPR166C14 kDa mitochondrialribosomal protein\homologous to E. coliS14 protein(12.68/17)M263 F4YPR167C3′ phosphoadenylylsulfate reductase(28.74/36)M263 D6YPR169W(56.65/62)M263 C7YPR170C(12.24/18)M263 C2YPR172W(22.11/33)M263 C3YPR173Cdefective in vacuolarprotein sorting(48.10/56)M264 A4YPR174C(24.34/35)M263 G4YPR175WDNA polymeraseepsilon subunit B(76.23/76)M264 F5YPR176CGeranylgeranyltransferase Type II betasubunit (35.78/39)M264 D6YPR177C(13.56/17)M263 D7YPR178Wassociated with theU4$$U6 snRNP(51.36/55)M264 D2YPR180WAlong with Uba2pforms a heterodimericactivating enzyme forSmt3p (38.38/40)M264 B4YPR182WSm or Sm-like snRNPprotein (9.57/10)M264 H4YPR183Wdolichol phosphatemannose synthase(29.48/36)M263 E7YPR186CTranscription factorIIIA (47.22/51)M264 E1YPR187W97-544 subunitcommon to RNApolymerases I II andIII (17.26/29)M263 E2YPR188C(17.96/30)M263 A5YPR191W40 kDa ubiquinolcytochrome-creductase core protein2 (40.59/46)M263 H5YPR192W(33.66/40)M264 E6YPR193C(17.29/28)M264 B5YPR199C(32.37/39)M265YPR200C(14.33/16)A10M264 E7YPR202W168-865(26.39/26)M264 G1YPR203W(11.33/16)



Example 2


High-Throughput Expression of Human Gene Sequences

[0077] The following example illustrates the construction of a library of expressible human gene sequences using the method of the invention. Primers were constructed based on sequences of human genes available from GenBank.


[0078] Fetal human heart tissue was obtained from the International Institute for the advancement of Medicine (IIAM). Poly A+mRNA was isolated using the FastTrack™ 2.0 Kit (Invitrogen, Carlsbad, Calif.) according to the manufacturer's instructions. The mRNA was converted to first-strand cDNA using a cDNA Cycle® Kit (Invitrogen) using the oligo dT primer provided and the protocols suggested. A single cDNA synthesis reaction was split into 12 separate wells of a 96-well PCR amplification plate, and PCR amplifications were performed using specific primer sets, essentially as described above, with the exception that the ratio of Taq to Pfu was 50:1 in the initial amplification (final conc. 2 U Taq:0.04 U Pfu/well). Sequence specific primers for each sequence being amplified were designed to start amplification at the start codon (ATG) of each sequence and end at the stop codon. In some cases, the primer design removed the stop codon from the DNA sequence, allowing for generation of a fusion protein when inserted into suitable expression vectors. Primers were synthesized using a Primerstation 960 (Intelligent Automation Systems, Inc.) used according to the manufacturer's instructions and were designed from sequences downloaded from Unigene and sent directly to the synthesizer Approximately 15 nMoles of each primer, having an average length of 25 basepairs (melting point between 60°-64° C., was synthesized in a 96-well format. After synthesis, the primers were cleaved from the supports, deprotected and dried in the same 96-well format (see manufacturer's instructions). zThe amplified gene sequences were purified and inserted into the pcDNA3.1/GS expression vector or pTYB2.2 expression vector (Invitrogen, Carlsbad, Calif.) essentially as described above. The expression vectors containing sequences verified to be in the correct orientation were transfected into CHO cells in 96-well deep-well blocks using the Pfx-6 PerFect Lipid system (Invitrogen, Cat #T930-16). Cell lysates were made 48 hours after transfection, and the lysates were separated by SDS-PAGE and analyzed by Western blot according to standard protocols using an anti-V5 epitope tag Mab/horseradish peroxidase conjugate. Table 2 below lists the human proteins successfully expressed using this methodology. The ORFs identified as HP—were expressed in pTYB2.2. All other ORFs were expressed in pDNA3.1.


[0079] Additional collections of human sequences were obtained from a variety of sources, including adult lung, heart and mammary tissue and fetal liver tissue. Sequences were inserted into several expression vectors having features suitable for different purposes, including pIND/GS, pRSET, pCRT7, pcDNA3.1/GS, and pBAD/Thio-V5-His (Invitrogen, Carlsbad, Calif.). Sequences obtained are listed in Table 2 below.
2TABLE 2Human ORFsPredictedActualPlate NumberAccession NumberDescriptionSizeSizeM235 C7H-A06977albumin67.167.0 kDaE1H-AB002391Human mRNA for KIAA039368.0968gene, complete cdsH3H-AB006969Homo sapiens hGAA1 mRNA,68.4270complete cdsE2H-AB007875Homo sapiens KIAA0415 mRNA,51.4851complete cdsD1H-AB007887Homo sapiens KIAA0427 mRNA,66.5570complete cdsM421 D6H-AB010710Homo sapiens mRNA for lectin-30.1445.0 kDalike oxidized LDL receptor,complete cdsG3H-AD001528Homo sapiens spermidine40.3740aminopropyltransferase mRNA,complete cdsB5H-AE000659Homo sapiens T-cell receptor12.3916alpha delta locus from bases250472 to 501670 (section 2 of 5)of the CE2H-AF004022Homo sapiens protein kinase38.2844mRNA, complete cdsM428 C1H-AF004231Homo sapiens65.7870.0 kDamonocyte/macrophage Ig-relatedreceptor MIR-10 (MIR cl-10)mRNA, complete cdsA5H-AF004327Homo sapiens angiopoietin-254.6760mRNA, complete cdsC1H-AF006501Homo sapiens chromosome 2214.0824cosmid clone c1155, RNApolymerase II subunit 14.4 kDa(POLRF) gene, complete cdsH4H-AF008936Homo sapiens syntaxin-16B35.7547mRNA, complete cdsH5H-AF009243Homo sapiens proline-rich Gla22.3336protein 2 (PRGP2) mRNA,complete cdsM462 D6H-AF013249Homo sapiens leukocyte-31.6840.0 kDaassociated Ig-like receptor-1(LAIR-1) mRNA, complete cdsA1H-AF013512untitled53.0253A3H-AF013970Homo sapiens MTG8-like protein66.5570(MTGR1) mRNA, complete cdsM467 A7H-AF014807Homo sapiens23.5429.0 kDaphosphatidylinositol synthase(PIS) mRNA, complete cdsD2H-AF015257Homo sapiens flow-induced41.3640endothelial G protein-coupledreceptor (FEG-1) mRNA,complete cdsM422 B5H-AF017307Homo sapiens Ets-related40.9249.0 kDatranscription factor (ERT) mRNA,complete cdsA6H-AF017656Homo sapiens G protein beta 538.9448subunit mRNA, complete cdsE1H-AF017995Homo sapiens 3-phosphoinositide61.2752dependent protein kinase-1(PDK1) mRNA, complete cdsG1H-AF019612Homo sapiens S2P mRNA,57.257complete cdsD3H-AF020591Homo sapiens zinc finger protein78.7674mRNA, complete cdsA7H-AF022385Homo sapiens apoptosis-related23.4333protein TFAR15 (TFAR15)mRNA, complete cdsH6H-AF024714Homo sapiens interferon-37.8448inducible protein (AIM2) mRNA,complete cdsB1H-AF025527Homo sapiens leucocyte48.447immunoglobulin-like receptor-4(LIR-4) mRNA, complete cdsM424 B4H-AF025532Homo sapiens leucocyte49.3959.0 kDaimmunoglobulin-like receptor-5(LIR-5) mRNA, complete cdsH5H-AF026071Homo sapiens soluble death30.5850receptor 3 beta (DR3) mRNA,complete cdsM428 A1H-AF026273Homo sapiens interleukin-165.0168.0 kDareceptor-associated kinase-2mRNA, complete cdsB6H-AF026293Homo sapiens chaperonin58.9658containing t-complex polypeptide1, beta subunit (Cctb) mRNA,complete cdsB5H-AF026548Homo sapiens branched chain45.4350alpha-ketoacid dehydrogenasekinase precursor, mRNA, nucleargene encoding mitochondrialprotein, complete cdsB2H-AF027204Homo sapiens putative tetraspan21.7827transmembrane protein L6H(TM4SF5) mRNA, complete cdsM426 D3H-AF028008Homo sapiens SP1-like zinc56.4364.0 kDafinger transcription factor SLPmRNA, complete cdsB1H-AF029232Homo sapiens calpamodulin70.6270(CalpM) mRNA, complete cdsM422 A7H-AF029761Homo sapiens decoy receptor 242.5750.0 kDamRNA, complete cdsM477 F3H-AF029893Homo sapiens i-beta-1,3-N-45.7650.0 kDaacetylglucosaminyltransferasemRNA, complete cdsC5H-AF032437Homo sapiens mitogen activated51.9250protein kinase activated proteinkinase gene, complete cdsM416 F3H-AF035824Homo sapiens vesicle soluble25.6336.0 kDaNSF attachment protein receptor(VTI1) mRNA, complete cdsF3H-AF037335Homo sapiens carbonic anhydrase39.0539precursor (CA 12) mRNA,complete cdsG1H-AF039019Homo sapiens zinc finger DNA87.4587binding protein 89 kDa (ZBP-89)mRNA, complete cdsG1H-AF039136Homo sapiens Fas binding protein81.5198(hDaxx) mRNA, complete cdsA7H-AF040705Homo sapiens putative tumor31.5741suppressor protein unspliced form(Fus-2) mRNA, complete cdsM469 F1H-AF040958Homo sapiens lysosomal45.7646.0 kDaneuraminidase precursor, mRNA,complete cdsG2H-AF043472Homo sapiens Shab-related54.1264delayed-rectifier K+ channelalpha subunit (Kv9.3) mRNA,complete cdsE2H-AJ001340Homo sapiens mRNA for U352.3660snoRNP associated 55 kDaproteinG1H-D00096Transtyretin (prealbumin)16.2820C4H-D00408Cytochrome P450 IIIA7 (P450-55.4464HFLa)M302 E7H-D00682cofilin18.3730M383 G2H-D00726ferrochelatase46.6450.0 kDaM383 C3H-D00760proteasome, subunit HC325.8534.0 kDaM305 B4H-D00761proteasome, subunit HC526.6233M266 F7H-D00763proteasome, subunit HC928.8233E2H-D00860Phosphoribosyl pyrophosphate35.0947synthetase subunit I215-13H-D10522human mRNA for 80 K-L protein3536.59M423 F5H-D11086Interleukin 2 receptor gamma40.745.0 kDachainM248 D2H-D11094positive modulator of HIV tat-47.7440.0 kDamediated transactivationG3H-D11428Peripheral myelin protein 2217.7117M424 D3H-D13168Human gene for endothelin-B48.7348.0 kDareceptor (hET-BR)M271 B8H-D13315glyoxalase I,20.3534.0 kDaLACTOYLGLUTATHIONELYASE. CATALYZES THECONVERSION OFHEMIMERCAPTAL, FORMEDFROM METHYLGLYOXALAND GLUTATHIONE, TO S-LACTOYLGLUTATHIONE.M306 F1H-D13627hypothetical protein60.3990(GB: D13627)M248 D1H-D13630hypothetical protein46.249(GB: D13630) , Human mRNA forKIAA0005 gene, complete cdsM270 D5H-D13634hypothetical protein34.6542.0 kDa(GB: D13634)M250 D2H-D13642hypothetical protein4448.0 kDa(GB: D13642), Human mRNA forKIAA0017 gene, complete cdsM250 E6H-D13748translation initiation factor 4A44.7749.0 kDaM305 C3H-D13892carboxyl methyltransferase,25.1934aspartateD1H-D13900enoyl-Coenzyme A hydratase,32.0158short chain, mitochondrialE1H-D14446Human HFREP-1 mRNA for34.4340unknown protein, complete cds167-14H-D14497H. sapiens (Ewing's sarcoma cell51.4464line) mRNA encoding openreading frameM266 D2H-D14520basic transcription element-24.233.0 kDabinding protein 2M318 D2H-D14658hypothetical protein13.6417(GB: D14658)D2H-D14661Human mRNA for KIAA010516.7228gene, complete cdsM236 E2H-D14662HYPOTHETICAL 29.5 KD24.7536.0 kDaPROTEIN IN UBP13-KIP1INTERGENIC REGION[Saccharomyces cerevisiae]M271 G6H-D14695hypothetical protein43.1250.0 kDa(GB: D14695), Human mRNA forKIAA0025 gene, complete cds.M311 A3H-D14696hypothetical protein25.7430.0 kDa(GB: D14696)H3H-D14697Farnesyl diphosphate synthase46.255(farnesyl pyrophosphatesynthetase,dimethylallyltranstransferase,geranyltranstransferase)M271 E7H-D14705catenin, alpha 2(E). Catenin99.77110(cadherin-associated protein),alpha 1 (102 kD). ASSOCIATESWITH THE CYTOPLASMICDOMAIN OF A VARIETY OFCADHERINS.M236 A6H-D14811hypothetical protein30.2542(GB: D14811)M250 A3H-D14812hypothetical protein(GB: D14812), Human mRNA forKIAA0026 gene, complete cdsA5H-D14874Human mRNA for20.4633adrenomedullin, complete cdsF3H-D14887Human mRNA for TFIIA-42,41.4750complete cdsM250 H6H-D16234phospholipase C, alpha,55.6656.0 kDaPROBABLE PROTEINDISULFIDE ISOMERASE ER-60 PRECURSOR [Homo sapiens]M305 B1H-D16480enoyl-CoA hydratase/3-84.0484hydroxyacyl-CoA dehydrogenasetrifunctional protein, alpha-subunit, mitochobdrialM271 G2H-D164813-ketoacyl-CoA thiolase, betasubunit, mitochodrial,Hydroxyacyl-Coenzyme Adehydrogenase/3-ketoacyl-Coenzyme Athiolase/enoyl-Coenzyme A hydratase(trifunctional protein), betasubunitH1H-D16626Histidine ammonia-lyase72.3864A2H-D17532Human mRNA for RCK,52.0353complete cdsM266 F4H-D17554DNA-binding protein TAX31.7938M248 A3H-D21235xeroderma pigmentosum group C40.0455repair complementing proteinHHR23AM235 E1H-D21261SM22-ALPHA HOMOLOG,2231hypothetical protein(GB: D21261)M311 E1H-D21262hypothetical protein77.95063(GB: D21262)M466 B4H-D21853Human mRNA for KIAA011145.3249.0 kDagene, complete cdsM311 H3H-D23660ribosomal protein L447.0847M419 E1H-D26309human mRNA for LIMK (LIM71.24075.0 kDakinase)M271 B9H-D26362hypothetical protein79.9770(GB: D26362), Human mRNA forKIAA0043 gene, complete cdsM361 H2H-D26598proteasome, subunit HsC10-II22.6633.0 kDaM302 G4H-D26599proteasome, subunit HsC7-I22.2234G1H-D26600Human mRNA for proteasome29.1536subunit HsN3, complete cdsG9H-D28540hypothetical protein, CDC1044.7760homologM266 A5H-D29011proteasome, subunit X22.9923M236 F3H-D29012Proteasome (prosome, macropain)26.432.0 kDadelta subunit, beta type, 6C1H-D30037Human mRNA for29.9238phosphatidylinositol transferprotein (PI-TPbeta), complete cdsM250 H4H-D30655translation initiation factor 4AII,44.8845.0 kDaand ribosomal binding protein167-26H-D30742human mRNA for calmodulin-52.1055dependent protein kinase IVM236 A4H-D31767hypothetical protein18.5930(GB: D31767), Human mRNA forKIAA0058 gene, complete cdsE1H-D31883Human mRNA for KIAA005950.9364gene, complete cdsG2H-D32129MHC class I protein HLA-A40.2650M422 A6H-D37965Human mRNA for PDGF receptor41.3645.0 kDabeta-like tumor suppressor(PRLTS), complete cdsM305 H4H-D3804726S proteasome regulatory28.34034.0 kDasubunit P31M423 B2H-D38081Thromboxane A2 receptor37.8445.0 kDaM317 D3H-D38305ErbB-2 transducer38.0649M270 A8H-D38583calgizzarin, Human mRNA for11.6612calgizzarin, complete cdsM270 A6H-D42038hypothetical protein15.2927(GB: D42038), Human mRNA forKIAA0087 gene, complete cdsM318 F3H-D42085hypothetical protein90.2100(GB: D42085)M311 C2H-D43642YL-1 protein homolog40.1536E1H-D45213Human mRNA for zinc finger12.8720protein, complete cdsM236 B2H-D45248proteasome activator hPA28,26.438subunit beta, may be celladhesion proteinH3H-D45887Human mRNA for calmodulin,16.520complete cds166-3H-D45906human mRNA for LIMK-27070.25A7H-D49357Human mRNA for S-43.5651adenosylmethionine synthetase,complete cdsC5H-D49489Human mRNA for protein48.5154disulfide isomerase-relatedprotein P5, complete cdsM482 E2H-D49958Human fetus brain mRNA for30.6932.0 kDamembrane glycoprotein M6,complete cdsM305 G5H-D50063proteasome, subunit p4035.7539M250 B6H-D50310cyclin I, Human mRNA for cyclin41.5847I, complete cdsE3H-D50419Homo sapiens mRNA for OTK18,78.3264complete cdsM298 B1H-D50495transcription elongation factor h-3333.0 kDaSII-T1 (GB: D50495)M302 A3H-D50840ceramide glucosyltransferase43.4544167-40H-D50863human mRNA for TESK168.9370166-28H-D50927human myeloblast mRNA for60.4664KIAA0137 geneD1H-D63521Homo sapiens mRNA for LECT216.7216precursor, complete cdsM302 A5H-D78134glycine-rich binding protein CIRP19.0330.0 kDaM313 E5H-D78275proteasome subunit p4242.948.0 kDaB3H-D79205Human mRNA for ribosomal5.7210protein L39, complete cdsA4H-D79206Human gene for ryudocan core21.8933protein, exon1-5, complete cdsA1H-D80008Human mRNA for KIAA018621.6732gene, complete cdsM298 H4H-D83004ubiquitin-conjugating enzyme E216.8332.0 kDasimilar to Drosophila bendlessgene productC3H-D83702Human brain mRNA for64.5764photolyase homolog, completecdsM306 A1H-D83735neutral calponin34.134.0 kDaH2H-D86322Homo sapiens mRNA for67.2164calmegin, complete cdsB1H-D86979Human mRNA for KIAA022682.7282gene, complete cds169-16H-D87116dual specificity mitogen-activated38.2442protein kinase kinase 3166-27H-D87119human cancellous bone osteoblast37.8040mRNA for GS3955E2H-D88308Homo sapiens mRNA for very-68.3164long-chain acyl-CoA synthetase,complete cds166-26H-D89077human mRNA for Src-like30.4338adapter proteinM440 H2H-D89479Homo sapiens mRNA for ST1B2,32.6738.0 kDacomplete cdsH1H-D90086Human pyruvate dehydrogenase39.635(EC 1.2.4.1) beta subunit gene,exons 1-10M362 F1H-D90209DNA-binding protein38.7248.0 kDaTAXREB67M316 B2H-J00068actin, alpha 1, skeletal muscle41.5850M250 B2H-J00194major histocompatibility complex,28.0536.0 kDaMHC class II, DR alphaG2H-J00212Interferon, alpha 2120.930G1H-J00287Human pepsinogen gene42.7948M298 C2H-J02611apolipoprotein D20.931.0 kDaM266 C4H-J02683ADP/ATP carrier protein32.8936M383 H2H-J02685plasminogen activator inhibitor,45.7650.0 kDaplacenta167-3H-J02853“casein kinase II, alpha chain”43.0850E3H-J02854Human 20-kDa myosin light19.0331chain (MLC-2) mRNA, completecdsM248 F3H-J02874fatty-acid-binding protein 4,14.6317adipocyte, LIPID TRANSPORTPROTEIN IN ADIPOCYTESM235 D5H-J02939antigen 4F2, heavy chain58.358C3H-J02943Corticosteroid binding globulin44.6650M248 F2H-J02966adenine nucleotide translocator 132.7833(skeletal muscle) [ANT1],CATALYZES THE EXCHANGEOF ADP AND ATP ACROSSTHE MITOCHONDRIALINNER MEMBRANE.E1H-J02982Glycophorin B10.1220167-91H-J03075“protein kinase c substrate, 80 kD58.0498protein heavy chain”M266 A3H-J031891profilin 115.5117.0 kDaM248 H4H-J03231glucose-6-phosphate56.7651dehydrogenase [G6PD]M266 F2H-J03459LEUKOTRIENE A-467.3264HYDROLASE [Homo sapiens]A2H-J03460Prolactin-induced protein16.1726M271 E5H-J03799laminin receptor 1, Laminin32.56receptor (2H5 epitope). 40SRIBOSOMAL PROTEIN SA[Homo sapiens].M440 A4H-J03890Human pulmonary surfactant21.7830.0 kDaprotein C (SP-C) and pulmonarysurfactant protein C1 (SP-C1)genes, complete cdsM271 D8H-J03934NAD(P)H menadione30.2538oxidoreductase 1, dioxin-inducible. INVOLVED INDETOXICATION PATHWAYS.M271 A8H-J04031trifunctional enzyme102.96117.0 kDa (GB: J04031). C-1-TETRAHYDROFOLATESYNTHASE, CYTOPLASMIC[Homo sapiens]M305 F6H-J04046calmodulin 3 [CALM3]16.520M305 G7H-J04071cytotoxic T-lymphocyte-27.2838associated serine esterase 1(cathepsin G-like 1, granzyme B)[CTLA1]M311 D2H-J04183lysosomal-associated membrane44.9947protein 2M300 F4H-J04205Sjogren syndrome antigen B44.9951.0 kDaM416 G8H-J04430Acid phosphatase 5, tartrate35.6445.0 kDaresistantB1H-J04501Glycogen synthase 1 (muscle)81.1881M313 B5H-J04543synexin51.3751B1H-J04605Peptidase D54.3455M250 C6H-J04615small nuclear ribonucleoprotein26.5134.0 kDaSM-D, ROLE IN THE PRE-mRNA SPLICING OR INSNRNPSTRUCTURE.M248 E2H-J04964steroid sulfatase (microsomal)64.2460.0 kDa[STS]M250 A7H-J05249replication protein A, 32 kDa29.8136.0 kDasubunit, REQUIRED FOR SV40 DNA REPLICATION INVITRO, RP-A IS SINGLE-STRANDED DNA-BINDINGPROTEIN.F1H-J05272IMP (inosine monophosphate)56.6551dehydrogenase 1169-15H-J05401“creatine kinase, sarcomeric5046.16mitochondrial precursor”M266 E4H-J05448RNA polymerase II, subunit B3330.3635.0 kDaM305 C2H-K00558tubulin, alpha k1 [TUBA*]49.7252.0 kDaM416 H7H-K01571Human T-cell receptor active34.4336.0 kDabeta-chain, mRNA from cell lineMOLT-3, complete cdsM311 E4H-K01763haptoglobin38.2847.0 kDaG5H-K02100Human ornithine39.0547transcarbamylase (OTC) mRNA,complete coding sequenceM302 D5H-K02574purine nucleoside phosphorylase31.936.0 kDa169-39H-K02581“thymidine kinase, cytosolic”3425.81M248 E4H-K03020phenylalanine hydroxylase [PAH]49.8350M556 B3H-K03191Cytochrome P450, subfamily I56.4353.02 kDa(aromatic compound-inducible),polypeptide 1H2H-L00190Antithrombin III51.1555169-62H-L01087“protein kinase c, theta type”8077.7M318 C2H-L01124ribosomal protein S1316.7228M313 F1H-L02321glutathione S-transferase M524.0928M305 E5H-L02426protease 26S, regulatory subunit 448.5153M302 D4H-L02547cleavage stimulation factor, 5047.5250.0 kDakDa subunitM266 H7H-L02648transcobalamin II47.0848.0 kDaE2H-L02932Human peroxisome proliferator51.5959activated receptor mRNA,complete cdsM270 A1H-L03380gonadotropin-releasing hormone36.1936receptor [GRHR], THISRECEPTOR MEDIATES ITSACTION BY ASSOCIATIONWITH G PROTEINSM270 H1H-L03411RD protein [RDBP], Radin blood41.9159.0 kDagroupD3H-L03426Human XE7 mRNA, complete42.4645alternate coding regionsB1H-L03785Myosin, light polypeptide 5,19.1432regulatoryA7H-L04483ribosomal protein S219.2434M416 B2H-L05147Human dual specificity20.4630.0 kDaphosphatase tyrosine/serinemRNA, complete cds215-38H-L05624dual specificity mitogen-activated5043.30protein kinase kinase 1M271 D4H-L06132anion channel, voltage-gated,31.2437isoform 1. FORMS A CHANNELTHROUGH THE CELLMEMBRANE, THAT ALLOWSDIFFUSION FROM SMALLHYDROPHYLIC MOLECULES.169-27H-L06139tyrosine-protein kinase receptor125123.7TIE-2 precursorH1H-L06147Human (clone SY11) golgin-9568.3168mRNA, complete cdsM250 A1H-L06419procollagen-lysine, 2-oxoglutarate80.0880.0 kDa5-dioxygenase (lysinehydroxylase) [PLOD]M236 F6H-L06498ribosomal protein S2013.223.0 kDaM318 D1H-L06499ribosomal protein L37a10.2327M270 D1H-L07414CD40 antigen ligand [CD40LG],28.8236NVOLVED INIMMUNOGLOBULIN CLASSSWITCHING.M298 A6H-L07548aminoacylase 144.9952.0 kDaM424 C3H-L07592Human peroxisome proliferator48.6248.0 kDaactivated receptor mRNA,complete cdsM298 G6H-L07633proteasome (prosome, macropain)27.533.0 kDaactivator subunit 1 (PA28 alpha)[PSME1]M318 B1H-L08096CD70 antigen (CD27 ligand)21.3428[CD70]D2H-L08187cytokine receptor EB1325.342M313 F4H-L08850amyloid, non-A beta component,15.5131.0 kDaAlzheimer's diseaseM426 E1H-L08895MADS box transcription enhancer52.1460.0 kDafactor 2, polypeptide C (myocyteenhancer factor 2C)M266 A8H-L09235ATPase, vacuolar67.9864.0 kDaM266 D1H-L09604differentiation-dependent16.8317.0 kDaintestinal membrane A4 protein(Homo sapiens)M317 C1H-L10338sodium channel, voltage-gated,24.0924type I, beta polypeptide [SCN1B]M317 E1H-L10717tyrosine-protein kinase ITK/TSK68.27068.0 kDaM300 B5H-L10820formyl peptide receptor 1 [FPR1]38.6137M312 A4H-L10838pre-mRNA splicing factor SRp2018.1531.0 kDaM300 A5H-L10918chemokine (C-C) receptor 139.1630[CMKBR1]M311 F2H-L11245complement component 4-binding27.8330protein, betaM266 B7H-L11353neurofibromatosis 2 (bilateral65.5663.0 kDaacoustic neuroma) [NF2]M311 B3H-L11667cyclophilin 4040.8150.0 kDa215-49H-L11695serine/threonine-protein kinase6455.40receptor R4 precursorM466 C2H-L11931Human cytosolic serine53.2456.0 kDahydroxymethyltransferase(SHMT) mRNA, complete cdsM271 B7H-L12168ADENYLYL CYCLASE-52.3660.0 kDaASSOCIATED PROTEIN 1[Homo sapiens]M416 D4H-L12964Interleukin-activated receptor,28.1638.0 kDahomolog of mouse Ly63B3H-L13203Human HNF-3/fork-head38.7249homolog-3 HFH-3 mRNA,complete cdsD2H-L13744Human AF-9 mRNA, complete62.5963cds167-8H-L13943glycerol kinase6057.71M311 G3H-L13974leucine zipper protein41.1451(GB: L13974)M271 H5H-L13977LYSOSOMAL PRO-X54.6757CARBOXYPEPTIDASEPRECURSOR [Homo sapiens].M270 G2H-L14283protein kinase C, zeta [PRKCZ],65.2398SERINE- AND THREONINE-SPECIFIC ENZYME.M235 A3H-L14286antioxidant protein, thiol-specific21.8932.0 kDaM426 H3H-L14778Protein phosphatase 3 (formerly57.4260.0 kDa2B), catalytic subunit, alphaisoform (calcineurin Aalpha){alternative products}B4H-L15702complement factor B84.15100M426 A4H-L16794Human transcription factor57.4260.0 kDa(MEF2) mRNA, complete cds215-25H-L16862g protein-coupled receptor kinase7063.4GRK6167-74H-L16991thymidylate kinase3623.39169-3H-L18964“protein kinase c, iota type”8064.64M305 E2H-L18972hypothetical protein (GB: L18972)75.2478M426 D4H-L19067Human NF-kappa-B transcription59.1863.0 kDafactor p65 subunit mRNA,complete cds215-26H-L19268Homo sapiens myotonic7068.71dystrophy associated proteinkinase mRNAM271 E1H-L19297carbonic anhydrase V [CA5],33.6642Mitochondrial carbonicanhydrase. REVERSIBLEHYDRATATION OF CARBONDIOXIDE.M298 G4H-L19437transaldolase37.1839.0 kDaM423 C4H-L19593Interleukin 8 receptor, beta39.7141.0 kDaG1H-L19686Homo sapiens macrophage12.7613migration inhibitory factor (MIF)gene, complete cdsG2H-L19739metallopanstimulin 19.3532M302 E3H-L19871activating transcription factor 320.0236.0 kDa167-86H-L2042214-3-3 protein eta3427.13M440 B2H-L20492Human gamma-glutamyl24.8635.0 kDatranspeptidase mRNA, completecdsM315 B1H-L20688GDP-dissociation inhibitor22.2232protein rhoAM271 H3H-L20941ferritin, heavy polypeptide.20.2432FERRITIN IS ANINTRACELLULARMOLECULE THAT STORESIRON IN A SOLUBLE,NONTOXIC, READILYAVAILABLE FORM.M235 B7H-L21893Na+/taurocholate cotransporter,STRICTLY DEPENDENT ONTHEF1H-L21934Sterol O-acyltransferase (acyl-60.6160Coenzyme A: cholesterolacyltransferase)C2H-L22075Human guanine nucleotide41.5850regulatory protein (G13) mRNA,complete cds169-18H-L22206vasopressin v2 receptor6058.00M421 A10H-L22214Human adenosine A1 receptor35.9738.0 kDa(ADORA1) mRNA exons 1-6,complete cdsM424 F1H-L23959Homo sapiens E2F-related45.2153.0 kDatranscription factor (DP-1)mRNA, complete cdsC2H-L24498Human gadd45 gene, complete18.2628cdsM302 E2H-L25080proto-oncogene rhoA, multidrug21.3431resistance proteinM270 B8H-L25081guanine nucleotide-binding and21.3430transforming protein rhoC,Aplysia ras-related homolog 9M236 E3H-L25085Sec61 complex, beta subunit,10.6719PROTEIN TRANSLOCATIONIN THE ENDOPLASMICRETICULUM167-85H-L25610cyclin-dependent kinase inhibitor 13218.11B2H-L25610cyclin-dependent kinase inhibitor 118.11040M297 H2H-L26232cathepsin A/phospholipid transfer54.3464.0 kDaprotein167-4H-L26318stress-activated protein kinase5242.31JNK1M428 F1H-L27586Human TR4 orphan receptor67.7667.0 kDamRNA, complete cdsM302 E5H-L27711protein phosphatase KAP123.4328M250 A6H-L28010Homo sapiens HnRNP F proteinmRNA, complete cds,F1H-L28821Alpha mannosidase II isozyme87.6787167-89H-L28824tyrosine-protein kinase SYK7069.92M298 E6H-L28997ADP-ribosylation factor-like gene 120.0233.0 kDaD4H-L29219Homo sapiens clk1 mRNA,53.3560complete cds169-63H-L29222Homo sapiens clk1 mRNA2515.03M429 B3H-L29277Signal transducer and activator of84.8188.0 kDatranscription 3 (acute-phaseresponse factor)C1H-L29433Human factor X (blood53.7964coagulation factor) geneG3H-L31860Glycophorin A16.6126D1H-L31881Nuclear factor I/X (CCAAT-48.6248binding transcription factor)169-13H-L31951human protein kinase (JNK2)5546.71mRNAA1H-L32179Arylacetamide deacetylase4450(esterase)B2H-L33404Human stratum corneum27.9436chymotryptic enzyme mRNA,complete cdsM312 D3H-L33799procollagen C-proteinase49.551.0 kDaenhancer169-77H-L33801human protein kinase mRNA5546.27GSK-3M305 D6H-L34041L-glycerol-3-phosphate: NAD+38.542.0 kDaoxidoreductaseB4H-L34355Homo sapiens (clone p4) 50 kD42.6847dystrophin-associatedglycoprotein mRNA, completecdsM297 B3H-L35013spliceosomal protein SAP 4946.7552.0 kDa167-32H-L35253human CSaids binding protein5239.67(CSBP1) mRNAM266 D6H-L35545C/activated protein C receptor,26.2938.0 kDaendothelialM300 F1H-L35594autotaxin100.7691.0 kDaM318 E2H-L36720bystin33.7729M305 H2H-L37127RNA polymerase II12.9816M300 D1H-L38490ADP-ribosylation factor22.2232(GB: L38490)M318 E1H-L38941ribosomal protein L3412.9818C2H-L38969Homo sapiens thrombospondin 3105.27110(THBS3) gene, complete cdsM476 F4H-L39060Homo sapiens transcription factor49.6153.0 kDaSL1 mRNA, complete cdsM300 E4H-L40399hypothetical protein (GB: L40399)29.2636E3H-L40802Homo sapiens 17-beta-42.6860hydroxysteroid dehydrogenase(17-HSD) geneM478 F1H-L40904H. sapiens peroxisome52.6960.0 kDaproliferator activated receptorgamma, complete cdsM306 C2H-L41268natural killer associated transcript37.62402 [NKAT2*]M306 E2H-L41270natural killer associated transcript50.1665.0 kDa4 [NKAT4*]M306 F2H-L41347natural killer associated transcript33.55405 [NKAT5*]M468 C3H-L41351Homo sapiens prostasin mRNA,37.8445.0 kDacomplete cds169-53H-L41816Homo sapiens cam kinase I4840.77mRNA167-25H-L41939tyrosine-protein kinase receptor108108.6EPH-3 precursorC3H-L42374Homo sapiens protein54.7864phosphatase 2A B56-beta (PP2A)mRNA, complete cdsM306 B1H-L42531glutathione synthetase52.2554.0 kDaM302 F6H-L42856RNA polymerase II transcription13.0920.0 kDafactor SIII, p18 subunitM313 C7H-L76200guanylate kinase (GUK1)21.7832.0 kDaM428 E1H-L76702Homo sapiens protein66.3368.0 kDaphosphatase 2A B56-delta (PP2A)mRNA, complete cdsM478 A1H-L76703Homo sapiens protein51.4860.0 kDaphosphatase 2A B56-epsilon(PP2A) mRNA, complete cds166-52H-L77213H. sapiens phosphomevalonate3421.19kinase mRNA169-64H-L77964H. sapiens ERK3 mRNA10079.38M360 C3H-M10050fatty-acid-binding protein 2,14.0820.0 kDaintestinalD5H-M10050fatty-acid-binding protein 2,14.0836intestinalM421 E7H-M10058Asialoglycoprotein receptor 132.1248.0 kDaM429 D3H-M10901Glucocorticoid receptor85.5885.0 kDaM312 G1H-M11025asialoglycoprotein receptor 234.3234.0 kDa167-44H-M11026interferon alpha-4 precursor3320.86F2H-M11321Human group-specific component52.2556vitamin D-binding proteinmRNA, complete cdsM236 B5H-M11354histone H3.2, CENTRAL ROLE15.0724IN NUCLEOSOMEFORMATION.M236 G2H-M11433retinol-binding protein 1, cellular14.9628transport proteinM270 G7H-M11560aldolase A, FRUCTOSE-40.1540BISPHOSPHATE ALDOLASE A[Homo sapiens]H3H-M11717Human heat shock protein (hsp70.516070) gene, complete cdsE1H-M12523Human serum albumin (ALB)67.170gene, complete cdsB5H-M12963Alcohol dehydrogenase 1 (class41.3648I), alpha polypeptideD6H-M1322851.1550D4H-M13981Inhibin, alpha40.3750M236 G4H-M13982interleukin 4 [IL4] precursor, B-16.9430cell activatorM271 B6H-M14043lipocortin II, Annexin II37.445.0 kDa(lipocortin II). CALCIUM-REGULATED MEMBRANE-BINDING PROTEINM271 F4H-M14218argininosuccinate lyase51.0456M297 A3H-M14221cathepsin B37.432.0 kDaM305 B2H-M14328enolase, alpha47.8550167-54H-M14333human c-syn protooncogene6059.14167-51H-M14505H. sapiens mRNA (open reading3633.40frame; patient SK29(AV))215-74H-M14676human src-like kinase (slk)6059.14mRNA167-55H-M14780“creatine kinase, m chain”5241.98M416 F8H-M15059Fc fragment of IgE, low affinity35.4245.0 kDaII, receptor for (CD23A)M271 F1H-M15182glucuronidase, beta [GUSB],71.7272PLAYS AN IMPORTANT ROLEIN THE DEGRADATION OFDERMATAN AND KERATANSULFATES.215-37H-M15465human pyruvate kinase type L6459.80mRNAM298 A4H-M15796cyclin28.8243.0 kDaC3H-M15800Mal, T-cell differentiation protein16.9417M440 E1H-M15841Human U2 small nuclear RNA-24.8634.0 kDaassociated B” antigen mRNA,complete cdsM248 C3H-M15887endozepine9.6815.0 kDaM463 A2H-M15990human c-yes-1 mRNA59.80065.0 kDaM418 E2H-M16038tyrosine-protein kinase LYN56.39064.0 kDaM266 D3H-M16342HETEROGENEOUS NUCLEAR32.0149RIBONUCLEOPROTEINSC1/C2 [Homo sapiens]; smallnuclear ribonucleoprotein,polypeptide C167-20H-M16591tyrosine-protein kinase HCK6055.62C7H-M16591tyrosine-protein kinase HCK55.62070M305 E7H-M16660heat shock 90 kD protein 1, beta79.7580[HSPCB]167-65H-M16750PIM-1 proto-oncogene3834.50serine/threonine-protein kinaseM311 A1H-M16827acyl-Coenzyme A dehydrogenase,46.4250.0 kDaC-4 to C-12 straight-chainD3H-M16961Alpha-2-HS-glycoprotein alpha40.4850and beta chainD3H-M16974Complement component 8, alpha64.3555polypeptideM248 C2H-M17017INTERLEUKIN-8 PRECURSOR1111[Homo sapiens]M305 E4H-M17885ribosomal phosphoprotein P0,34.9837.0 kDaacidicM339 E2H-M17887ribosomal phosphoprotein P212.7619.0 kDaM248 D5H-M18731galactose-1-phosphate41.9142uridylyltransferase [GALT]F2H-M19309Troponin T1, skeletal, slow30.6940M385 E2H-M19713tropomyosin, alpha, muscle31.3541.0 kDa167-79H-M19722proto-oncogene tyrosine-protein6458.26kinase FGRM248 H1H-M20560Annexin III (lipocortin III),35.6437INHIBITOR OFPHOSPHOLIPASE A2M235 H1H-M20681GLUCOSE TRANSPORTER54.6750TYPE 3, BRAIN167-29H-M21616beta platelet-derived growth121121.7factor receptor precursorM305 A3H-M21812myosin light chain 218.8130167-30H-M22146“40S ribosomal protein S4, x3426.91isoform”M302 D6H-M22430phospholipase A2 RASF-A15.9531.0 kDaE2H-M22491Bone morphogenetic protein 352.0355(osteogenic)M340 A2H-M22538NADH-ubiquinone reductase, 2427.533kDa subunit, mitochondrialB2H-M22632Glutamic-oxaloacetic47.4147transaminase 2, mitochondrial(aspartate aminotransferase 2)B4H-M22960Protective protein for beta-52.9160galactosidase (galactosialidosis)M250 C4H-M22995ras-related protein RAP1A,member of RAS oncogene familyB3H-M23254Calpain, large polypeptide L277.1177M266 B4H-M23613Nucleophosmin (nucleolar32.4542phosphoprotein B23, numatrin),BELIEVED TO BIND SINGLE-STRANDED NUCLEIC ACIDSM469 D2H-M23668Homo sapiens adrenodoxin gene20.3525.0 kDaM478 H3H-M24439Human liver/bone/kidney-type57.7564.0 kDaalkaline phosphatase (ALPL)geneF5H-M24470Glucose-6-phosphate38.0644dehydrogenaseM270 E5H-M24898thyroid hormone triiodothyronine67.6585receptor c-erbA, ear-1, Thyroidhormone receptor, alpha (avianerythroblastic leukemia viral (v-erb-a) oncogene homolog)D3H-M24902Acid phosphatase, prostate42.5754D6H-M25809ATPase, H+ transporting,56.3257lysosomal (vacuolar protonpump), beta polypeptide,56/58 kD, isoform 1167-77H-M26252“pyruvate kinase, M2 isozyme”6058.48M271 F8H-M26326keratin 1847.4150.0 kDaB1H-M26901Human renin gene44.4450M271 G4H-M27396asparagine synthetase61.8262M338 B3H-M27542globulin, sex hormone-binding39.20040M512 B6H-M27602Protease, serine, 2 (trypsin 2)27.2836.0 kDaM270 B6H-M27691DNA-binding protein CREB,36.0850cAMP-responsiveC1H-M27878Zinc finger protein 84 (HPF2)81.2981M270 F6H-M28209guanine nucleotide-binding22.6630.0 kDaprotein rab1M512 H5H-M28210RAB3A, member RAS oncogene24.3136.0 kDafamilyB3H-M28214Homo sapiens GTP-binding24.234protein (RAB3B) mRNA,complete cdsM300 C5H-M28249integrin, alpha 2 (CD49B, alpha 2130.02130.0 kDa subunit of VLA-2 receptor)[ITGA2]M248 B6H-M28372zinc finger protein 9 (a cellular19.5828.0 kDaretroviral nucleic acid bindingprotein) [ZNF9]M248 C5H-M28983interleukin 1, alpha [IL1A]29.9242M298 C1H-M29536translation initiation factor 2, beta36.7450.0 kDasubunitM425 A5H-M29696Interleukin 7 receptor50.663.0 kDaE1H-M29960Human steroid receptor (TR2-11)66.4465mRNA, complete cdsM361 D3H-M299716-O-methylguanine-DNA22.8833.0 kDamethyltransferase [MGMT]167-67H-M30448“casein kinase II, beta chain”3423.72M250 E2H-M31211MYOSIN LIGHT CHAIN 1,22.9930.0 kDaSLOW-TWITCH MUSCLE AISOFORM [Homo sapiens]M311 C4H-M31452proline-rich protein65.7868M312 H3H-M31469ras-like protein TC423.8732.0 kDa167-41H-M31606“phosphorylase B kinase gamma5044.7catalytic chain, testis isoform”B4H-M31642Hypoxanthine24.0936phosphoribosyltransferase 1(Lesch-Nyhan syndrome)M416 D8H-M31932Fc fragment of IgG, low affinity34.9845.0 kDaIIa, receptor for (CD32)M305 A8H-M32011neutrophil cytosolic factor 257.9758(65 kD, chronic granulomatousdisease, autosomal 2) [NCF2]B2H-M32315Human tumor necrosis factor50.8260receptor mRNA, complete cdsM266 C2H-M33374cell adhesion protein SQM114.9618.0 kDaM431 F1H-M33375dihydrodiol dehydrogenase 433.9940.0 kDaG6H-M33680Human 26-kDa cell surface26.0724protein TAPA-1 mRNA, completecdsF1H-M33772Human fast skeletal muscle17.7129troponin C gene167-15H-M34065m-phase inducer phosphatase 35552.10F4H-M34079Human immunodeficiency virus44.5552tat transactivator binding protein-1 (tbp-1) mRNA, complete cds169-86H-M34181“cAMP-dependent protein kinase,5038.68beta-catalytic subunit”D1H-M34379Elastatse 2, neutrophil29.4835M314 E1H-M34671CD59 glycoprotein precursor14.15020M266 C3H-M35252CO-029 (GB: M35252)26.1830M315 A4H-M36035benzodiazapine receptor18.719(peripheral) [BZRP]M300 C1H-M36340ADP-ribosylation factor 120.0230M312 C3H-M36341ADP-ribosylation factor 219.9129D6H-M36634Vasoactive intestinal peptide18.8128169-26H-M36881proto-oncogene tyrosine-protein6056.06kinase LCK167-76H-M36981nucleoside diphosphate kinase B2616.79M298 D6H-M37400aspartate aminotransferase,45.5450.0 kDacytosolic167-88H-M37712galactosyltransferase associated5548.36protein kinase P58/GTAM424 F4H-M38258Retinoic acid receptor, gamma 150.0558.0 kDaM266 H3H-M38690CD9 antigen, INVOLVED IN25.1926.0 kDaPLATELET ACTIVATION ANDAGGREGATION.M270 A5H-M55265casein kinase II, alpha catalytic43.1250subunit169-74H-M55284human protein kinase C-L8075.09(PRKCL) mRNAM512 B3H-M55514Potassium voltage-gated channel,71.94100.0 kDa shaker-related subfamily, member 4M271 F5H-M57567ADP-ribosylation factor 5 [AR5].19.9132.0 kDaINVOLVED IN PROTEINTRAFFICKING AND ACTS ASAN ALLOSTERIC ACTIVATOROF CHOLERA TOXIN.M250 D1H-M57627interleukin 10 [IL10],19.6927SUPPRESSOR FACTOR FORTH1 IMMUNE RESPONSES(BY SIMILARITY).M302 D3H-M57730EPH-related receptor tyrosine22.62036.0 kDakinase ligand 1 precursorM248 B5H-M58458ribosomal protein S4, X-linked29.0436.0 kDa[RPS4X]M248 A5H-M58459ribosomal protein S4, Y-linked29.0436[RPS4Y]M248 G5H-M58525CATECHOL O-29.9236METHYLTRANSFERASE,MEMBRANE-BOUND FORM[Homo sapiens], COMTM482 B2H-M59916Sphingomyelin phosphodiesterase69.369.0 kDa1, acid lysosomal (acidsphingomyelinase)M390 C1H-M60091galactose-1-phosphate41.850.0 kDauridylyltransferaseM316 B1H-M60314bone morphogenetic protein 550.0555[BMP5]B4H-M60459Erythropoietin receptor55.9960C7H-M60483Human protein phosphatase 2A34.156catalytic subunit-alpha gene,complete cdsM462 D7H-M60484Human protein phosphatase 2A34.144.0 kDacatalytic subunit-beta gene,complete cdsA12H-M60527deoxycytidine kinase28.67050167-5H-M60724human p70 ribosomal S6 kinase6657.82alpha-I mRNA167-17H-M60725human p70 ribosomal S6 kinase6255.29alpha-II mRNAM271 A4H-M61199cleavage signal 1, ESTs, Highly27.536.0 kDasimilar to CLEAVAGE SIGNAL-1 PROTEIN [Homo sapiens]B1H-M61733Homo sapiens erythroid70.6271membrane protein 4.1 mRNA,complete cdsM298 A1H-M61764tubulin, gamma49.7255.0 kDaM422 E2H-M62505Complement component 538.6138.0 kDareceptor 1 (C5a ligand)M313 G5H-M62810transcription factor 1,27.1735.0 kDamitochondrialC9H-M62839apolipoprotein H38.0660G5H-M63154Gastric intrinsic factor (vitamin B45.9852synthesis)167-6H-M63167RAC-alpha serine/threonine6452.87kinaseB1H-M63573Peptidylprolyl isomerase B23.8733(cyclophilin B)M302 H2H-M63603phospholamban5.836M306 D1H-M63838interferon, gamma-inducible80.3108protein 16M423 H3H-M63959Low density lipoprotein-related39.3848.0 kDaprotein-associated protein 1(alpha-2-macroglobulin receptor-associated protein 1G3H-M64099Human gamma-glutmyl64.5752transpeptidase-related protein(GGT-Rel) mRNA, complete cdsM475 B8H-M64673Human heat shock factor 158.365.0 kDa(TCF5) mRNA, complete cdsM266 D5H-M64716ribosomal protein S2513.8617.0 kDaM248 C6H-M64752glutamate receptor, ionotropic,99.88100AMPA 1 [GRIA1]M312 G3H-M64925palmitoylated membrane protein,51.3751.0 kDaerythrocyte, 55 kDaM302 C7H-M65292complement factor H-related36.4150protein (GB: M65292)D3H-M68516Human protein C inhibitor gene,44.7754complete cds167-27H-M68520cell division protein kinase 23832.85M236 D5H-M68867Cellular retinoic acid-binding15.2919.0 kDaprotein 2, MAY REGULATETHE ACCESS OF RETINOICACID TO THE NUCLEARRETINOIC ACID RECEPTORS.M441 E1H-M69226monoamine oxidase A [MAOA]58.0864.0 kDaM298 D5H-M72393calcium-dependent phospholipid-82.5117.0 kDa binding protein [PLA2*]M422 D5H-M73238Ciliary neurotrophic factor41.0351.0 kDareceptorC1H-M73255Human vascular cell adhesion81.481molecule-1 (VCAM1) gene,complete CDSM422 G6H-M73481Human gastrin releasing peptide42.3545.0 kDareceptor (GRPR) mRNA,complete cdsM235 G6H-M73499carboxylesterase, INVOLVED IN62.4890.0 kDaTHE DETOXIFICATION OFXENOBIOTICS AND THEACTIVATION OF ESTER ANDAMIDE PRODRUGS.M302 D1H-M73547polyposis locus DP120.4628M300 H4H-M73969interleukin 8 receptor, beta39.7136[IL8RB]G1H-M74491ADP-ribosylation factor 320.0231B4H-M7481649.550B2H-M75110H,K-ATPase, beta subunit32.1237M416 B8H-M76766General transcription factor IIB34.8744.0 kDa167-18H-M77198RAC-beta serine/threonine kinase6457.27167-87H-M77348PMEL 17 protein precursor7473.55C4H-M77698YY1 transcription factor45.6548M248 G6H-M80261apurinic/apyrimidinic (abasic)35.0937.0 kDaendonuclease [APE], REPAIRSOXIDATIVE DNA DAMAGESIN VITRO169-50H-M80359putative serine/threonine-protein8078.50kinase P78M330 H1H-M80461immunoglobulin-associated beta25.37027.0 kDa(B29) [IGB]169-1H-M80613ring3 protein10083.01M298 A2H-M80783B12 protein34.8743.0 kDa217-1H-M81457calpactin I light chain1010.74M422 C6H-M81589Homo sapiens serotonin 1D41.5841.0 kDareceptor (5-HT1D‘) mRNA,complete cdsM424 A1H-M81590Homo sapiens serotonin 1D43.0148.0 kDareceptor (5-HT1D˜) mRNA,complete cdsM250 H1H-M81592gamma-glutamyl carboxylase83.4985[GGCX], CONVERTSGLUTAMATE RESIDUES TOGAMMA-CARBOXYGLUTAMATEM250 F2H-M81601TRANSCRIPTION33.2236.0 kDaELONGATION FACTOR S-II[Homo sapiens]C2H-M81650Human semenogelin I (SEMGI)50.9352gene, complete cdsM266 A4H-M81757ribosomal protein S1916.0618169-61H-M81933m-phase inducer phosphatase 15757.60M302 H1H-M82809annexin IV35.4238.0 kDaM300 C4H-M83653cytoplasmic phosphotyrosyl17.4928.0 kDaprotein phosphatase, type 1169-14H-M83941tyrosne-protein kinase receptor108108.2ETK1 precursorF1H-M84443Galactokinase 250.4952M305 H6H-M84747interleukin 9 receptor [IL9R]57.5358167-53H-M8640014-3-3 protein zeta/delta3327.02M271 C8H-M86521transketolase68.6468.0 kDa169-51H-M86699human kinase (TTK) mRNA9292.58M316 F2H-M86752transformation-sensitive protein59.8460.0 kDaM270 C8H-M86921membrane glycoprotein mb-1,24.9734Immunoglobulin-associatedalpha, ASSOCIATED TOSURFACE IGM-RECEPTOR;MAY BE INVOLVED INSIGNAL TRANSDUCTIONA5H-M87507Homo sapien interleukin-1 beta44.5550convertase (IL1BCE) mRNA,complete cdsM305 B7H-M88011glucokinase [GCK]51.2660M305 H1H-M88279immunophilin FKBP5250.664.0 kDaM420 F1H-M88468mevalonate kinase43.60047.0 kDaM305 A7H-M89913dUTP pyrophosphatase15.6219(dUTPase) [DUT*]M316 E2H-M90657tumor-associated antigen L622.3328167-31H-M90813human D-type cyclin (CCND2)3631.86mRNAA1H-M91036H. sapiens G-gamma globin and16.2818A-gamma globin genes, completecds'sG2H-M91463Human glucose transporter55.6652(GLUT4) gene, complete cdsA1H-M91670Human ubiquitin carrier protein24.8636(E2-EPF) mRNA, complete cdsE4H-M92444Homo sapiens35.0945apurinic/apyrimidinicendonuclease (HAP1) gene,complete cdsM305 C4H-M94556single-stranded DNA-binding16.3920protein, mitochondrialG12H-M94856fatty-acid-binding protein14.9636homologM453 C3H-M95623Homo sapiens39.8250.0 kDahydroxymethylbilane synthasegene, complete cdsM302 F2H-M95787smooth muscle protein SM2222.2233.0 kDaA1H-M95809Human basic transcription factor60.396462 kD subunit (BTF2), completecdsM271 E8H-M96982small nuclear ribonucleoprotein26.5139.0 kDaU2 auxiliary factor, 35 kDa,SPLICING FACTOR U2AF 35KD SUBUNIT. NECESSARYFOR THE SPLICING OF PRE-mRNA.M416 B3H-M96995Growth factor receptor-bound23.9832.0 kDaprotein 2G2H-M96995Growth factor receptor-bound23.9849protein 2H4H-M97016Bone morphogenetic protein 844.3361(osteogenic protein 2)M271 D1H-M97190Sp2 transcription factor [SP2],54.5660BINDS TO GC BOXPROMOTERS ELEMENTS ANDSELECTIVELY ACTIVATESmRNA SYNTHESIS FROMGENES THAT CONTAINFUNCTIONAL RECOGNITIONSITES.M271 C1H-M97191Sp3 transcription factor [SP3],71.9472BINDS TO GT AND GC BOXESPROMOTERS ELEMENTS.PROBABLETRANSCTRIPTIONALACTIVATOR.M305 C7H-M97388transcription repressor (interacting19.4730with the TATA-binding protein)[DR1*]217-13H-M97675human transmembrane receptor100103.1(ror1) mRNAB3H-M97856Nuclear autoantigenic sperm86.6887protein (histone-binding)M429 G2H-M97935Homo sapiens transcription factor82.6189.0 kDaISGF-3 mRNA, complete cdsD1H-M99487Human prostate-specific82.6192membrane antigen (PSM) mRNA,complete cdsM363 A1H-P0002riboflavin synthase beta chain17.27(ribE)M363 B1H-P0004carbonic anhydrase (icfA)24.42M363 C1H-P0005orotidine 5′-phosphate25.08decarboxylase (pyrF)M363 D1H-P0006pantoate-beta-alanine ligase30.47(panC)M379 A1H-P0010-2chaperone and heat shock protein60.17(groEL)M363 E1H-P0011co-chaperone (groES)13.09M363 F1H-P0012DNA primase (dnaG)61.6M363 G1H-P0013hypothetical protein38.61M363 H1H-P0014hypothetical protein30.36M363 A2H-P0015hypothetical protein10.34M363 B2H-P0016hypothetical protein9.68M363 C2H-P0017virB4 homolog (virB4)86.68M363 D2H-P0018hypothetical protein51.7M363 E2H-P0021hypothetical protein21.01M363 F2H-P0022conserved hypothetical integral57.42membrane proteinM363 G2H-P0026citrate synthase (gltA)46.97M363 H2H-P0027isocitrate dehydrogenase (icd)46.86M363 A3H-P0028conserved hypothetical secreted19.58proteinM363 B3H-P0030hypothetical protein65.34M363 C3H-P0031hypothetical protein15.18M363 D3H-P0034aspartate 1-decarboxylase (panD)12.98M363 E3H-P0035conserved hypothetical protein10.78M363 F3H-P0037NADH-ubiquinone38.72oxidoreductase subunitM363 G3H-P0044GDP-D-mannose dehydratase42.02(rfbD)M363 H3H-P0047hydrogenase expression/formation36.63protein (hypE)M363 A4H-P0048transcriptional regulator (hypF)84.7M363 B4H-P0052hypothetical protein36.41M363 C4H-P0055proline permease (putP)54.67M363 D4H-P0056delta-1-pyrroline-5-carboxylate130.46dehydrogenaseM363 E4H-P0057hypothetical protein7.7M363 F4H-P0063hypothetical protein54.67M363 G4H-P0064hypothetical protein15.4M363 H4H-P0066conserved hypothetical ATP-91.52binding proteinM363 A5H-P0067urease accessory protein (ureH)29.26M363 B5H-P0068urease accessory protein (ureG)22M363 C5H-P0075urease protein (ureC)49.06M363 D5H-P0077peptide chain release factor RF-138.83(prfA)M363 E5H-P0082methyl-accepting chemotaxis74.14transducer (tlpC)M363 F5H-P0086conserved hypothetical protein49.61M363 G5H-P0087hypothetical protein50.38M363 H5H-P0088RNA polymerase sigma-70 factor73.92(rpoD)M363 A6H-P0089pfs protein (pfs)25.52M363 B6H-P0090malonyl coenzyme A-acyl carrier34.1protein transacylase (fabD)M363 C6H-P0093hypothetical protein12.21M363 D6H-P0096phosphoglycerate dehydrogenase34.65M304 A1H-P0099methyl-accepting chemotaxis74.36protein (tlpA)M304 B1H-P0100conserved hypothetical protein40.59M304 C1H-P0101hypothetical protein27.94M304 D1H-P01042′,3′-cyclic-nucleotide 2′-64.02phosphodiesterase (cpdB)M304 E1H-P0105conserved hypothetical protein17.16M304 F1H-P0106cystathionine gamma-synthase41.91(metB)M304 G1H-P0107cysteine synthetase (cysK)33.77M304 H1H-P0108hypothetical protein20.57M304 A2H-P0109chaperone and heat shock protein68.3170 (dnaK)M304 B2H-P0110co-chaperone and heat shock20.9protein (grpE)M304 C2H-P0111hypothetical protein30.47M304 D2H-P0113hypothetical protein10.89M304 E2H-P0114hypothetical protein69.19M304 F2H-P0115flagellin B (flaB)56.65M304 G2H-P0116DNA topoisomerase I (topA)81.07M304 H2H-P0117conserved hypothetical protein33.99M304 A3H-P0118hypothetical protein43.56M304 B3H-P0119hypothetical protein50.82M304 C3H-P0120hypothetical protein43.89M304 D3H-P0121phosphoenolpyruvate synthase89.43(ppsA)M304 E3H-P0122hypothetical protein4.84M304 F3H-P0123threonyl-tRNA synthetase (thrS)67.43M304 G3H-P0124translation initiation factor IF-322.44(infC)M304 H3H-P0125ribosomal protein L35 (rpl35)7.15M304 A4H-P0126ribosomal protein L20 (rpl20)12.87M304 B4H-P0127outer membrane protein (omp4)31.57M304 C4H-P0128hypothetical protein4.62M304 D4H-P0129hypothetical protein15.62M304 E4H-P0130hypothetical protein31.57M304 F4H-P0131hypothetical protein3.74M304 G4H-P0132L-serine deaminase (sdaA)50.16M304 H4H-P0133serine transporter (sdaC)45.54M304 A5H-P01343-deoxy-D-arabino-heptulosonate49.57-phosphate synthase (dhs1)M304 B5H-P0135hypothetical protein4.95M304 C5H-P0136bacterioferritin comigratory16.83protein (bcp)M304 D5H-P0137hypothetical protein23.32M304 E5H-P0138conserved hypothetical iron-sulfur53.02proteinM304 F5H-P0139conserved hypothetical secreted26.73proteinM304 G5H-P0140L-lactate permease (lctP)60.5M304 H5H-P0141L-lactate permease (lctP)60.72M304 A6H-P0142A/G-specific adenine glycosylase36.19(mutY)M304 B6H-P0144cytochrome c oxidase, heme b53.79and copper-binding subunit,membrane-bound (fixN)M304 C6H-P0145cytochrome c oxidase, monoheme25.63subunit, membrane-bound (fixO)M304 D6H-P0146cbb3-type cytochrome c oxidase8.14subunit Q (CcoQ)M304 E6H-P0147cytochrome c oxidase, diheme31.57subunit, membrane-bound (fixP)M304 F6H-P0148hypothetical protein7.59M304 G6H-P0150hypothetical protein21.67M304 H6H-P0152hypothetical protein31.68M304 A7H-P0153recombinase (recA)38.28M304 B7H-P0154enolase (eno)46.97M304 C7H-P0155hypothetical protein10.12M304 D7H-P0157shikimic acid kinase I (aroK)17.93M304 E7H-P0158hypothetical protein35.09M304 F7H-P0159lipopolysaccharide 1,2-41.03glucosyltransferase (rfaJ)M304 G7H-P0161hypothetical protein4.07M304 H7H-P0162conserved hypothetical protein26.51M304 A8H-P0163delta-aminolevulinic acid35.64dehydratase (hemB)M304 B8H-P0164signal-transducing protein,28.05histidine kinaseM304 C8H-P0165hypothetical protein19.14M304 D8H-P0166response regulator (ompR)24.86M304 E8H-P0167hypothetical protein17.38M304 F8H-P0168hypothetical protein9.68M304 G8H-P0170hypothetical protein27.94M304 H8H-P0171peptide chain release factor RF-240.04(prfB)M304 A9H-P0172molybdopterin biosynthesis43.12protein (moeA)M304 B9H-P0173flagellar biosynthetic protein28.16(fliR)M304 C9H-P0174hypothetical protein28.49M304 D9H-P0175cell binding factor 233M304 E9H-P0176fructose-bisphosphate aldolase33.88(tsr)M304 F9H-P0177translation elongation factor EF-P20.68(efp)M304 G9H-P0178spore coat polysaccharide37.51biosynthesis protein EM304 H9H-P0179ABC transporter, ATP-binding23.54proteinM304 A10H-P0180apolipoprotein N-acyltransferase46.86(cute)M304 B10H-P0182lysyl-tRNA synthetase (lysS)55.22M304 C10H-P0183serine hydroxymethyltransferase45.87(glyA)M304 D10H-P0184hypothetical protein19.91M304 E10H-P0185hypothetical protein29.48M304 F10H-P0186hypothetical protein44.55M304 G10H-P0187hypothetical protein10.56M304 H10H-P0188hypothetical protein3.74M304 A11H-P0189conserved hypothetical integral19.58membrane proteinM304 B11H-P0190conserved hypothetical secreted55.33proteinM304 C11H-P0191fumarate reductase, iron-sulfur27.06subunit (frdB)M304 D11H-P0192fumarate reductase, flavoprotein78.65subunit (frdA)M304 E11H-P0193fumarate reductase, cytochrome b28.16subunit (frdC)M304 F11H-P0194triosephosphate isomerase (tpi)25.85M304 G11H-P0195enoyl-(acyl-carrier-protein)30.36reductase (NADH) (fabI)M365 A1H-P0197S-adenosylmethionine synthetase42.462 (metX)M365 B1H-P0203hypothetical protein10.12M365 C1H-P0209hypothetical protein49.61M365 D1H-P0213glucose inhibited division protein68.42(gidA)M381 E1H-P0218hypothetical protein20.24M365 E1H-P0221nifU-like protein35.97M365 F1H-P0227outer membrane protein (omp5)76.12M365 G1H-P0228conserved hypothetical integral43.01membrane proteinM365 H1H-P0230CTP: CMP-3-deoxy-D-manno-26.84octulosonate-cytidylyl-transferase(kdsB)M365 A2H-P0233conserved hypothetical protein43.01M365 B2H-P0235conserved hypothetical secreted39.16proteinM365 C2H-P0236hypothetical protein13.64M365 D2H-P0238prolyl-tRNA synthetase (proS)63.58M381 E2H-P0243neutrophil activating protein15.95(napA) (bacterioferritin)M365 E2H-P0244signal-transducing protein,42.02histidine kinase (atoS)M365 F2H-P0246flagellar basal-body P-ring protein37.73(flgI)M365 G2H-P0247ATP-dependent RNA helicase,54.23DEAD-box family (deaD)M365 H2H-P0248conserved hypothetical protein39.93M379 B1H-P0249-2hypothetical protein19.8M379 C1H-P0250-2oligopeptide ABC transporter,56.87ATP-binding protein (oppD)M381 A3H-P0251oligopeptide ABC transporter,37.29permease protein (oppC)M379 E1H-P0252-2outer membrane protein (omp7)53.68M365 A3H-P0254outer membrane protein (omp8)47.52M365 B3H-P0255adenylosuccinate synthetase45.32(purA)M365 C3H-P0257conserved hypothetical secreted24.2proteinM365 D3H-P0259exonuclease VII, large subunit46.31(xseA)M381 D3H-P0260adenine specific DNA42.35methyltransferase (mod)M365 E3H-P0263adenine specific DNA27.83methyltransferase (hpaim)M365 F3H-P0264ATP-dependent protease binding94.27subunit (clpB)M365 G3H-P0266dihydroorotase (pyrC)41.69M365 H3H-P0267chlorohydrolase45.1M365 A4H-P0271hypothetical protein36.08M365 B4H-P0275ATP-dependent nuclease (addB)47.41M381 G3H-P0276hypothetical protein20.46M365 C4H-P0278guanosine pentaphosphate53.35phosphohydrolase (gppA)M365 D4H-P0279lipopolysaccharide37.51heptosyltransferase-1 (rfaC)M365 E4H-P0280heat shock protein B (ibpB)36.19M365 F4H-P0282hypothetical protein52.91M365 G4H-P02833-dehydroquinate synthase (aroB)37.84M365 H4H-P0284conserved hypothetical integral57.64membrane proteinM365 A5H-P0285conserved hypothetical protein46.09M381 A4H-P0287hypothetical protein19.03M381 C4H-P0288hypothetical protein17.38M366 A1H-P0389superoxide dismutase (sodB)23.54M366 B1H-P0390adhesin-thiol peroxidase (tagD)18.37M366 C1H-P0391purine-binding chemotaxis18.26protein (cheW)M366 D1H-P0392histidine kinase (cheA)88.44M366 E1H-P0393chemotaxis protein (cheV)34.32M366 F1H-P0394hypothetical protein27.83M366 G1H-P0395conserved hypothetical protein24.53M366 H1H-P0396conserved hypothetical protein67.87M366 A2H-P0397phosphoglycerate dehydrogenase57.75(serA)M366 B2H-P0398hypothetical protein20.13M366 C2H-P0399ribosomal protein S1 (rps1)61.27M366 D2H-P0403phenylalanyl-tRNA synthetase,36.19alpha subunit (pheS)M366 E2H-P0404protein kinase C inhibitor11.55(SP: P16436)M366 F2H-P0405nifS-like protein48.51M366 G2H-P0406hypothetical protein21.67M366 H2H-P0407biotin sulfoxide reductase (bisC)87.67M381 D1H-P0409GMP synthase (guaA)55.99M381 F1H-P0410putative neuraminyllactose-27.5binding hemagglutinin homolog(hpaA)M366 A3H-P0411hypothetical protein11.66M366 B3H-P0412hypothetical protein3.63M366 C3H-P0413transposase-like protein, PS3IS29.59M366 D3H-P0414IS200 insertion sequence from15.29SARA17M366 E3H-P0415conserved hypothetical integral68.64membrane proteinM366 F3H-P0416cyclopropane fatty acid synthase42.9(cfa)M366 G3H-P0417methionyl-tRNA synthetase71.61(metS)M366 H3H-P0418hypothetical protein36.96M366 A4H-P0419conserved hypothetical protein28.82M366 B4H-P0420hypothetical protein15.73M366 C4H-P0421type 1 capsular polysaccharide42.9biosynthesis protein J (capJ)M366 D4H-P0422arginine decarboxylase (speA)67.76M366 E4H-P0424hypothetical protein68.2M366 F4H-P0425hypothetical protein45.98M366 G4H-P0427hypothetical protein12.32M366 H4H-P0433hypothetical protein16.28M366 A5H-P0436hypothetical protein13.42M366 B5H-P0437IS605 transposase (tnpA)15.73M366 C5H-P0438IS605 transposase (tnpB)47.08M366 D5H-P0442hypothetical protein9.79M366 E5H-P0445hypothetical protein6.82M366 F5H-P0452hypothetical protein57.09M366 G5H-P0455hypothetical protein11.44M366 H5H-P0457hypothetical protein9.68M366 A6H-P0463type I restriction enzyme M53.68protein (hsdM)M366 B6H-P0464type I restriction enzyme R116.16protein (hsdR)M366 C6H-P0465conserved hypothetical protein69.52M366 D6H-P0466conserved hypothetical protein28.16M366 E6H-P0467conserved hypothetical integral12.76membrane proteinM366 F6H-P0468conserved hypothetical protein54.56M366 G6H-P0469conserved hypothetical protein17.93M366 H6H-P0471glutathione-regulated potassium-45.87efflux system protein (kefB)M366 A7H-P0472outer membrane protein (omp11)20.57M366 B7H-P0473molybdenum ABC transporter,27.17periplasmic molybdate-bindingprotein (modA)M366 C7H-P0474molybdenum ABC transporter,24.75permease protein (modB)M366 D7H-P0475molybdenum ABC transporter,29.26ATP-binding protein (modD)M366 E7H-P0476glutamyl-tRNA synthetase (gltX)51.04M366 F7H-P0477outer membrane protein (omp12)40.48M366 G7H-P0478adenine specific DNA60.06methyltransferase (VSPIM)M366 H7H-P0479hypothetical protein31.13M366 A8H-P0481adenine specific DNA23.32methyltransferase (MFOKI)M366 B8H-P0482hypothetical protein18.81M366 C8H-P0483cytosine specific DNA36.3methyltransferase (H-PHIMC)M367 A1H-P0486hypothetical protein58.19M367 B1H-P0487hypothetical protein52.91M367 C1H-P0489hypothetical protein32.56M367 D1H-P0490putative potassium channel41.69protein, putativeM367 E1H-P0491ribosomal protein L28 (rpL28)6.93M367 F1H-P0492hypothetical protein30.69M367 G1H-P0494UDP-N-acetylmuramoylalanine-46.53D-glutamate ligase (murD)M367 H1H-P0495hypothetical protein9.57M367 A2H-P0496conserved hypothetical protein14.74M367 B2H-P0498sodium- and chloride-dependent48.73transporterM367 C2H-P0499phospholipase A1 precursor (DR-39.16phospholipase A)M367 D2H-P0500DNA polymerase III beta-subunit41.25(dnaN)M367 E2H-P0501DNA gyrase, sub B (gyrB)85.14M367 F2H-P0503hypothetical protein27.17M367 G2H-P0504hypothetical protein5.5M367 H2H-P0505hypothetical protein17.05M367 A3H-P0507conserved hypothetical protein23.43M367 B3H-P0509glycolate oxidase subunit (glcD)50.6M367 C3H-P0510dihydrodipicolinate reductase28.05(dapB)M367 D3H-P0512glutamine synthetase (glnA)53.02M367 E3H-P0514ribosomal protein L9 (rpl9)16.61M367 F3H-P0515heat shock protein (hslV)19.91M367 G3H-P0516heat shock protein (hslU) ORF148.84M367 H3H-P0517GTP-binding protein (era)33.33M367 A4H-P0519conserved hypothetical protein30.47M367 B4H-P0520cag pathogenicity island protein12.76(cag1)M367 C4H-P0522cag pathogenicity island protein53.02(cag3)M367 D4H-P0523cag pathogenicity island protein18.7(cag4)M367 E4H-P0525virB11 homolog36.41M367 F4H-P0526cag pathogenicity island protein22(cag6)M367 G4H-P0528cag pathogenicity island protein57.53(cag8)M379 H1H-P0531-2cag pathogenicity island protein24.09(cag11)M367 H4H-P0532cag pathogenicity island protein30.91(cag12)M367 A5H-P0534cag pathogenicity island protein21.67(cag13)M367 B5H-P0541cag pathogenicity island protein40.81(cag20)M367 C5H-P0542cag pathogenicity island protein15.73(cag21)M367 D5H-P0545cag pathogenicity island protein22.88(cag24)M367 E5H-P0549glutamate racemase (glr)28.16M367 F5H-P0550transcription termination factor48.29Rho (rho)M367 G5H-P0551ribosomal protein L31 (rpl31)7.48M367 H5H-P0552conserved hypothetical protein31.68M367 A6H-P0553conserved hypothetical protein25.08M367 B6H-P0554hypothetical protein35.42M367 C6H-P0555hypothetical protein30.14M367 D6H-P0556hypothetical protein16.06M367 E6H-P0557acetyl-coenzyme A carboxylase34.43(accA)M367 F6H-P0558beta ketoacyl-acyl carrier protein45.43synthase II (fabF)M367 G6H-P05613-ketoacyl-acyl carrier protein27.28reductase (fabG)M367 H6H-P0562ribosomal protein S21 (rps21)7.81M367 A7H-P0563hypothetical protein45.87M367 B7H-P0566diaminopimelate epimerase30.14(dapF)M367 C7H-P0568hypothetical protein28.16M367 D7H-P0570aminopeptidase a/i (pepA)54.67M367 E7H-P0571conserved hypothetical integral21.23membrane proteinM379 A2H-P0572-2adenine19.8phosphoribosyltransferase (apt)M379 B2H-P0573-2hypothetical protein12.21M379 C2H-P0574-2galactosidase acetyltransferase16.72(lacA)M379 D2H-P0575-2conserved hypothetical membrane25.63proteinM379 E2H-P0576-2signal peptidase I (lepB)32.01M367 F7H-P0577methylene-tetrahydrofolate32.23dehydrogenase (folD)M367 G7H-P0579hypothetical protein20.35M367 H7H-P0580hypothetical protein41.03M367 A8H-P0581dihydroorotase (pyrC)37.4M367 B8H-P0582hypothetical protein35.75M367 C8H-P0583hypothetical protein32.34M368 A1H-P0584flagellar switch protein (fliN)13.64M368 B1H-P0585endonuclease III (nth)24.09M368 C1H-P0587aminodeoxychorismate lyase36.3(pabC)M368 D1H-P0591ferredoxin oxidoreductase,20.57gamma subunitM368 E1H-P0593adenine specific DNA65.89methyltransferase (mod)M368 F1H-P0594hypothetical protein6.05M368 G1H-P0596hypothetical protein21.23M368 H1H-P0597penicillin-binding protein 1A72.6(PBP-1A)M368 A2H-P0599hemolysin secretion protein47.74precursor (hylB)M368 B2H-P0601flagellin A (flaA)56.21M368 C2H-P0602endonuclease III24.09M368 D2H-P0603hypothetical protein20.9M379 F2H-P0608-2hypothetical protein17.71M368 E2H-P0614hypothetical protein12.32M368 F2H-P0616chemotaxis protein (cheV)34.54M368 G2H-P0617aspartyl-tRNA synthetase (aspS)63.58M368 H2H-P0621DNA mismatch repair protein83.93(MutS)M368 A3H-P0622hypothetical protein13.31M368 B3H-P0623UDP-N-acetylmuramate-alanine49.5ligase (murC)M368 C3H-P0625protein E (gcpE)39.6M368 D3H-P0626tetrahydrodipicolinate N-44.22succinyltransferase (dapD)M368 E3H-P0627hypothetical protein12.21M368 F3H-P0629hypothetical protein75.02M368 G3H-P0630modulator of drug activity21.45(mda66)M368 H3H-P0631quinone-reactive Ni/Fe42.35hydrogenase, small subunit(hydA)M368 A4H-P0632quinone-reactive Ni/Fe63.69hydrogenase, large subunit(hydB)M368 B4H-P0633quinone-reactive Ni/Fe24.75hydrogenase, cytochrome bsubunit (hydC)M368 C4H-P0634quinone-reactive Ni/Fe19.69hydrogenase (hydD)M368 D4H-P0635hypothetical protein56.43M368 E4H-P0636hypothetical protein10.23M368 F4H-P0637hypothetical protein16.61M368 G4H-P0638outer membrane protein (omp13)33.66M368 H4H-P0643glutamyl-tRNA synthetase (gltX)48.4M368 A5H-P0644conserved hypothetical integral10.78membrane proteinM368 B5H-P0645soluble lytic murein61.71transglycosylase (slt)M368 C5H-P0646UDP-glucose pyrophosphorylase30.14(galU)M368 D5H-P0647hypothetical protein14.96M368 E5H-P0648UDP-N-acetylglucosamine46.53enolpyruvyl transferase (murZ)M368 F5H-P0649aspartate ammonia-lyase (aspA)51.59M368 G5H-P0650hypothetical protein21.67M379 A3H-P0651-2fucosyltransferase52.47M381 E3H-P0652phosphoserine phosphatase (serB)22.88M368 H5H-P0653nonheme iron-containing ferritin18.48(pfr)M379 G2H-P0654-2conserved hypothetical protein39.71M379 H2H-P0655-2protective surface antigen D15100.87M368 A6H-P0656conserved hypothetical protein42.24M368 B6H-P0657processing protease (ymxG)47.63M368 C6H-P0658PET112-like protein52.36M368 D6H-P0659hypothetical protein45.65M368 E6H-P0660hypothetical protein37.29M368 F6H-P0661ribonuclease H (rnhA)15.84M368 G6H-P0662ribonuclease III (rnc)26.51M368 H6H-P0663chorismate synthase (aroC)40.26M368 A7H-P0665oxygen-independent50.38coproporphyrinogen III oxidase(hemN)M368 B7H-P0667hypothetical protein9.46M368 C7H-P0668hypothetical protein66.88M368 D7H-P0671outer membrane protein (omp14)29.81M368 E7H-P0672solute-binding signature and43.01mitochondrial signature protein(aspB)M379 B3H-P0673-2hypothetical protein46.97M381 H3H-P0674hypothetical protein25.19M368 F7H-P0676methylated-DNA-protein-18.59cysteine methyltransferase (dat1)M368 G7H-P0677conserved hypothetical integral28.16membrane proteinM368 H7H-P0679lipopolysaccharide biosynthesis31.9protein (wbpB)M369 A1H-P0681hypothetical protein18.59M369 B1H-P0682hypothetical protein13.97M369 C1H-P0683UDP-N-acetylglucosamine47.74pyrophosphorylase (glmU)M369 D1H-P0685flagellar biosynthetic protein19.03(fliP)M369 E1H-P0687iron(II) transport protein (feoB)70.73M369 F1H-P0688hypothetical protein18.37M369 G1H-P0690acetyl coenzyme A43.12acetyltransferase (thiolase) (fadA)M381 A1H-P06913-oxoadipate coA-transferase25.63subunit A (yxjD)M381 B1H-P06923-oxoadipate coA-transferase22.88subunit B (yxjE)M369 H1H-P0694hypothetical protein28.38M369 A2H-P0695hydantoin utilization protein A78.54(hyuA)M369 B2H-P0697hypothetical protein18.59M369 C2H-P0699hypothetical protein37.73M369 D2H-P0700diacylglycerol kinase (dgkA)14.19M369 E2H-P0701DNA gyrase, sub A (gyrA)91.08M369 F2H-P0703response regulator42.02M369 G2H-P0707conserved hypothetical protein33.99M369 H2H-P0711hypothetical protein44.77M369 A3H-P0715ABC transporter, ATP-binding26.51proteinM369 B3H-P0716conserved hypothetical protein14.74M369 C3H-P0718conserved hypothetical integral23.21membrane proteinM369 D3H-P0719hypothetical protein12.1M369 E3H-P0723L-asparaginase II (ansB)36.41M369 F3H-P0724anaerobic C4-dicarboxylate48.84transport protein (dcuA)M369 G3H-P0727transcriptional regulator, putative36.19M369 H3H-P0728conserved hypothetical protein37.07M369 A4H-P0730hypothetical protein11.22M369 B4H-P0732hypothetical protein13.09M369 C4H-P0734conserved hypothetical protein48.4M369 D4H-P0735xanthine guanine phosphoribosyl16.94transferase (gpt)M369 E4H-P0737conserved hypothetical integral17.49membrane proteinM381 H2H-P0738D-alanine: D-alanine ligase A38.28(ddlA)M369 F4H-P07392-hydroxy-6-oxohepta-2,4-26.62dienoate hydrolaseM369 G4H-P0741conserved hypothetical protein17.82M369 H4H-P0745conserved hypothetical protein36.08M369 A5H-P0747conserved hypothetical protein43.34M369 B5H-P0748cell division protein (ftsE)24.64M369 C5H-P0749cell division membrane protein29.59(ftsX)M369 D5H-P0750hypothetical protein44.11M369 E5H-P0752flagellar hook-associated protein74.252 (fliD)M381 F3H-P0755molybdopterin biosynthesis23.21protein (moeB)M379 C3H-P0757-2beta-alanine synthetase homolog32.23M369 F5H-P0758conserved hypothetical integral48.18membrane proteinM369 G5H-P0759conserved hypothetical integral45.98membrane proteinM369 H5H-P0761hypothetical protein22.11M369 A6H-P0762hypothetical protein20.46M369 B6H-P0767hypothetical protein2.75M369 C6H-P0768molybdenum cofactor35.42biosynthesis protein A (moaA)M369 D6H-P0769molybdopterin-guanine22.22dinucleotide biosynthesis proteinA (mobA)M369 E6H-P0771hypothetical protein27.06M369 F6H-P0772N-acetylmuramoyl-L-alanine48.51amidase (amiA)M369 G6H-P0773hypothetical protein40.04M369 H6H-P0777uridine 5′-monophosphate (UMP)26.51kinase (pyrH)M370 A1H-P0782hypothetical protein50.16M370 B1H-P0783hypothetical protein18.26M370 C1H-P0792sigma-54 interacting protein55.77M370 D1H-P0793polypeptide deformylase (def)19.25M370 E1H-P0794ATP-dependent clp protease21.67proteolytic component (clpP)M370 F1H-P0796outer membrane protein (omp18)30.69M379 G3H-P0797-2flagellar sheath adhesin hpaA28.71M379 H3H-P0798-2molybdenum cofactor17.49biosynthesis protein C (moaC)M370 G1H-P0799molybdopterin biosynthesis19.47protein (mog)M370 H1H-P0800molybdopterin converting factor,16.06subunit 2 (moaE)M379 A4H-P0801-2molybdopterin converting factor,8.25subunit 1 (moaD)M379 B4H-P0802-2GTP cyclohydrolase II (ribA)21.23M379 D3H-P0803-2hypothetical protein30.8M379 E3H-P0804-2GTP cyclohydrolase II/3,4-37.95dihydroxy-2-butanone 4-phosphate synthase (ribA, ribB)M379 F3H-P0805-2lipooligosaccharide 5G8 epitope31.35biosynthesis-associated protein(lex2B)M370 A2H-P0806hypothetical protein22.77M379 C4H-P0807-2iron(III) dicitrate transport protein86.68(fecA)M370 B2H-P0808holo-acp synthase (acpS)13.2M370 C2H-P0809hypothetical protein20.24M370 D2H-P0810conserved hypothetical protein22.11M370 E2H-P0811hypothetical protein11.99M370 F2H-P0812hypothetical protein37.07M370 G2H-P0813conserved hypothetical protein22.66M370 H2H-P0814thiamin biosynthesis protein28.16(thiF)M370 A3H-P0815flagellar motor rotation protein28.38(motA)M370 B3H-P0831conserved hypothetical ATP21.67binding proteinM379 D4H-P0832-2spermidine synthase (speE)28.93M379 E4H-P0833-2hypothetical protein32.23M370 C3H-P0834GTP-binding protein homologue50.49(yphC)M370 D3H-P0835histone-like DNA-binding protein10.45HU (hup)M370 E3H-P0836hypothetical protein13.2M370 F3H-P0837hypothetical protein11.33M370 G3H-P0838hypothetical protein22.66M370 H3H-P0839outer membrane protein P164.68(ompP1)M370 A4H-P0840flaA1 protein36.74M370 B4H-P0841pantothenate metabolism46.86flavoprotein (dfp)M370 C4H-P0843thiamin phosphate24.2pyrophosphorylase/hyroxyethylthiazole kinase (thiB)M370 D4H-P0845thiamin phosphate30.14pyrophosphorylase/hyroxyethylthiazole kinase (thiM)M370 E4H-P0850type I restriction enzyme M58.08protein (hsdM)M370 F4H-P0851conserved hypothetical integral25.08membrane proteinM370 G4H-P0854GMP reductase (guaC)36.08M370 H4H-P0858ADP-heptose synthase (rfaE)50.82M370 A5H-P0859ADP-L-glycero-D-mannoheptose-36.416-epimerase (rfaD)M370 B5H-P0861hypothetical protein27.17M370 C5H-P0862hypothetical protein24.64M379 F4H-P0863-2hypothetical protein59.73M370 D5H-P0865deoxyuridine 5′-triphosphate16.06nucleotidohydrolase (dut)M370 E5H-P0866transcription elongation factor18.15GreA (greA)M379 G4H-P0867-2lipid A disaccharide synthetase39.71(lpxB)M379 H4H-P0870-2flagellar hook (flgE)79.09M370 F5H-P0871CDP-diglyceride hydrolase (cdh)26.95M370 G5H-P0872alkylphosphonate uptake protein12.1(phnA)M370 H5H-P0873hypothetical protein7.92M371 A1H-P0879hypothetical protein22.33M371 B1H-P0883Holliday junction DNA helicase20.24(ruvA)M371 C1H-P0885virulence factor mviN protein50.82(mviN)M371 D1H-P0886cysteinyl-tRNA synthetase (cysS)51.26M371 E1H-P0889iron(III) dicitrate ABC35.97transporter, permease protein(fecD)M371 F1H-P0890conserved hypothetical protein28.27M371 G1H-P0891conserved hypothetical protein19.25M371 H1H-P0892conserved hypothetical protein10.01M371 A2H-P0894conserved hypothetical protein9.79M371 B2H-P0895hypothetical protein13.86M371 C2H-P0896outer membrane protein (omp19)77.99M371 D2H-P0897hypothetical protein22.99M371 E2H-P0898hydrogenase expression/formation40.81protein (hypD)M371 F2H-P0899hydrogenase expression/formation8.58protein (hypC)M371 G2H-P0900hydrogenase expression/formation26.73protein (hypB)M371 H2H-P0905phosphotransacetylase (pta)24.64M371 A3H-P0906hypothetical protein58.08M371 B3H-P0907hook assembly protein, flagella33.22(flgD)M371 C3H-P0909hypothetical protein22.22M371 D3H-P0912outer membrane protein (omp20)56.76M371 E3H-P0913outer membrane protein (omp21)58.3M371 F3H-P0914hypothetical protein56.65M371 G3H-P0915iron-regulated outer membrane61.93protein (frpB)M371 H3H-P0916iron-regulated outer membrane27.5protein (frpB)M380 A1H-P0917-2hypothetical protein2.64M371 A4H-P0918hypothetical protein15.84M371 B4H-P0920conserved hypothetical integral25.41membrane protein M371 C4H-P0921glyceraldehyde-3-phosphate36.63dehydrogenase (gap)M371 D4H-P0923outer membrane protein (omp22)40.7M371 E4H-P0925recombinational DNA repair21.34protein (recR)M371 F4H-P0927heat shock protein (htpX)35.97M371 G4H-P0928GTP cyclohydrolase I (folE)19.91M371 H4H-P0929geranyltranstransferase (ispA)33.44M371 A5H-P0930stationary-phase survival protein29.48(surE)M371 B5H-P0931hypothetical protein16.17M371 C5H-P0932hypothetical protein11.11M371 D5H-P0933hypothetical protein22.11M371 E5H-P0934conserved hypothetical protein27.72M371 F5H-P0935hypothetical protein17.82M371 G5H-P0936proline/betaine transporter (proP)42.9M371 H5H-P0938hypothetical protein12.76M371 A6H-P0939amino acid ABC transporter,26.18permease protein (yckJ)M371 B6H-P0940amino acid ABC transporter,28.27periplasmic binding protein(yckK)M371 C6H-P0941alanine racemase, biosynthetic41.58(alr)M371 D6H-P0942D-alanine glycine permease49.61(dagA)M371 E6H-P0943D-amino acid dehydrogenase45.21(dadA)M371 F6H-P0944translation initiation inhibitor,13.86putativeM371 G6H-P0946conserved hypothetical integral54.67membrane proteinM371 H6H-P0947hypothetical protein13.31M371 A7H-P0949conserved hypothetical secreted16.61proteinM371 B7H-P0950acetyl-CoA carboxylase beta31.9subunit (accD)M371 C7H-P0951hypothetical protein22.66M371 D7H-P0952conserved hypothetical integral24.09membrane proteinM371 E7H-P0953hypothetical protein20.79M371 F7H-P0955prolipoprotein diacylglyceryl31.35transferase (lgt)M371 G7H-P0956conserved hypothetical protein26.73M371 H7H-P09573-deoxy-d-manno-octulosonic-43.34acid transferase (kdtA)M371 A8H-P0958hypothetical protein28.05M371 B8H-P0960glycyl-tRNA synthetase, alpha33.44subunit (glyQ)M371 C8H-P0961glycerol-3-phosphate34.43dehydrogenase (NAD(P)+)M380 B1H-P0965-2hypothetical protein48.84M371 D8H-P0966conserved hypothetical protein60.5M380 F1H-P0968-2hypothetical protein2.42M371 E8H-P0969cation efflux system protein112.31(czcA)M371 F8H-P0970nickel-cobalt-cadmium resistance39.6protein (nccB)M371 G8H-P0971hypothetical protein45.54M371 H8H-P0972glycyl-tRNA synthetase, beta77.22subunit (glyS)M371 A9H-P0973hypothetical protein38.94M380 C1H-P0974-2phosphoglycerate mutase (pgm)54.12M380 D1H-P0975-2conserved hypothetical protein10.34M380 E1H-P0976-2adenosylmethionine-8-amino-7-48.07oxononanoate aminotransferase(bioA)M380 H1H-P0994-2hypothetical protein29.48M380 G1H-P1000-2PARA protein24.09M380 A2H-P1001-2hypothetical protein10.45M380 B2H-P1002-2hypothetical protein43.45M380 C2H-P1003-2hypothetical protein40.81M380 D2H-P1004-2hypothetical protein30.14M380 E2H-P1005-2hypothetical protein11.55M380 F2H-P1006-2conjugal transfer protein (traG)19.58M380 G2H-P1017-2amino acid permease (rocE)57.2M380 H2H-P1042-2hypothetical protein38.39M380 A3H-P1056-2hypothetical protein31.35M380 B3H-P1075-2conserved hypothetical secreted48.29proteinM373 A1H-P1076hypothetical protein18.92M373 B1H-P1077nickel transport protein (nixA)36.52M373 C1H-P1080conserved hypothetical integral20.9membrane proteinM373 D1H-P1081hypothetical protein22.88M373 E1H-P1082multidrug resistance protein60.72(msbA)M373 F1H-P1083hypothetical protein52.8M373 G1H-P1084aspartate transcarbamoylase33.88(pyrB)M373 H1H-P1085hypothetical protein18.92M373 A2H-P1086hemolysin (tly)25.96M373 B2H-P1087riboflavin biosynthesis regulatory30.91protein (ribC)M373 C2H-P1088transketolase A (tktA)70.62M373 D2H-P1091alpha-ketoglutarate permease46.97(kgtP)M373 E2H-P1092flagellar basal-body rod protein29.7(flgG)M373 F2H-P1096IS605 transposase (tnpA)15.73M373 G2H-P1098conserved hypothetical secreted32.01proteinM373 H2H-P1101glucose-6-phosphate46.86dehydrogenase (g6pD)M373 A3H-P1102glucose-6-phosphate 1-25.08dehydrogenase (devB)M373 B3H-P1103glucokinase (glk)37.07M373 C3H-P1108pyruvate ferredoxin20.57oxidoreductase, gamma subunitM373 D3H-P1109pyruvate ferredoxin14.41oxidoreductase, delta subunitM373 E3H-P1110pyruvate ferredoxin44.88oxidoreductase, alpha subunitM373 F3H-P1111pyruvate ferredoxin34.65oxidoreductase, beta subunitM373 G3H-P1112adenylosuccinate lyase (purB)48.51M380 C3H-P1113-2outer membrane protein (omp24)30.58M373 H3H-P1117conserved hypothetical secreted28.27proteinM373 A4H-P1120hypothetical protein15.95M373 B4H-P1121cytosine specific DNA34.43methyltransferase (BSP6IM)M380 D3H-P1122-2hypothetical protein8.47M373 C4H-P1123peptidyl-prolyl cis-trans20.46isomerase, FKBP-type rotamase(slyD)M373 D4H-P1124hypothetical protein36.52M373 E4H-P1125peptidoglycan associated19.8lipoprotein precursor (omp18)M373 F4H-P1126colicin tolerance-like protein45.98(tolB)M373 G4H-P1128hypothetical protein9.35M373 H4H-P1129biopolymer transport protein14.74(exbD)M373 A5H-P1131ATP synthase F1, subunit epsilon13.75(atpC)M373 B5H-P1134ATP synthase F1, subunit alpha55.44(atpA)M373 C5H-P1135ATP synthase F1, subunit delta19.91(atpH)M373 D5H-P1137ATP synthase F0, subunit b'15.95(atpF')M373 E5H-P1138plasmid replication-partition32.01related proteinM373 F5H-P1139SpoOJ regulator (soj)29.15M373 G5H-P1140biotin operon repressor/biotin23.43acetyl coenzyme A carboxylasesynthetase (birA)M373 H5H-P1141methionyl-tRNA33.44formyltransferase (fmt)M373 A6H-P1144hypothetical protein9.46M373 B6H-P1145hypothetical protein11.44M373 C6H-P1147ribosomal protein L19 (rpl19)13.09M373 D6H-P1148tRNA (guanine-N1)-25.3methyltransferase (trmD)M373 E6H-P1149conserved hypothetical protein20.35M380 F3H-P1150-2hypothetical protein12.76M373 F6H-P1152signal recognition particle protein49.39(ffh)M380 G3H-P1153-2valyl-tRNA synthetase (valS)96.25M380 E3H-P1157-2outer membrane protein (omp26)135.41M373 G6H-P1158pyrroline-5-carboxylate reductase28.38(proC)M373 H6H-P1159cell filamentation protein (fic)19.58M373 A7H-P1160conserved hypothetical protein15.51M380 A4H-P1163-2hypothetical protein7.04M373 B7H-P1165tetracycline resistance protein42.57tetA(P), putativeM373 C7H-P1168carbon starvation protein (cstA)75.68M373 D7H-P1169glutamine ABC transporter,23.98permease protein (glnP)M380 H3H-P1169-2glutamine ABC transporter,23.98permease protein (glnP)M374 A1H-P1170glutamine ABC transporter,24.64permease protein (glnP)M374 B1H-P1171glutamine ABC transporter, ATP-27.39binding protein (glnQ)M374 C1H-P1172glutamine ABC transporter,30.58periplasmic glutamine-bindingprotein (glnH)M374 D1H-P1173hypothetical protein20.24M374 E1H-P1174glucose/galactose transporter44.88(gluP)M374 F1H-P1175conserved hypothetical integral47.96membrane proteinM374 G1H-P1177outer membrane protein (omp27)70.62M374 H1H-P1178purine-nucleoside phosphorylase25.74(deoD)M374 A2H-P1179phosphopentomutase (deoB)45.54M374 B2H-P1180pyrimidine nucleoside transport46.09protein (nupC)M374 C2H-P1183NA+/H+ antiporter (napA)42.24M374 D2H-P1184conserved hypothetical integral50.6membrane proteinM374 E2H-P1185conserved hypothetical integral43.12membrane proteinM374 F2H-P1186carbonic anhydrase22.33M374 G2H-P1187hypothetical protein42.46M374 H2H-P1188hypothetical protein29.7M374 A3H-P1189aspartate-semialdehyde38.17dehydrogenase (asd)M374 B3H-P1191ADP-heptose-lps38.5heptosyltransferase II (rfaF)M374 C3H-P1196ribosomal protein S7 (rps7)17.16M374 D3H-P1200ribosomal protein L10 (rpl10)18.15M374 E3H-P1201ribosomal protein L1 (rpl1)25.85M374 F3H-P1202ribosomal protein L11 (rpl11)15.62M374 G3H-P1203transcription termination factor19.47NusG (nusG)M380 B4H-P1205-2translation elongation factor EF-44Tu (tufB)M374 H3H-P1206multidrug resistance protein63.69(hetA)M374 A4H-P1207hypothetical protein24.53M374 B4H-P1210serine acetyltransferase (cysE)18.92M380 F4H-P1213-2polynucleotide phosphorylase75.79(pnp)M380 G4H-P1214-2conserved hypothetical protein26.51M380 C4H-P1215-2hypothetical protein8.91M380 D4H-P1216-2conserved hypothetical secreted72.71proteinM380 E4H-P1217-2hypothetical protein17.6M374 C4H-P1220ABC transporter, ATP-binding25.19protein (yhcG)M374 D4H-P1221conserved hypothetical protein25.85M374 E4H-P1222D-lactate dehydrogenase (dld)104.39M374 F4H-P1224uroporphyrinogen III cosynthase24.97(hemD)M374 G4H-P1225conserved hypothetical integral14.41membrane proteinM374 H4H-P1226oxygen-independent38.83coproporphyrinogen III oxidase(hemN)M380 H4H-P1227-2cytochrome c55310.67M380 A5H-P1228-2invasion protein (invA)17.16M380 B5H-P1229-2aspartokinase (lysC)44.66M374 A5H-P1230hypothetical protein19.91M374 B5H-P1231DNA polymerase III delta prime24.09subunit (holB)M374 C5H-P1232dihydropteroate synthase (folP)41.91M380 D5H-P1233-2hypothetical protein16.94M374 D5H-P1234conserved hypothetical integral32.89membrane proteinM374 E5H-P1235conserved hypothetical integral45.76membrane proteinM374 F5H-P1236hypothetical protein20.24M374 G5H-P1237carbamoyl-phosphate synthetase41.36(pyrAa)M374 H5H-P1240conserved hypothetical protein21.01M380 C5H-P1241-2alanyl-tRNA synthetase (alaS)93.28M374 A6H-P1242conserved hypothetical protein8.47M380 H5H-P1243-2outer membrane protein (omp28)80.74M374 B6H-P1244ribosomal protein S18 (rps18)9.46M374 C6H-P1245single-strand DNA-binding19.8protein (ssb)M374 D6H-P1246ribosomal protein S6 (rps6)15.73M380 A6H-P1247-2hypothetical protein37.51M374 E6H-P1248virulence associated protein70.95homolog (vacB)M380 B6H-P1249-2shikimate 5-dehydrogenase (aroE)29.04M380 E5H-P1251-2oligopeptide ABC transporter,38.39permease protein (oppB)M380 F5H-P1252-2oligopeptide ABC transporter,65.45periplasmic oligopeptide-bindingprotein (oppA)M380 G5H-P1253-2tryptophanyl-tRNA synthetase37.4(trpS)M374 F6H-P1254biotin synthesis protein (bioC)26.51M374 G6H-P1255protein translocation protein, low22.22temperature (secG)M374 H6H-P1256ribosome releasing factor (frr)20.46M374 A7H-P1257orotate phosphoribosyltransferase22.22(pyrE)M374 B7H-P1258conserved hypothetical17.05mitochondrial protein 4M374 C7H-P1260NADH-ubiquinone14.74oxidoreductase, NQO7 subunit(NQO7)M374 D7H-P1262NADH-ubiquinone29.37oxidoreductase, NQO5 subunit(NQO5)M374 E7H-P1263NADH-ubiquinone45.1oxidoreductase, NQO4 subunit(NQO4)M380 C6H-P1264-2hypothetical protein8.47M374 F7H-P1265hypothetical protein36.19M375 A1H-P1268NADH-ubiquinone24.31oxidoreductase, NQO9 subunit(NQO9)M375 B1H-P1275phosphomannomutase (algC)50.6M375 C1H-P1277tryptophan synthase, alpha28.93subunit (trpA)M375 D1H-P1278tryptophan synthase, beta subunit43.34(trpB)M375 E1H-P1279anthranilate isomerase (trpC)49.83M375 F1H-P1282anthranilate synthase component I55.11(trpE)M375 G1H-P1285conserved hypothetical secreted25.41proteinM375 H1H-P1286conserved hypothetical secreted20.13proteinM375 A2H-P1287transcriptional regulator (tenA)23.98M375 B2H-P1288hypothetical protein14.63M375 C2H-P1289hypothetical protein17.82M375 D2H-P1290nicotinamide mononucleotide24.31transporter (pnuC)M375 E2H-P1291conserved hypothetical protein22.55M375 F2H-P1292ribosomal protein L17 (rpl17)12.87M375 G2H-P1293DNA-directed RNA polymerase,37.95alpha subunit (rpoA)M375 H2H-P1294ribosomal protein S4 (rps4)22.99M375 A3H-P1295ribosomal protein S11 (rps11)14.52M375 B3H-P1296ribosomal protein S13 (rps13)13.31M380 D6H-P1298-2translation initiation factor EF-18.03(infA)M375 C3H-P1299methionine amino peptidase27.94(map)M375 D3H-P1302ribosomal protein S5 (rps5)16.94M375 E3H-P1303ribosomal protein L18 (rpl18)13.2M375 F3H-P1305ribosomal protein S8 (rps8)14.52M375 G3H-P1307ribosomal protein L5 (rpl5)20.02M375 H3H-P1308ribosomal protein L24 (rpl24)8.14M375 A4H-P1309ribosomal protein L14 (rpl14)13.53M375 B4H-P1310ribosomal protein S17 (rps17)9.57M375 C4H-P1312ribosomal protein L16 (rpl16)15.62M375 D4H-P1314ribosomal protein L22 (rpl22)13.53M375 E4H-P1315ribosomal protein S19 (rps19)10.34M375 F4H-P1318ribosomal protein L4 (rpl4)23.76M375 G4H-P1319ribosomal protein L3 (rpl3)21.12M375 H4H-P1320ribosomal protein S10 (rps10)11.55M375 A5H-P1321conserved hypothetical ATP-41.58binding proteinM375 B5H-P1322hypothetical protein22.22M375 C5H-P1323ribonuclease HII (rnhB)23.1M375 D5H-P1324hypothetical protein9.24M375 E5H-P1326hypothetical protein13.86M375 F5H-P1327hypothetical protein45.43M375 G5H-P1328cation efflux system protein37.29(czcA)M375 H5H-P1330conserved hypothetical integral12.76membrane proteinM375 A6H-P1331conserved hypothetical integral25.19membrane proteinM375 B6H-P1332co-chaperone and heat shock40.7protein (dnaJ)M375 C6H-P1333hypothetical protein42.13M375 D6H-P1335conserved hypothetical protein39.71M375 E6H-P1336hypothetical protein27.94M375 F6H-P1337conserved hypothetical protein19.25M375 G6H-P1338conserved hypothetical protein16.39M375 H6H-P1340biopolymer transport protein14.3(exbD)M375 A7H-P1341siderophore-mediated iron31.46transport protein (tonB)M375 B7H-P1342outer membrane protein (omp29)76.12M375 C7H-P1343conserved hypothetical integral26.73membrane proteinM375 D7H-P1344magnesium and cobalt transport35.09protein (corA)M375 E7H-P1345phosphoglycerate kinase44.33M375 F7H-P1346glyceraldehyde-3-phosphate36.41dehydrogenase (gap)M375 G7H-P1347uracil-DNA glycosylase (ung)25.74M375 H7H-P1349hypothetical protein42.68M375 A8H-P1350protease50.6M375 B8H-P1355nicotinate-nucleotide30.14pyrophosphorylase (nadC)M375 C8H-P1356quinolinate synthetase A (nadA)37.07M375 D8H-P1357phosphatidylserine decarboxylase29.48proenzyme (psd)M375 E8H-P1358hypothetical protein18.59M375 F8H-P13604-hydroxybenzoate32.45octaprenyltransferase (ubiA)M375 G8H-P1361competence locus E (comE3)45.98M375 H8H-P1362replicative DNA helicase (dnaB)53.79M375 A9H-P1363conserved hypothetical integral51.37membrane proteinM376 A1H-P1364signal-transducing protein,43.78histidine kinaseM376 B1H-P1365response regulator23.54M376 C1H-P1371type III restriction enzyme R106.59proteinM376 D1H-P1372rod shape-determining protein27.39(mreC)M376 E1H-P1373rod shape-determining protein38.28(mreB)M376 F1H-P1374ATP-dependent protease ATPase49.17subunit (clpX)M376 G1H-P1375UDP-N-acetylglucosamine29.81acyltransferase (lpxA)M376 H1H-P1376(3R)-hydroxymyristoyl-(acyl17.6carrier protein) dehydratase(fabZ)M376 A2H-P1377hypothetical protein16.17M376 B2H-P1378competence lipoprotein (comL)24.31M376 C2H-P1379ATP-dependent protease (lon)91.96M376 D2H-P1380prephenate dehydrogenase (tyrA)29.26M381 C1H-P1381hypothetical protein8.58M376 E2H-P1382hypothetical protein14.41M376 F2H-P1383restriction modification system S17.71subunitM376 G2H-P1384hypothetical protein7.59M376 H2H-P1385fructose-1,6-bisphosphatase32.01M376 A3H-P1386D-ribulose-5-phosphate 323.98epimerase (rpe)M376 B3H-P1388hypothetical protein16.5M376 C3H-P1389hypothetical protein6.71M376 D3H-P1390hypothetical protein18.37M376 E3H-P1391hypothetical protein10.89M376 F3H-P1392fibronectin/fibrinogen-binding47.96proteinM376 G3H-P1393DNA repair protein (recN)57.75M376 H3H-P1394conserved hypothetical protein31.35M376 A4H-P1395outer membrane protein (omp30)26.73M376 B4H-P1396hypothetical protein31.79M376 C4H-P1398alanine dehydrogenase (ald)41.91M376 D4H-P1399arginase (rocF)35.53M376 E4H-P1400iron(III) dicitrate transport protein92.73(fecA)M376 F4H-P1401conserved hypothetical protein25.96M381 A2H-P1402type I restriction enzyme R109.34protein (hsdR)M381 B2H-P1403type I restriction enzyme M89.98protein (hsdM)M376 G4H-P1405hypothetical protein3.85M376 H4H-P1406biotin synthetase (bioB)31.13M376 A5H-P1407conserved hypothetical integral32.23membrane proteinM381 C2H-P1408hypothetical protein12.32M381 D2H-P1409hypothetical protein63.69M376 B5H-P1410hypothetical protein43.45M376 C5H-P1411hypothetical protein68.2M376 D5H-P1412hypothetical protein33.99M376 E5H-P1413conserved hypothetical protein16.39M376 F5H-P1414conserved hypothetical protein12.54M376 G5H-P1415tRNA delta(2)-29.37isopentenylpyrophosphatetransferase (miaA)M376 H5H-P1418UDP-N-28.6acetylenolpyruvoylglucosaminereductase (murB)M376 A6H-P1419flagellar biosynthetic protein9.79(fliQ)M376 B6H-P1420flagellar export protein ATP47.85synthase (fliI)M376 C6H-P1421conjugative transfer regulon33.55protein (trbB)M376 D6H-P1423conserved hypothetical protein9.35M376 E6H-P1424hypothetical protein22.77M376 F6H-P1425hypothetical protein8.36M376 G6H-P1427histidine-rich, metal binding6.71polypeptide (hpn)M376 H6H-P1428conserved hypothetical protein39.38M376 A7H-P1429polysialic acid capsule expression36.3protein (kpsF)M376 B7H-P1430conserved hypothetical ATP-75.9binding proteinM376 C7H-P143116S rRNA (adenosine-N6,N6-)-29.92dimethyltransferase (ksgA)M376 D7H-P1432histidine and glutamine-rich8.03proteinM376 E7H-P1433hypothetical protein94.27M376 F7H-P1434formyltetrahydrofolate hydrolase32.34(purU)M376 G7H-P1435protease IV (PspA)32.23M376 H7H-P1436hypothetical protein9.13M376 A8H-P1438conserved hypothetical37.29lipoproteinM376 B8H-P1439hypothetical protein9.02M376 C8H-P1440hypothetical protein28.6M376 D8H-P1441peptidyl-prolyl cis-trans18.04isomerase B, cyclosporin-typerotamase (ppi)M376 E8H-P1442carbon storage regulator (csrA)8.47M376 F8H-P1443conserved hypothetical protein29.59M376 G8H-P1444small protein (smpB)16.83M376 H8H-P1445biopolymer transport protein16.61(exbB)M376 A9H-P1446biopolymer transport protein14.74(exbD)M376 B9H-P1447ribosomal protein L34 (rpl34)4.95M376 C9H-P1448ribonuclease P, protein17.82component (rnpA)M376 D9H-P1449conserved hypothetical protein12.98M376 E9H-P145060 kDa inner-membrane protein60.28M376 F9H-P1451hypothetical protein29.15M376 G9H-P1452thiophene and furan oxidizer50.82(tdhF)M376 H9H-P1453conserved hypothetical protein82.17M376 A10H-P1454hypothetical protein33.44M376 B10H-P1455hypothetical protein14.41M376 C10H-P1456membrane-associated lipoprotein19.36(lpp20)M376 D10H-P1457hypothetical protein23.21M376 E10H-P1458thioredoxin11.55M376 F10H-P1461cytochrome c551 peroxidase38.61M377 A1H-P1462secreted protein involved in19.03flagellar motilityM377 B1H-P1463hypothetical protein24.86M377 C1H-P1464conserved hypothetical secreted29.92proteinM377 D1H-P1465ABC transporter, ATP-binding28.82protein (HI1087)M377 E1H-P1466conserved hypothetical integral41.58membrane proteinM377 F1H-P1467hypothetical protein25.52M377 G1H-P1468branched-chain-amino-acid37.51aminotransferase (ilvE)M377 H1H-P1469outer membrane protein (omp31)27.39M377 A2H-P1473hypothetical protein21.12M377 B2H-P1474thymidylate kinase (tmk)21.12M377 C2H-P1475lipopolysaccharide core17.38biosynthesis protein (kdtB)M377 D2H-P1476phenylacrylic acid decarboxylase20.68M377 E2H-P1479hypothetical protein92.95M377 F2H-P1480seryl-tRNA synthetase (serS)45.76M377 G2H-P1481hypothetical protein29.26M377 H2H-P1482hypothetical protein9.57M377 A3H-P1483gerC2 protein (gerC2)27.17M377 B3H-P1484conserved hypothetical integral16.39membrane proteinM377 C3H-P1485proline dipeptidase (pepQ)21.01M377 D3H-P1486conserved hypothetical integral41.47membrane proteinM377 E3H-P1487conserved hypothetical integral40.26membrane proteinM377 F3H-P1488conserved hypothetical secreted36.3proteinM377 G3H-P1489lipase-like protein56.21M381 G1H-P1490hemolysin49.5M377 H3H-P1491phosphate permease58.74M377 A4H-P1492conserved hypothetical nifU-like9.9proteinM377 B4H-P1493hypothetical protein22.44M377 C4H-P1494UDP-MurNac-tripeptide49.28synthetase (murE)M377 D4H-P1495transaldolase (tal)34.87M377 E4H-P1496general stress protein (ctc)19.69M377 F4H-P1497peptidyl-tRNA hydrolase (pth)20.57M377 G4H-P1499hypothetical protein30.03M377 H4H-P1501outer membrane protein (omp32)42.79M377 A5H-P1502hypothetical protein16.06M377 B5H-P1503cation-transporting ATPase, P-86.79type (copA)M377 C5H-P1504conserved hypothetical protein26.29M377 D5H-P1505riboflavin biosynthesis protein37.95(ribG)M377 E5H-P1506glutamate permease (gltS)44.99M377 F5H-P1507conserved hypothetical ATP-42.46binding proteinM381 F2H-P1508ferrodoxin-like protein50.49M377 G5H-P1509conserved hypothetical integral28.93membrane proteinM377 H5H-P1510conserved hypothetical protein12.98M377 A6H-P1511hypothetical protein11.99M377 B6H-P1512iron-regulated outer membrane96.58protein (frpB)M377 C6H-P1513selenocystein synthase (selA)42.57M377 D6H-P1514transcription termination factor43.56NusA (nusA)M377 E6H-P1518hypothetical protein10.56M381 B3H-P1521type III restriction enzyme R106.48protein (res)M381 C3H-P1523DNA recombinase (recG)68.64M377 F6H-P1524hypothetical protein12.76M377 G6H-P1525hypothetical protein23.32M377 H6H-P1526exodeoxyribonuclease (lexA)27.61M377 A7H-P1527hypothetical protein52.8M377 B7H-P1530purine nucleoside phosphorylase19.91(punB)M377 C7H-P1531hypothetical protein8.8M377 D7H-P1532glucosamine fructose-6-phosphate65.78aminotransferase (isomerizing)(glmS)M377 E7H-P1533conserved hypothetical protein25.52M377 F7H-P1534IS605 transposase (tnpB)47.08M377 G7H-P1535IS605 transposase (tnpA)15.73M377 H7H-P1541transcription-repair coupling110factor (trcF)M377 A8H-P1548conserved hypothetical integral12.43membrane proteinM377 B8H-P1551conserved hypothetical secreted14.08proteinM377 C8H-P1552Na+/H+ antiporter (nhaA)48.29M381 B4H-P1554ribosomal protein S2 (rps2)29.15M381 D4H-P1555translation elongation factor EF-39.16Ts (tsf)M377 D8H-P1556cell division protein (ftsI)67.76M381 E4H-P1557flagellar basal-body protein (fliE)12.1M381 F4H-P1558flagellar basal-body rod protein17.82(flgC) (proximal rod protein)M381 G4H-P1559flagellar basal-body rod protein15.51(flgB) (proximal rod protein)M378 A1H-P1560cell division protein (ftsW)42.79M378 B1H-P1561iron(III) ABC transporter,36.96periplasmic iron-binding protein(ceuE)M378 C1H-P1562iron(III) ABC transporter,36.74periplasmic iron-binding protein(ceuE)M378 D1H-P1563alkyl hydroperoxide reductase21.89(tsaA)M378 E1H-P1564outer membrane protein29.92M378 F1H-P1565penicillin-binding protein 264.79(pbp2)M378 G1H-P1566hypothetical protein16.28M378 H1H-P1567conserved hypothetical ATP-22.99binding proteinM378 A2H-P1568hypothetical protein20.24M378 B2H-P1569hypothetical protein21.78M378 C2H-P1570conserved hypothetical protein18.15M378 D2H-P1571rare lipoprotein A (rlpA)34.76M378 E2H-P1572regulatory protein DniR41.03M378 F2H-P1573conserved hypothetical protein28.05M378 G2H-P1576ABC transporter, ATP-binding36.08protein (abc)M378 H2H-P1577ABC transporter, permease23.76protein (yaeE)M378 A3H-P1580hypothetical protein24.31M378 B3H-P1581methicillin resistance protein37.07(llm)M378 C3H-P1582pyridoxal phosphate biosynthetic28.93protein J (pdxJ)M378 D3H-P1583pyridoxal phosphate biosynthetic33.88protein A (pdxA)M378 E3H-P1584sialoglycoprotease (gcp)37.51M378 F3H-P1585flagellar basal-body rod protein28.93(flgG)M378 G3H-P1587conserved hypothetical protein17.16M378 H3H-P1588conserved hypothetical protein27.94M381 H1H-P1590hypothetical protein4.4M318 G2H-S38729autoimmune antigen Ku, p7067.167subunitH1H-S39329Kallikrein 124.6430(renal/pancreas/salivary){alternative products}M270 G4H-S43855Recoverin, photoreceptor protein22.1132.0 kDaM300 C2H-S56151milk fat globule protein HMFG24.0930M318 C1H-S57153retinoblastoma-binding protein 1,101.31101isoform I [RBBP1]M271 B2H-S57162retinoblastoma-binding protein 1,93.72110isoform III [RBBP1],INTERACTS WITH THE VIRALPROTEIN-BINDING DOMAINOF THE RETINOBLASTOMAPROTEIN.M317 H3H-S62027transducin, gamma subunit8.2511M270 G6H-S66793arrestin, X-arrestin = S-antigen42.7950.0 kDahomolog [human, retina, mRNA,1314 nt], MAY PLAY A ROLEIN AN AS YET UNDEFINEDRETINA-SPECIFIC SIGNALTRANSDUCTION.M419 C2H-S67859“transcription initiation factor IIe,48.36064.0 kDaalpha subunit”M302 D7H-S69022myosin, light polypeptide 2,18.2631ventricularH5H-S69272cytoplasmic antiproteinase = 3841.4750kda intracellular serine proteinaseinhibitor [human, placenta,mRNA, 1465 nt]D1H-S72043GIF = growth inhibitory factor7.5919[human, brain, Genomic, 2015 nt]M266 B3H-S74221cytokine IK factor17.9336.0 kDaD1H-S74445cellular retinoic acid-binding15.1823protein [human, skin, mRNA, 735nt]E3H-S74728antiquitin = 26 g turgor protein56.3253homolog [human, kidney, mRNA,1809 nt]D4H-S75174E2F transcription factor 4,45.8758p107/p130-binding166-61H-S76474“trkB {alternately spliced}5552.54[human, brain, mRNA]”169-40H-S76617“Blk = protein tyrosine kinase6055.62[human, B lymphocytes, mRNA,2608 nt]”M250 D3H-S79522ubiquitin carboxyl-terminal17.2717.0 kDaextension protein, Ubiquitin A-52residue ribosomal protein fusionproduct 1M236 B4H-S80562calponin, acidic36.349G1H-S82470BB1 = malignant cell expression-37.7334enhanced gene/tumorprogression-enhanced gene[human, UM-UC-9 bladdercarcinoma cell line, mRNA, 1897nt]M313 E1H-S85655prohibitin [PHB]30.0340.0 kDaM465 A6H-S87759protein phosphatase 2C alpha42.1352.0 kDa[human, teratocarcinoma, mRNA,2346 nt]M472 B1H-U00803tyrosine-protein kinase FRK55.62064.0 kDaB2H-U02390Human adenylyl cyclase-52.5855associated protein homolog CAP2(CAP2) mRNA, complete cds167-2H-U02680human protein tyrosine kinase3638.57mRNAG2H-U03056Human tumor suppressor (LUCA-47.96471) mRNA, complete cdsM512 E3H-U03100Human alpha2(E)-catenin mRNA,102.52102.0 kDa complete cdsM306 G3H-U0318772.9395.0 kDaH3H-U03398Human receptor 4-1BB ligand28.0551mRNA, complete cdsD3H-U03486Human connexin40 gene,39.4940complete cdsM300 C3H-U03643leukophysin25.9634F5H-U03749Human chromogranin A (CHGA)50.3850gene, promoter andM314 C3H-U03886GS2 (GB: U03886)27.9432.0 kDaM306 E3H-U04343CD86 antigen (CD28 antigen35.6447ligand 2, B7-2 antigen) [CD86]167-61H-U05012TrkC9290.82M302 G5H-U05340cell division cycle protein p555555A4H-U05659Hydroxysteroid (17-beta)34.2136dehydrogenase 3F1H-U05861Human hepatic dihydrodiol35.6440dehydrogenase geneM302 B2H-U06452antigen MART-1, melanoma13.0920.0 kDa169-52H-U06454human AMP-activated protein7060.79kinase (hAMPK) mRNAM315 A3H-U06643lectin, epidermal15.0718H1H-U06715Cytochrome B56127.0625M476 E5H-U07132Human steroid hormone receptor50.8255.0 kDaNer-I mRNA, complete cdsM236 D3H-U07151guanine nucleotide-binding20.1334protein ADP-ribosylation factorlike gene 3M317 G3H-U07559homeotic protein Islet-138.1738M266 H1H-U07681Human NAD(H)-specific40.3740isocitrate dehydrogenase alphasubunit precursor mRNA,complete cdsE3H-U07919Aldehyde dehydrogenase 656.4353M298 A3H-U08021nicotinamide N-methyltransferase29.1536.0 kDaM297 B1H-U08024alcohol/hydroxysteroid31.4650.0 kDasulfotransferaseA2H-U08336Human basic helix-loop-helix21.8942transcription factor mRNA,complete cdsE2H-U09303Human T cell leukemia LERK-238.1740(EPLG2) mRNA, complete cdsM250 H5H-U09559RCH1, RAG (recombination58.358.0 kDaactivating gene) cohort 1167-50H-U09564human serine kinase mRNA7272.12166-74H-U09578human MAPKAP kinase (3pK)5042.09mRNAM302 C4H-U09813ATP synthase, subunit 9,15.7330mitochondrialA1H-U09850Zinc finger protein 143 (clone68.9768pHZ-1)M423 E1H-U09937Human urokinase-type36.9649.0 kDaplasminogen receptorM450 H4H-U10117Human endothelial-monocyte34.4338.0 kDaactivating polypeptide II mRNA,complete cdsM314 G1H-U10248ribosomal protein L2917.627M298 H1H-U10323nuclear factor 4544.7745E1H-U10492Human Mox1 protein (MOX1)28.0537mRNA, complete cdsF3H-U10686Human MAGE-11 antigen35.235(MAGE11) gene, complete cds167-38H-U11050human NIMA-like protein kinase5549.021 (NLK1) mRNAM266 B2H-U11292Human Ki nuclear autoantigen29.4832mRNA, complete cds, may play arol in cell adhesion167-62H-U11791human cyclin H mRNA4035.60M423 D5H-U12255immunoglobulin gamma heavy40.2648.0 kDachain Fc receptor RI, high affinityM302 F7H-U12404Csa-1923.9832M236 A2H-U12465ribosomal protein L3513.6424169-4H-U12535human epidermal growth factor10090.49receptor kinase substrate (Eps8)mRNAF3H-U12597Human tumor necrosis factor type55.22642 receptor associated protein(TRAP3) mRNA, complete cdsM314 D1H-U12979transcriptional coactivator PC414.0823M476 G4H-U13044GA-binding protein transcription50.0553.0 kDafactor, alpha subunit (60 kD)M302 F3H-U13665cathepsin O (GB: U13665)36.350.0 kDaM311 G4H-U13831cellular retinol binding protein II14.8520.0 kDaA2H-U13991Human TATA-binding protein24.0934associated factor 30 kDa subunit(tafII30) mRNA, complete cdsM416 A4H-U14187Human receptor tyrosine kinase26.2929.0 kDaligand LERK-3 (EPLG3) mRNA,complete cdsM250 A2H-U14188eph-related receptor tyrosine22.2227kinase ligand 4 [EPLG4]M302 D2H-U14193human TFIIA gamma subunit12.06028.0 kDamRNAM416 G1H-U14603Human protein-tyrosine18.4830.0 kDaphosphatase (HU-PP-1) mRNA,partial sequenceE2H-U14747Visinin-like 121.1225M266 D4H-U14966ribosomal protein L532.7838M314 E2H-U14967ribosomal protein L2117.7129M266 F5H-U14968ribosomal protein L27a16.3919.0 kDaM248 E3H-U14969ribosomal protein L2815.1827M266 E1H-U14971ribosomal protein S921.4530M250 C2H-U15009small nuclear ribonucleoprotein,13.9717.0 kDaSm D3M311 D4H-U16660enoyl-Coenzyme A hydratase-like36.1938protein, peroxisomalM302 H4H-U17074cyclin-dependent kinase 618.5929inhibitor p18M306 A2H-U17195A-kinase anchor protein 10072.05100[AKAP100*]D1H-U17280Steroidogenic acute regulatory31.4635proteinM316 F1H-U18291cell division cycle protein 1668.271.0 kDaC5H-U18420Human ras-related small GTP23.8733binding protein Rab5 (rab5)mRNA, complete cdsM311 A2H-U18423spinal muscular atrophy gene32.4541M248 D4H-U18914hypothetical protein, (Human20.353219.8 kDa protein mRNA,complete cds)M302 B5H-U19718microfibril-associated20.2434.0 kDaglycoprotein 2M305 E3H-U20240CCAAT/enhancer-binding protein16.6129gammaM302 A8H-U20352malate dehydrogenase36.8540M416 F4H-U20391Human folate receptor (FOLR1)28.3834.0 kDagene, complete cdsM311 D1H-U20536apoptotic cysteine protease Mch232.3438.0 kDaM431 G2H-U20659RNA polymerase II, subunit B719.0331.0 kDaM499 C1H-U20938Human lymphocyte112.86100.0 kDa dihydropyrimidine dehydrogenasemRNA, complete cdsM305 F2H-U2097214-3-3 protein, epsilon28.1636M271 D3H-U21049hypothetical protein12.6516(GB: U21049), ESTs, Highlysimilar to DD96 [H. sapiens].M421 G5H-U21858Human transcriptional activation29.1538.0 kDafactor TAFII32 mRNA, completecdsM424 H3H-U22662Human nuclear orphan receptor49.2849.0 kDaLXR-alpha mRNA, complete cdsM271 D2H-U24074killer cell inhibitory receptor37.6243[KIR], Homo sapiens naturalkiller-associated transcript 3(NKAT3), complete cds.RECEPTOR ON NATURALKILLER (NK) CELLS FORHLA-C ALLELES.169-29H-U24153human p21-activated protein6057.82kinase (Pak2) geneM385 H2H-U24166EB129.5936.0 kDaG1H-U24169Human JTV-1 (JTV-1) mRNA,34.4340complete cdsE1H-U24576Human breast tumor autoantigen18.2627mRNA, complete sequenceG4H-U24577Human LDL-phospholipase A248.6252mRNA, complete cdsH1H-U25789Human ribosomal protein L2117.7132mRNA, complete cdsM416 D1H-U25849Human red cell-type low17.4928.0 kDamolecular weight acidphosphatase (ACP1) gene, 5′flanking region andM300 A3H-U26312heterochromatin protein H-P1Hs-19.1430gammaM416 D3H-U26403Human receptor tyrosine kinase25.1930.0 kDaligand LERK-7 precursor(EPLG7) mRNA, complete cdsM317 E2H-U27143human protein kinase C inhibitor-13.90017.0 kDaI cDNAE5H-U28249Human 11 kd protein mRNA,12.3212complete cdsF4H-U28386Human nuclear localization58.354sequence receptor hSRP1 alphamRNA, complete cdsM423 E3H-U28694Chemokine (C-C) receptor 339.1639.0 kDaM266 G6H-U28963Gps236.0836M306 D3H-U30610CD94 antigen (NK/T-cell C-type19.827lectin receptor) [CD94]B1H-U31116Human beta-sarcoglycan A3b35.0933mRNA, complete cdsM297 C2H-U31278mitotic feedback control protein22.6631.0 kDaMadp2 homologM302 G2H-U31384guanine nucleotide-binding8.1410protein, gamma 11 subunitF4H-U31986Human cartilage-specific35.9747homeodomain protein Cart-1mRNA, complete cdsM390 F3H-U32114caveolin 217.9318.0 kDaE4H-U32324Human interleukin-11 receptor46.5354alpha chain mRNA, complete cdsF1H-U32576Apolipoprotein C-IV14.0816M298 C4H-U32907p37NB protein34.5439M300 D3H-U32944dynein, light chain 1, cytoplasmic9.915M297 D1H-U32989tryptophan 2,3-dioxygenase44.7750.0 kDa166-51H-U33052“protein kinase PRK2 [human,110108.3DX3 B-cell myeloma cell line,mRNA]”166-64H-U33054“human G protein-coupled5263.65receptor kinase GRK4 mRNA,alpha splice variant”166-88H-U33055“human G protein-coupled6060.1receptor kinase GRK4 mRNA,beta splice variant”166-76H-U33056“human G protein-coupled5858.59receptor kinase GRK4 mRNA,gamma splice variant”A2H-U3458417.7131169-87H-U34820human MAP kinase mRNA5546.49215-2H-U34822human JNK1 alpha2 protein5547.04kinase (JNK1A2) mRNA169-37H-U35002human JNK2 betal protein kinase5042.09(JNK2B1) mRNA169-25H-U35003human JNK2 beta2 protein kinase5546.71(JNK2B2) mRNA167-16H-U35004human JNK1 betal protein kinase5242.31(JNK1B1) mRNAM300 B2H-U35048TSC-22 protein15.9527M423 E5H-U35398Human G protein-coupled40.2648.0 kDareceptor mRNA, complete cdsA3H-U35735Human RACH1 (RACH1)42.978mRNA, complete cdsM250 E5H-U36764Eukaryotic translation initiation35.8636.0 kDafactor 3 (eIF-3) p36 subunit,transforming growth factor-betareceptor II interacting protein 1M270 E4H-U37283microfibril-associated19.1432glycoprotein-2 (GB: U37283)M426 F3H-U37352Protein phosphatase 2A,56.6555.0 kDaregulatory subunit B′alpha-1E1H-U37529Human substance P beta-PPT-A14.322mRNA, complete cdsM305 H5H-U37547apoptosis inhibitor68.0964M424 D5H-U38480Human retinoid X receptor-51.0461.0 kDagamma mRNA, complete cdsM270 F4H-U38810Human mab-21 cell fate-determining protein homolog(CAGR1) mRNA,M467 F6H-U38904Human zinc finger protein C2H2-40.4847.0 kDa25 mRNA, complete cdsE2H-U39318Human E2 ubiquitin conjugating16.2822enzyme UbcH5C (UBCH5C)mRNA, complete cds166-75H-U39657human MAP kinase kinase 64036.81(MKK6) mRNAM298 E4H-U39945human adenylate kinase 2 (adk2)26.363338.0 kDamRNA166-38H-U40282human integrin-linked kinase5549.68(ILK) mRNA169-65H-U40343human CDK inhibitor p19INK4d1818.33mRNAE2H-U40705Homo sapiens telomeric repeat48.452binding factor (TRF1) mRNA,complete cds166-50H-U40989human tat interactive protein6053.09mRNAM266 H6H-U41767metargidin precursor89.6590M270 F3H-U41804Human putative T1/ST2 receptor25.0835.0 kDabinding protein precursor mRNA,complete cdsD5H-U42360Human N33 gene38.2838A1H-U43368Vascular endothelial growth22.8833factor BM421 G7H-U43901Human 37 kD laminin receptor32.5658.0 kDaprecursor/p40 ribosomeassociated protein gene, completecdsM392 C2H-U43923transcription factor SUPTH412.9816.0 kDaE2H-U46024Myotubular myopathy 166.4458M330 A1H-U46838p105MCM90.4297M476 E2H-U47677Human transcription factor E2F148.1853.0 kDa(E2F1) gene, promoter andM421 H1H-U48707Human protein phosphatase-118.9236.0 kDainhibitor mRNA, complete cdsM302 B7H-U49070peptidyl-prolyl isomerase PIN118.0428.0 kDaC1H-U49188Human placenta (Diff33) mRNA,54.4570complete cdsM485 H2H-U49837Human LIM protein MLP mRNA,21.4534.0 kDacomplete cdsD2H-U49897Homo sapiens phenylalanine49.8364hydroxylase (PAH) mRNA,complete cdsB2H-U49957Human LIM protein (LPP)67.4367mRNA, partial cds166-16H-U50196human adenosine kinase mRNA5038.02A4H-U50939Human amyloid precursor58.8560protein-binding protein 1 mRNA,complete cdsG3H-U51224Human U2AFBPL gene, complete52.855cdsM486 E3H-U51333Hexokinase 3 (white cell)101.64100.0 kDa M305 D1H-U51478ATPase, Na+/K+ transporting,30.836beta 3 subunitM416 H3H-U52112Homo sapiens Xq28 genomic25.9636.0 kDaDNA in the region of the L1CAMlocus containing the genes forneural cell adhesion molecule L1(L1CAM), arginine-vasopressinreceptor (AVPR2), C1 p115 (C1),ARD1 N-acetyltransferase relatedprotein (TE2), renin-bindingprotein (RbP), host cell factor 1(HCF1), and interleukin-1receptor-associated kinase(IRAK) genes, complete cds, andXq28lu2 geneM463 E1H-U53442human p38Beta MAP kinase40.9949.0 kDamRNAG3H-U53446Human mitogen-responsive84.8198phosphoprotein DOC-2 mRNA,complete cdsM463 C1H-U54617human pyruvate dehydrogenase45.2852.0 kDakinase isoform 4 mRNA169-38H-U54645methylmalonyl-coA mutase3825.59precursorM300 H3H-U56255t-complex sterility protein12.5416homolog CW-1C4H-U56417Human lysophosphatidic acid31.2446acyltransferase-alpha mRNA,complete cdsM305 A2H-U56637actin-capping protein alpha31.5731subunit isoform 1M235 E6H-U56814Human DNase1-Like III protein33.6640.0 kDa(DNAS1L3) mRNA, completecds, involved in apoptosis Bindsspecifically to G-ACTIN ANDBLOCKS ACTINPOLYMERIZATION.D5H-U5705931.0236B3H-U57093Human small GTP-binding24.0934protein rab27b mRNA, completecdsD3H-U57099Human APEG-1 mRNA,12.5420complete cdsF1H-U58331Sarcoglycan, delta (35 kD28.2724dystrophin-associatedglycoprotein)M512 F4H-U58334Human Bcl2, p53 binding protein110.66108.0 kDa Bbp/53BP2 (BBP/53BP2) mRNA,complete cdsB3H-U58516Human breast epithelial antigen42.6850BA46 mRNA, complete cdsM250 E4H-U58522Human huntingtin interacting22.1130protein (HIP2) mRNA, completecdsM419 G2H-U60207human stress responsive53.64063.0 kDaserine/threonine protein kinaseKrs-2 mRNAM298 B2H-U60276arsA homolog (hASNA-I)36.6347.0 kDaB2H-U60521Human protease proMch6 (Mch6)45.8752mRNA, complete cdsF3H-U61166Human SH3 domain-containing57.3157protein SH3P17 mRNA, completecdsM250 B5H-U61232cofactor E (tubulin-foldingprotein), REQUIRED FORVIABILITY IN THE ABSENCEOF THE KINESIN-RELATEDCIN8A5H-U62392Homo sapiens zinc finger protein43.4552mRNA, complete cdsG1H-U62801Human protease M mRNA,26.9533complete cdsM266 B1H-U62962Int-6 , Human Int-6 mRNA,49.0652.0 kDacomplete cdsM300 G1H-U63295seven in absentia homolog31.1336M306 H3H-U6419894.9398H3H-U64863Human hPD-1 (hPD-1) mRNA,31.7937complete cdsB3H-U65581Human ribosomal protein L3-like44.8852mRNA, complete cdsM341 D1H-U65918DAZ homologue [DAZLA]32.5636.0 kDaM302 E1H-U65928Jun activation domain binding36.8548.0 kDaproteinM512 D3H-U66347Homo sapiens cAMP46.9760.0 kDaphosphodiesterase (PDE4C)mRNA, 4C-426 isoform,complete cdsM306 F3H-U66867ubiquitin-conjugating enzyme E2I17.4928[UBE2I]M416 E2H-U68111Human protein phosphatase22.6637.0 kDainhibitor 2 (PPP1R2) geneF2H-U68382Mannosidase, alpha B, lysosomal35.6436G2H-U69141Glutaryl-Coenzyme A48.2956dehydrogenaseB2H-U70660Human copper transport protein7.5916HAH1 (HAH1) mRNA, completecdsM297 B2H-U71374peroxisomal membrane protein40.1540.0 kDa(Pex13p)M306 A3H-U75272progastricsin [PGC]42.7949.0 kDaA2H-U75285Homo sapiens apoptosis inhibitor15.7325survivin gene, complete cdsB2H-U77456Human nucleosome assembly41.3650protein 2 mRNA, complete cdsC2H-U78294Homo sapiens 15S-lipoxygenase74.4774mRNA, complete cdsF6H-U78302Human 2,4-dienoyl-CoA36.9640reductase geneM478 G3H-U78798Human TNF receptor associated57.5365.0 kDafactor 6 (TRAF6) mRNA,complete cdsG3H-U80982Human myeloid-specific C/EBP-27.551epsilon transcription factor(CEBPE) gene, complete cdsM468 B7H-U82256Homo sapiens arginase type II39.0545.0 kDamRNA, complete cdsM465 B2H-U82812Human scavenger receptor38.2848.0 kDacysteine rich Sp alpha mRNA,complete cdsM484 D7H-U83410Human CUL-2 (cul-2) mRNA,82.0685.0 kDacomplete cdsM467 E6H-U83460Human high-affinity copper21.0132.0 kDauptake protein (hCTR1) mRNA,complete cdsD2H-U84763Homo sapiens UCP3 mRNA,34.4342complete cdsB2H-U86070Homo sapiens28.9336phosphomannomutase mRNA,complete cdsC2H-U90441Human prolyl 4-hydroxylase58.9664alpha (II) subunit mRNA,complete cdsB2H-U90543Human butyrophilin (BTF1)58.0854mRNA, complete cdsH2H-U90545Human sodium phosphate44.2236transporter (NPT4) mRNA,complete cdsG2H-U90552Human butyrophilin (BTF5)56.5448mRNA, complete cdsC3H-U91521Peroxisomal biogenesis factor 1239.648H1H-U91641Human alpha2,8-sialyltransferase41.4745mRNA, complete cdsC1H-U93869Human RNA polymerase III34.9836subunit (RPC39) mRNA,complete cdsF2H-U94346Human calpain-like protease70.465(htra-3) mRNA, complete cdsC2H-U94855Human translation initiation39.3836factor 3.47 kDa subunit mRNA,complete cdsM271 F7H-U95089Epidermal growth factor receptor.44.6647M424 A5H-U95847Human GDNF receptor alpha50.7152.0 kDamRNA, complete cdsD2H-U96094Human sarcolipin (SLN) mRNA,3.5210complete cdsB3H-U96769Homo sapiens chondroadherin39.643gene, 5'flanking region andM298 G2H-V00566prolactin25.0835M298 H2H-V00571corticotropin-releasing factor21.6749217-61H-V00572phosphoglycerate kinase 15045.94M314 B3H-V00597parathyroid hormone12.7614M305 B8H-X00129retinol-binding protein 4,2251interstitial [RBP4]F2H-X00351Human mRNA for beta-actin41.3641A4H-X00570apolipoprotein C-I9.2435M362 E1H-X01057interleukin 2 receptor, alpha30.0340.0 kDa[IL2RA]A4H-X01677PHuman liver mRNA for10.4510glyceraldehyde-3-phosphatedehydrogenase (G3PD, EC1.2.1.12)M271 D6H-X02152lactate dehydrogenase A [LDHA],36.6345.0 kDaL-LACTATEDEHYDROGENASE M CHAINA1H-X02158Human gene for erythropoietin21.3432H4H-X02415Human gene for fibrinogen48.1850gamma chainA5H-X02750Protein C (inactivator of50.8253coagulation factors Va and VIIIa)M302 B3H-X02751proto-oncogene N-ras20.925.0 kDaD3H-X02812Human mRNA for transforming43.1250growth factor-beta (TGF-beta)M302 C1H-X03124tissue inhibitor of22.8836.0 kDametalloproteinase 1M362 B1H-X03342ribosomal protein L3214.9624.0 kDaM235 A2H-X03484human mRNA for raf oncogene71.35073.0 kDaM318 A3H-X03557interferon-induced protein 5652.6950.0 kDaA3H-X03747ATPase, Na+/K+ transporting,33.4445beta 1 polypeptideM305 D2H-X04297ATPase, Na+/K+ transporting,112.6499alpha subunitM305 A5H-X043272,3-bisphosphoglycerate mutase28.636M271 G5H-X04588tropomyosin TM30 nm,26.2940.0 kDacytoskeletalM305 C8H-X04741ubiquitin related protein23.4328.0 kDaM236 A5H-X05231matrix metalloproteinase 151.753.0 kDa(interstitial collagenase) [MMP1],CLEAVES COLLAGENS166-53H-X05246“phosphoglycerate kinase, testis5045.94specific”M236 A1H-X05908annexin I, REGULATES38.1740PHOSPHOLIPASE A2ACTIVITY, Binds CALCIUMIONSM250 A4H-X06234S100 calcium-binding protein A810.3410.0 kDa(calgranulin A)M266 B6H-X06323ribosomal protein L3, isoform 138.3939M313 A7H-X06617ribosomal protein S1117.4927M416 E4H-X06948High affinity IgE receptor alpha-28.3836.0 kDasubunit (FcERI)M421 H7H-X07203Human mRNA for CD20 receptor32.7840.0 kDa(S7)217-2H-X07743pleckstrin3838.57217-73H-X07767“cAMP-dependent protein kinase,4538.68alpha-catalytic subunit”M305 B3H-X07898troponin C, skeletal, fast17.7125M306 E1H-X07979integrin,beta 187.89110A11H-X08004ras-related protein rap 1 B20.2438M235 A7H-X12387Cytochrome P450 IIIA355.4460.0 kDa(nifedipine oxidase chain 3)M315 F1H-X12496glycophorin C14.1924M316 D3H-X12517small nuclear ribonucleoprotein17.630.0 kDaU1, CM236 E5H-X12534guanine nucleotide-binding20.2434.0 kDaprotein rap2, ras-oncogene relatedM266 E3H-X12597High-mobility group (nonhistone23.7637chromosomal) protein 1, placenta217-14H-X12656human mRNA for protein4034.06phosphatase 2A (beta type)H4H-X12662H. sapiens arginase gene exon 135.5350and flanking regions (EC 3.5.3.1)(and joined CDS)C1H-X12953RAB2, member RAS oncogene23.4329familyF5H-X13956Human 12S RNA induced by9.1319poly(rI), poly(rC) and Newcastledisease virusM297 A1H-X15005laminin receptor 133.1148.0 kDaM315 E3H-X15088guanine nucleotide binding38.6145protein (G protein), alphatransducing (transducin) activitypolypeptide 1 [GNAT1]G2H-X15183Human mRNA for 90-kDa heat-80.6380shock proteinM385 C1H-X15422mannose-binding lectin, soluble27.3927.0 kDa(opsonic defect) [MBL]M271 D7H-X15606INTERCELLULAR ADHESION30.3637.0 kDaMOLECULE-2 PRECURSOR[Homo sapiens].M298 C5H-X15653uracil-DNA glycosylase33.5537M302 B4H-X15822cytochrome-c oxidase, VIIa9.2420subunit, liverM305 A6H-X15940ribosomal protein L3113.8618M236 G5H-X15949interferon regulatory factor 2,38.554.0 kDaBINDS AND REPRESSESREGULATORY REGION OFTYPE I IFN AND IFN-INDUCIBLE MHC CLASS IGENES.M236 C2H-X16064translationally-controlled tumor19.0335proteinM512 B5H-X16323Hepatocyte growth factor80.19100.0 kDa (hepapoietin A)M315 C3H-X16461cell division cycle 2, G1 to S and32.7840G2 to M [CDC2]M297 G2H-X16832cathepsin H36.9645.0 kDaM271 B1H-X16983integrin, alpha 4 (CD49D, alpha 4114.29114subunit of VLA-4 receptor)[ITGA4], IMPORTANT FORCELL-CELL ADHESIONFUNCTION.M270 A7H-X17025plasminogen activator-inducible25.1934c54, Human homolog of yeast IPPisomeraseM302 C3H-X17042proteoglycan 1, secretory granule17.4926B1H-X17206ribosomal protein S224.4245B4H-X17254Transcription factor Eryf145.5453M311 H2H-X17610beta-1-glycoprotein, pregnancy-46.9748.0 kDaspecific (GB: X17610)M315 D1H-X17644G1 to S phase transition protein5555(GST1)M340 G1H-X51415lipase, hormone-sensitive [LIPE]84.5998.0 kDaM464 A7H-X51688Cyclin A47.6347.0 kDaM313 G1H-X51745major histocompatibility complex,40.2650class I, AM297 A2H-X51804putative receptor protein PMI21.2330D4H-X51952Human UCP gene for uncoupling33.8837protein exons 1 and 2M300 B1H-X52011muscle determining factor26.7339M419 G1H-X52479“protein kinase c, alpha type”82.2885.0 kDaA2H-X52486Uracil-DNA glycosylase35.9736E3H-X52520Tyrosine aminotransferase50.0558B1H-X526386-phosphofructo-2-51.9247kinase/fructose-2,6-bisphosphataseM509 C4H-X52730Human gene for31.1335.0 kDaphenylethanolamine N-methylase(PNMT) (EC 2.1.1.28)M235 C5H-X52839ribosomal protein L1715.5118M426 C2H-X52943Human mRNA for ATF-a53.2464.0 kDatranscription factorM266 G5H-X53777ribosomal protein L2320.3531B4H-X53961Lactotransferrin78.3278M462 C6H-X54150Fc fragment of IgA, receptor for31.6837.0 kDaM302 A6H-X54304myosin, light polypeptide 2,18.9232.0 kDaregulatoryM311 G2H-X54802cytochrome-c oxidase, IV subunit18.723.0 kDaM270 H3H-X54871guanine nucleotide-binding23.7633.0 kDaprotein Rab5B, ras-oncogenerelated [RAB5B], PROTEINTRANSPORT. PROBABLYINVOLVED IN VESICULARTRAFFIC (BYSIMILARITY): M313 B6H-X54936placenta growth factor [PLGF*]16.522.0 kDaM496 B2H-X55079Human lysosomal alpha-104.8398.0 kDaglucosidase gene exon 1D1H-X55330Aspartylglucosaminidase38.1736E1H-X55448H. sapiens G6PD gene for25.4130glucose-6-phosphatedehydrogenaseM421 G6H-X56253Human MPR46 gene for 46 kd30.5852.0 kDamannose 6-phosphate receptor169-89H-X5646814-3-3 protein tau3427.02M300 B4H-X56549fatty-acid-binding protein, muscle14.7417M298 D2H-X56740guanine nucleotide-binding23.8731.0 kDaprotein rab11 [RAB11*]M266 E5H-X56932highly basic protein, 23 kDa22.4430.0 kDaM318 G1H-X57025insulin-like growth factor I16.9418M305 F5H-X57348protein kinase C inhibitor27.3935.0 kDaM236 D6H-X57351interferon-induced protein 1-8D14.6324H3H-X57352interferon-induced protein 1-8U14.7438M305 B6H-X58079S-100 protein, alpha chain10.4511E6H-X59131H. sapiens D13S106 mRNA for a34.7650highly charged amino acidsequeneM248 H5H-X59268transcription factor IIB [TCF2B*]34.8749E2H-X59357Epstein-Barr virus small RNA-14.1936associated proteinM236 D4H-X59417macropain, iota subunit, THE27.1736INTERACTION OF CALPONINWITH ACTIN INHIBITSACTOMYOSIN MG-ATPASEACTIVITYM271 H4H-X59618ribonucleotide reductase, small42.946subunitM250 G3H-X59710CAAT-box DNA-binding protein,22.6634subunit B, CCAAT-BINDINGTRANSCRIPTION FACTORSUBUNIT A [Homo sapiens]M423 E2H-X59711Nuclear transcription factor Y,38.2848.0 kDaalphaM271 C7H-X59798Cyclin D1 (PRAD1; parathyroid32.5640.0 kDaadenomatosis 1). ESSENTIALFOR THE CONTROL OF THECELL CYCLE AT THE G1/S(START) TRANSITION.M270 H5H-X59834calmodulin41.1453.0 kDaM416 D5H-X59871Transcription factor 7 (T-cell29.5936.0 kDaspecific)M485 D6H-X60036Phosphate carrier, mitochondrial39.8237.0 kDaM250 D4H-X60489translation elongation factor 1,24.8633.0 kDabetaF5H-X60592Human CDw40 mRNA for nerve30.5846growth factor receptor-related B-lymphocyte activation moleculeM312 F3H-X61587ras-related rhoG21.1221.0 kDaF9H-X61622cyclin-dependent kinase 232.8956[CDK2]M313 E3H-X61970macropain, zeta subunit26.6235.0 kDaM428 D1H-X62055tyrosine phosphatase, non-65.7866.0 kDareceptor type 6M248 C4H-X62534high mobility group protein 2,23.137BINDS PREFERENTIALLYSINGLE-STRANDED DNAAND UNWINDS DOUBLESTRANDED DNA.M305 F3H-X62753folate-binding protein28.3836M476 G2H-X63468H. sapiens mRNA for transcription48.453.0 kDafactor TFIIE alphaG6H-X63469General transcription factor TFIIE32.1256beta subunit, 34 kDG4H-X63522H. sapiens mRNA DAUD16 for58.7454retinoic acid X receptor bM316 G2H-X63526translation elongation factor 1,48.1852.0 kDagammaM305 C5H-X63527ribosomal protein L1921.6733E2H-X63629Cadherin 3 (P-cadherin)91.3110D4H-X64037-2General transcription factor IIF,56.9864polypeptide 1 (74 kD subunit)M302 C6H-X64559tetranectin22.3332.0 kDaM271 H1H-X64728choroideremia-like [CHML],72.2798H. sapiens CHML mRNAM270 E1H-X64810proprotein convertase82.9490subtilisin/kexin type 1 [PCSK1],INVOLVED IN PROCESSINGOF HORMONE AND OTHERPROTEIN PRECURSORSM311 F4H-X64877complement factor H-related29.8136.0 kDaproteinM388 D1H-X65293protein kinase C, epsilon81.1896.0 kDa[PRKCE]B5H-X65873kinesin, heavy polypeptide106.0434F4H-X66079Spi-B transcription factor (Spi-28.93541/PU.1 related)F3H-X661142-oxoglutarate carrier protein037[OGMT*]M305 C6H-X66141myosin, light polypeptide 2,18.3731regulatory, ventricularM419 H1H-X66357cell division protein kinase 333.62044.0 kDa166-13H-X66358serine/threonine-protein kinase4539.45KKIALRE166-25H-X66360serine/threonine-protein kinase6057.60PCTAIRE-2M419 A2H-X66363serine/threonine-protein kinase54.60064.0 kDaPCTAIRE-1166-37H-X66364H. sapiens mRNA PSSALRE for3832.19serine/threonine protein kinaseM419 B2H-X66365cell division protein kinase 635.90046.0 kDaH3H-X66839H. sapiens MaTu MN mRNA for50.654p54/58N proteinM266 G3H-X67325interferon, alpha-inducible gene13.5313p27M462 H7H-X67594Melanocortin 1 receptor (alpha34.9844.0 kDamelanocyte stimulating hormonereceptor)M236 C5H-X67951Proliferation-associated gene A2234(natural killer-enhancing factorA), PAGAH3H-X68486Adenosine receptor A245.4345M429 E3H-X68561Sp4 transcription factor86.3586.0 kDaM430 F2H-X69151ATP synthase, H+ transporting,42.1358.0 kDasubunit C, vacuolarM236 C3H-X69392ribosomal protein L2616.0629B3H-X69532H. sapiens gene for inter-alpha-100.3298trypsin inhibitor heavy chain H1,exons 1-3M236 F5H-X69654ribosomal protein S2612.7618M421 C8H-X70218Protein phosphatase 4 (formerly33.88X), catalytic subunitM266 H5H-X70848protein phosphatase 1, alpha36.4137catalytic subunitE1H-X70940Eukaryotic translation elongation51.0460factor 1 alpha 2M270 F1H-X72215[PIT1], POU domain, class 1,32.1240.0 kDatranscription factor 1 (Pit1,growth hormone factor 1)M271 A7H-X72760Laminin, beta 2 (laminin S), S-67.8775.0 kDaLAMININ IS A LAMININ-LIKEADHESIVE PROTEINCONCENTRATED IN THESYNAPTIC CLEFT OF THENEUROMUSCULARJUNCTION.M235 B1H-X72841Human retinoblastoma-binding46.8652.0 kDaprotein (RbAp46) mRNA,complete cds, IEF 7442(GB: X72841)217-25H-X73428DNA-binding protein inhibitor2017.08ID-3M305 B5H-X73459signal recognition particle,15.0720subunit 14M250 D6H-X73460ribosomal protein L3, isoform 2,44.4450.0 kDaCOMPONENT OF THE LARGESUBUNIT OF CYTOPLASMICRIBOSOMESM462 D8H-X74008Protein phosphatase 1, catalytic35.6446.0 kDasubunit, gamma isoformM266 G2H-X74104Signal sequence receptor, beta;20.2427translocon-associated protein,beta subunitM266 E7H-X74262retinoblastoma binding protein46.8650.0 kDaRbAp48H1H-X74330DNA primase polypeptide 146.3151(49 kD)M313 F3H-X74570gal beta (1-3/1-4) GlcNAc alpha-36.346.0 kDa2,3 sialyltransferase (GB: X74570)M429 H3H-X74764H. sapiens mRNA for receptor94.12098.0 kDaprotein tyrosine kinaseM271 E6H-X75042V-rel avian reticuloendotheliosis68.288viral oncogene homologM305 G2H-X75252phosphatidylethanolamine-20.6830binding proteinM302 G1H-X75593guanine nucleotide-binding22.4432.0 kDaprotein rab13166-49H-X75958H. sapiens trkB mRNA for5552.54protein-tyrosine kinaseC4H-X76013H. sapiens QRSHs mRNA for85.3685glutaminyl-tRNA synthetaseA2H-X76029H. sapiens mRNA for neuromedin U19.2520M305 D5H-X76228ATP synthase, H+transporting,24.9736subunit E, vacuolarM298 F6H-X76648glutaredoxin11.7711.0 kDaM311 A4H-X76717metallothionein 116.8214C4H-X77533H. sapiens mRNA for activin type56.4361II receptorH2H-X77548H. sapiens cDNA for RFG67.6567169-41H-X77743H. sapiens CDK activating kinase4538.13mRNAA4H-X77909H. sapiens IKBL mRNA42.0252M305 C1H-X78136heterogeneous nuclear40.2640.0 kDaribonucleoprotein E2M306 G2H-X78416casein, alpha [CSN1]20.4633M271 C2H-X78678ketohexokinase (fructokinase)32.8939[KHK], H. sapiens KHK mRNAfor ketohexokinase, clonepHKHK3aM305 D4H-X79193cyclin-dependent kinase 738.1735(homolog of Xenopus MO15 cdk-activating kinase) [CDK7]M431 F2H-X79389glutathione S-transferase T126.5134.0 kDaM298 C6H-X79537glycogenin30.834.0 kDaM440 C1H-X79865H. sapiens Mrp17 mRNA21.8931.0 kDaM298 F5H-X80229protein kinase PKN52.864.0 kDa167-39H-X80230H. sapiens mRNA (clone C-2k)4240.99mRNA for serine/threonineprotein kinase217-49H-X80343H. sapiens p35 mRNA for4033.84regulatory subunit of cdk5 kinaseM270 D7H-X80695cytochrome oxidase-assembly47.9650protein, OXA1, H. sapiensOXA1Hs mRNAM266 B5H-X80909nascent polypeptide-associate23.7637.0 kDacomplex, alphaM416 D9H-X80910Protein phosphatase 1, catalytic36.0845.0 kDasubunit, beta isoformE2H-X81198Archain52.0363169-6H-X81817H. sapiens BAP31 mRNA3227.13E4H-X82018H. sapiens mRNA for ZID protein46.7557M313 D7H-X82456MLN5028.8233A2H-X82629H. sapiens mRNA for Mox-233.4442M236 D1H-X83006lipocalin, neutrophil gelatinase21.8934.0 kDaassociated166-40H-X83107H. sapiens Bmx mRNA for7574.32cytoplasmic tyrosine kinaseE3H-X83425H. sapiens LU gene for Lutheran69.1959blood group glycoproteinC6H-X83703H. sapiens mRNA for cytokine35.254inducible nuclear proteinM416 H2H-X83928H. sapiens mRNA for transcription23.3233.0 kDafactor TFIID subunit TAFII28166-17H-X85106H. sapiens mRNA for ribosomal9080.70S6 kinase166-39H-X85337H. sapiens mRNA for myosin light110109.0chain kinaseD2H-X85750H. sapiens mRNA for transcript26.2930associated with monocyte tomacrophage differentiationM266 E6H-X8717617-beta-hydroxysteroid81.0765dehydrogenase, type 4M297 F2H-X87689CLCP23.2133.0 kDaM300 A2H-X87843cyclin H assembly factor34.147M271 E3H-X89750homeotic protein, TGIF,30.0332.0 kDaH. sapiens mRNA for TGIFproteinM235 G1H-X90529guanine nucleotide-binding34.5440protein ragA [RAGA]M302 E6H-X90583translocon-associated protein,19.1428.0 kDadeltaM306 G1H-X90872gp251223.6533M416 D2H-X91504Transcription factor COUP 222.2232.0 kDa(a.k.a. ARP1)M250 B3H-X92098transmembrane protein rnp2422.2230M271 G7H-X92106bleomycin hydrolase.50.1655.0 kDaPROTECTING NORMAL ANDMALIGNANT CELLS FROMBLM TOXICITY.F3H-X92715Zinc finger protein 74 (Cos52)63.0347M270 H6H-X92720H. sapiens mRNA for70.5171phosphoenolpyruvatecarboxykinaseH5H-X92762H. sapiens mRNA for tafazzins32.2337proteinM298 D3H-X93036MAT-89.6816.0 kDaM476 A5H-X93595H. sapiens mRNA for NK receptor50.1656.0 kDa(clone 17.1C)M417 D2H-X93920protein tyrosine phosphatase41.98048.0 kDaforeskinA5H-X95592H. sapiens mRNA for C1D protein15.6228M298 B4H-X95648translation initiation factor 2B,33.6634.0 kDaalpha subunitF3H-X95735H. sapiens mRNA for zyxin 263.0372M386 B1H-X96752L-3-hydroxyacyl-CoA34.6545.0 kDadehydrogenase, SCHAD geneM422 B6H-X97229H. sapiens mRNA for NK41.5848.0 kDareceptor, clone library 15.212B3H-X98173H. sapiens mRNA for MACH-51.1551alpha-2 protein166-14H-X99325H. sapiens mRNA for Ste20-like5546.93kinaseC4H-X99459H. sapiens mRNA for sigma 3B21.3430proteinM424 C4H-Y00291Human hap mRNA encoding a49.3959.0 kDaDNA-binding hormone receptorM386 H1H-Y00345polyadenylate-binding protein69.7470.0 kDaM469 A2H-Y00630Plasminogen activator inhibitor,45.7646.0 kDatype II (arginine-serpin)M305 E1H-Y00711lactate dehydrogenase B36.8538.0 kDaH2H-Y00764ubiquinol/cytochrome c reductase10.1233hinge proteinF5H-Y07848H. sapiens EWS, gar22, rrp22 and36.350bam22 genesM305 G6H-Z11559iron-responsive element binding97.998protein 1 [IREB1]M250 F3H-Z11566Pr22 protein , STATHMIN16.522.0 kDa[Homo sapiens], SERVES ASRELAY (VIAPHOSPHORYLATION) FORDIVERSE SECONDMESSENGER PATHWAYS169-73H-Z11695H. sapiens 40 kDa protein kinase5038.35related to rat ERK2M475 C8H-Z11737Flavin-containing61.4970.0 kDamonooxygenase 4C1H-Z11898Octamer binding protein 339.7150M266 H4H-Z12830SSR, alpha subunit31.5742.0 kDaA3H-Z14000Ring finger protein 141.5850M300 E1H-Z14978actin-related protein41.4749G1H-Z19002H. sapiens of PLZF gene encoding74.1484kruppel-like zinc finger proteinH1H-Z21966POU homeobox protein33.2243M248 G3H-Z23139CLASS II29.0434HISTOCOMPATIBILITYANTIGEN, M BETA CHAINPRECURSOR [Homo sapiens]D3H-Z26876ribosomal protein L387.8135F2H-Z28339H. sapiens mRNA for delta 4-3-35.9743oxosteroid 5 beta-reductaseM298 B3H-Z28407ribosomal protein L828.3839.0 kDaM313 C3H-Z29330ubiquitin-conjugating enzyme20.2434UbcH2, 23 kDaM271 F3H-Z29677guanine nucleotide-binding20.3528.0 kDaprotein, ras-relatedM465 C2H-Z30425H. sapiens mRNA for orphan38.3934.0 kDanuclear hormone receptorM302 F5H-Z31357cysteine dioxygenase22.1131.0 kDaM340 C1H-Z31695inositol polyphosphate 5-40.0449.0 kDaphosphatase, 43 kDaE3H-Z32564-2H. sapiens FRGAMMA mRNA26.8436(819 bp) for folate receptorM236 H1H-Z35227small G protein, TTF, RAS-21.1230.0 kDaRELATED PROTEIN RAC1A10H-Z35491H. sapiens mRNA for novel30.2560glucocorticoid receptor-associatedproteinM440 G5H-Z37986H. sapiens mRNA for25.4128.0 kDaphenylalkylamine binding proteinM297 E2H-Z47087cyclin A/cyclin-dependent kinase18.0430.0 kDa2-associated p19F1H-Z48051H. sapiens gene for myelin27.2831oligodendrocyte glycoprotein(MOG)A2H-Z48475Glucokinase regulator68.8670M302 E4H-Z48570sperm zona pellucida-binding16.7224proteinM266 A2H-Z68907Human clone ID 193225 NAD43.3445.0 kDa(H)-specific isocitratedehydrogenase gamma subunitmRNA, alternatively spliced,partial cdsG1H-Z83850Human DNA sequence from PAC45.766082J11 and cosmid U134E6 onchromosome Xq22. Contains NIKlike and Thyroxin-bindingglobulin precursor (T4-bindingglobulin, TBG) genes, ESTs andSTSsH4H-Z97171Homo sapiens GLC1A (trabecular55.5555meshwork induced glucocortcoidresponse) gene, exon I, joinedCDSM421 D5H-Z97632Human DNA sequence from PAC28.4938.0 kDa196E23 on chromosome Xq26.1-27.2. Contains the TAT-SF1(HIV-1 transcriptional elongationfactor TAT cofactor TAT-SF1)gene, the BRS3 (BombesinReceptor subtype-3 (UterineBombesin Receptor, BRS-3)gene, an unknown gene codingfor two isoforms, a predicted CpGisland, ESTs and STSs



Example 3


Construction of Expression Plasmids

[0080] The following example illustrates the construction of the expression vectors used in the Examples above. Similar modifications can be made in other vectors for use in creating libraries of expressible gene sequences.


[0081] The vector pcDNA3.1/V5-His was obtained from Invitrogen (cat #V810-20) and modified slightly so that it carried an gene sequence for Zeocin™ resistance and lacked the multiple cloning site. A 100 μg aliquot was suspended in 200 μl medical irrigation (MI) water. A 5 μi aliquot was saved for gel analysis. The remainder was transfered to a 1.7 ml eppendorf tube. The vector was digested with HindIII (400 U) using Promega Buffer E (final volume=400 pi). The reaction ran 3 hours at 37° C. An aliquot was checked for completeness of digestion by running on an 0.8% agarose gele in 1×TAE, and visualizing with ethidium bromide.


[0082] The digested vector was treated with 200 μl phenolchloroform (pH 7.5) according to standard procedures, and the DNA precipitated from the aqueous phase using {fraction (1/10)} volume 3M NaOAc and 2 volumes 100% EtOH at room temperature, followed by washing with 80% EtOH. The pellet was resuspended in 100 μl MI water.


[0083] Two oligonucleotides were added to the resuspended DNA (Topo-H (40 pg) 5′-(P)AGCTCGCCCTTATTCCGATAGTG (SEQ. ID. NO.: 3), Topo-4 (12 μg) 5′-(P)AGGGCG (SEQ. ID. NO.: 4)), plus 17 μl 10×Promega T4 Ligase buffer. The tube was placed on ice and the volume increased to 170 μl with MI water. The oligos were ligated to the vector using 20U Promega T4 DNA ligase, incubated at 12° C. overnight.


[0084] The vector was treated with 100 μl phenol/chloroform and the aqueous phase precipitated as described above. The pelleted DNA was resuspended in 150 μl of steril water the redigested with HindIII (17 μl Promega Buffer E, 200 U HindIII −37° C., 1 hour). The redigested DNA was re-extracted with phenol/chloroform and precipitated with {fraction (1/10)} volume 3M NaOAc and {fraction (7/10)} volume isopropanol, then washed with 80% EtOH.


[0085] The pelleted DNA was resuspended in 82 μl TE buffer (10 mM Tris, pH 8.0, 1 mM EDTA, pH 8.0). A 2 μl aliquot was used to check the foregoing procedure using agorose gel electrophoresis as described above. The remaining 80 μl was transfered to a Falcon tube and mixed with 16 μg Topo-5 oligonucleotide (5′-(P)CAACACTATCGGAATA (SEQ ID NO: 5). To this mixture was added 190 μl NEB Restriction Buffer #1 (room temperature). The total reaction mixture was adjusted to 1.9 mls with MI water. Vaccinia Topoisomerase I enzyme was added (80 μg) and the reaction tube placed in a 37° C. water bath for 15 minutes.


[0086] After 15 minutes, 200 μl of room temperature Topo-10×stop buffer was added (100 mM Tris 7.4, 110 mM EDTA, bromophenol blue). The entire volume was loaded onto an agarose gell (1.2 gr agarose/130 mls 1×TAE) and run at 70 volts until the bromophenol blue dye had run down about ½ in (volume in the loading well was kept constant by the addition of 1×TE). The voltage was reversed for 90 seconds. The contents of the loading well were transfered to a 15 ml Falcon tube and placed on ice. 2 mls of cold Topo-2×Wash Buffer (60 mM Tris 7.4, 1 mM EDTA, 4 mM dithiothreitol (DTT), 200 μg/ml bovine serum albumin (BSA)) was added and the volume then adjusted to 4 mls with cold Topo-1×Enzyme Dilution Buffer (50% glycerol, 50 mM Tris 7.4, 1 mM EDTA, 2 mM DTT, 0.1% Triton X-100, 100 μg.ml BSA) plus 4 mls Topo-Glycerol mix (90% glycerol, 10% 50 mM TE pH 7.4, 0.1% Triton X-100) and stored until needed.


[0087] A similar procedure was used to make Topo-adapted pYES2 (Invitrogen cat #V825-20).


[0088] While the foregoing has been presented with reference to particular embodiments of the invention, it will be appreciated by those skilled in the art that changes in these embodiments may be made without departing from the principles and spirit of the invention, the scope of which is defined by the appended claims.


Claims
  • 1. A nucleic acid construct comprising 1) a gene sequence encoding a protein listed in Table 1 or an ORF listed in Table 2 and 2) an expression vector.
  • 2. A nucleic acid construct according to claim 1 wherein the expression vector comprises one or more elements selected from: a promoter-enhancer sequence, a selection marker sequence, an origin of replication, an epitope-tag encoding sequence or an affinity purification-tag encoding sequence.
  • 3. A nucleic acid construct according to claim 2 wherein the promoter-enhancer sequence is the T7 promoter, gall promoter, metallothionein promoter, AraC promoter, or CMV promoter-enhancer.
  • 4. A nucleic acid construct according to claim 2 wherein the selection marker sequence encodes an antibiotic resistance gene.
  • 5. A nucleic acid construct according to claim 2 wherein the epitope-tag sequence encodes V5, the peptide Phe-His-His-Thr-Thr, hemaglutinin, or glutathione-S-transferase.
  • 6. A nucleic acid construct according to claim 2 wherein the affinity purification-tag sequence encodes a polyamino acid sequence or a polypeptide.
  • 7. A nucleic acid construct according to claim 6 wherein said polyamino acid sequence is polyhistidine.
  • 8. A nucleic acid construct according to claim 6 wherein said polypeptide is chitin binding domain or glutathione-S-transferase.
  • 9. A nucleic acid construct according to claim 6 wherein said polypeptide encoding sequence includes an intein encoding sequence.
  • 10. A nucleic acid construct according to claim 1 wherein the expression vector is a eukaryotic expression vector or a prokaryotic expression vector.
  • 11. A nucleic acid construct according to claim 10 wherein the eukaryotic expression vector is pYES2/GS, pMT, pIND, or pcDNA3.1/GS.
  • 12. A nucleic acid construct according to claim 1 wherein the protein is selected from the group of proteins listed as number 1 through number 20 in Table 1.
  • 13. A nucleic acid construct according to claim 1 wherein the protein is selected from the group of proteins listed as number 21 through number 40 in Table 1.
  • 14. A nucleic acid construct according to claim 1 wherein the protein is selected from the group of proteins listed as number 41 through number 60 in Table 1.
  • 15. A nucleic acid construct according to claim 1 wherein the protein selected from the group of proteins listed as number 61 through number 80 in Table 1.
  • 16. A nucleic acid construct according to claim 1 wherein the protein is selected from the group of proteins listed as number 81 through number 100 in Table 1.
  • 17. A nucleic acid construct according to claim 1 wherein the protein is selected from the group of proteins listed as number 101 through number 118 in Table 1.
  • 18. A nucleic acid construct according to claim 1 wherein the construct comprises an ORF listed in Table 2.
  • 19. A recombinant cell comprising a nucleic acid construct of claim 1.
  • 20. A recombinant cell of claim 19 wherein the cell is a non-adherent cell.
  • 21. A recombinant cell of claim 20 wherein the non-adherent cell is a bacterial cell, a yeast cell, plant cell, an insect cell or a mammalian cell.
  • 22. A recombinant cell of claim 21 wherein the mammalian cell is CHO or 32D.
  • 23. A method of producing recombinant protein, said method comprising: (a) growing recombinant cells comprising a nucleic acid construct of claim 1 under suitable growth conditions; and (b) isolating the recombinant protein expressed thereby.
  • 24. A method according to claim 23 wherein the nucleic acid construct comprises an epitope-tag encoding sequence and the isolation step utilizes an antibody specific for said epitope-tag.
  • 25. A method according to claim 24 wherein the nucleic acid construct comprises a polyamino acid encoding sequence and the isolation step utilizes a resin comprising a polyamino acid binding substance.
  • 26. A method according to claim 23 wherein the nucleic acid construct comprises a polypeptide encoding sequence and the isolation step utilizes a resin comprising a polypeptide binding substance.
  • 27. A method according to claim 25 wherein the polyamino acid is polyhistidine and the polyamino binding resin is nickel-charged agarose resin.
  • 28. A method according to claim 26 wherein the polypeptide is chitin binding domain and the resin comprises chitin-Sepharose.
  • 29. A kit comprising a plurality of expression constructs, wherein each expression construct comprises a gene sequence encoding a protein listed in Table 1 and an expression vector.
  • 30. A kit according to claim 29 wherein the expression vector is pYES2/GS or pcDNA3.1/GS.
  • 31. A kit comprising a plurality of recombinant cells, wherein each cell comprises a gene sequence encoding a protein listed in Table 1 and an expression vector.
  • 32. A kit according to claim 31 wherein the expression vector is pYES2/GS or pcDNA3.1/GS and the recombinant cell is a yeast cell or a mammalian cell.
  • 33. A kit according to claim 32 wherein the mammalian cell is a CHO cell.
  • 34. A kit comprising a plurality of expression constructs, wherein each expression construct comprises an ORF listed in Table 2 and an expression vector.
  • 35. A kit according to claim 34 wherein the expression vector is pYES2/GS or pcDNA3.1/GS.
  • 36. A kit comprising a plurality of recombinant cells, wherein each cell comprises an ORF listed in Table 2 and an expression vector.
  • 37. A kit according to claim 36 wherein the expression vector is pYES2/GS or pcDNA3.1/GS and the recombinant cell is a yeast cell or a mammalian cell.
  • 38. A kit comprising one or more of: expression construct(s) comprising a gene sequence encoding a protein listed in Table 1 and an expression vector; recombinant cells comprising an expression construct comprising a gene sequence encoding a protein listed in Table 1 and an expression vector; and an isolated protein listed in Table 1 or an antibody specific for said isolated protein.
  • 39. A binding partner of an expressed gene product of a gene sequence listed in Table 1.
  • 40. A binding partner of an expressed gene product of a gene sequence listed in Table, 2.
RELATED APPLICATIONS

[0001] This application relies for priority on U.S. Provisional Application No. 60/080,626, filed Apr. 3, 1998, and U.S. Provisional Application No. 60/096,981, filed Aug. 18, 1998, each of which is hereby incorporated herein in its entirety.

Provisional Applications (2)
Number Date Country
60096981 Aug 1998 US
60080626 Apr 1998 US
Continuations (2)
Number Date Country
Parent 10003021 Nov 2001 US
Child 10210985 Aug 2002 US
Parent 09285386 Apr 1999 US
Child 10003021 Nov 2001 US